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Abstract 
Acquired urinary incontinence in the canine is a distressing and debilitating condition 
affecting up to 20% of neutered bitches, whilst less than 1% of entire bitches and males 
suffer from this condition.  Although a number of medical and surgical therapies exist for 
treatment of acquired urinary incontinence, none are able to cure the condition and many 
animals become refractory to treatment over time.  It has long been thought that a decrease 
in resting tone within the urethra of a bitch following neutering is responsible for the 
development of acquired urinary incontinence; however, recent studies show that low 
urethral tone does not always lead to urinary incontinence, suggesting further factors must 
be involved.  Although the exact aetiology and pathophysiology of the condition in the 
neutered bitch is unknown, it is thought to have many similarities to that of post 
menopausal urinary incontinence in women.  In this condition, urinary incontinence is 
known to be mediated primarily by changes in the structure and function of the urinary 
bladder post menopause.  The present study looks at the structure and function of the 
canine urinary bladder in vitro to determine if changes occur post neutering that could lead 
a bitch to develop acquired urinary incontinence and which may provide novel therapeutic 
targets for treatment of this disease.  
Contractility in response to carbachol (muscarinic) and electrical field stimulation was 
assessed in isolated strips of detrusor muscle from male and female, intact and 
gonadectomised canines.  The potential role of non-adrenergic, non-cholinergic mediated 
contraction of the detrusor muscle was also examined and this system does not appear to 
be significantly altered by gonadectomy.  Maximal contractile responses were, however, 
decreased in detrusor strips from neutered compared to entire canines regardless of gender, 
with detrusor strips from incontinent bitches having some of the weakest responses.  
Sensitivity to carbachol was also decreased in detrusor strips from neutered compared to 
entire canines.  This suggests a decrease in contractile function of the urinary bladder in 
neutered canines and is similar to that seen in the bladders of women suffering from 
urinary incontinence post-menopause due to impaired contractility of the bladder and 
idiopathic detrusor instability.  This suggests that changes in the function of the bladder 
post neutering may be partly responsible for the development of acquired urinary 
incontinence in the bitch. 
Post-menopausal urinary incontinence in women is hypothesised to be a linked to an 
increase in the collagen to smooth muscle ratio within the wall of the urinary bladder 3 
which is thought to impair bladder contractility and lead to the development of detrusor 
instability.  Morphometric analysis of the urinary bladder wall of canines showed that the 
percentage of collagen within this organ was significantly increased in neutered compared 
to entire bitches, with incontinent bitches having some of the highest percentage collagen.  
The percentage of collagen was unchanged in neutered compared to entire males which 
were similar to entire bitches.  These results support the long postulated theory that a 
decrease in oestrogen following gonadectomy / menopause is involved in the increase of 
collagen within the bladder. 
Results describing the pharmacological characterisation of muscarinic receptors (Schild 
analysis of pKB values) in strips of canine detrusor muscle suggest that the M3 receptor is 
the primary receptor responsible for bladder contraction in entire canines in vitro but that 
the M2 receptor predominates in neutered canines.  This previously unreported finding 
could be significant in providing a novel therapeutic target to treat this debilitating disease. 
Studies that looked at mRNA expression for the muscarinic as well as the LH and GnRH 
receptors in canine bladder wall showed that there was an increase in expression of all 
receptors in tissue from neutered compared to entire canines and that tissue from females 
had higher expression levels than that from their male counterparts.  It is known that 
gonadotrophin levels in the blood increase post neutering, and that decreasing these levels 
can provide continence in a number of animals.  It is therefore possible, that an up-
regulation of mRNA expression for these receptors is involved in the changes at the level 
of the detrusor that could lead to development of acquired urinary incontinence.  It is also 
acknowledged that the muscarinic pathway is the primary pathway responsible for bladder 
contraction and emptying, therefore, a change in the expression of muscarinic receptors has 
the potential to alter bladder contractility as demonstrated previously.   
In conclusion these studies have shown that the structure and function of the urinary 
bladder of a neutered canine is altered compared to that of an entire canine, and that these 
changes have the potential to be involved in the development of acquired urinary 
incontinence in the bitch.  Many of these changes mimic those seen in the bladders of post 
menopausal women suffering from urinary incontinence, thus suggesting that there may be 
commonality of disease process between the two species which may allow the use of the 
canine as a model of human urinary incontinence.  This data, the first to include male 
animals in the study of bladder function and structure, suggest that the loss of oestrogen in 
the female and the concurrent increase in percentage collagen within the urinary bladder 
are not significant factors in the development of decreased detrusor contractility per se.  On 4 
the contrary these results suggest that the muscarinic receptor effector pathway may play a 
crucial role in the development of altered bladder contractility and acquired urinary 
incontinence, and may provide a therapeutic target for effective treatment of this disease.5 
Table of Contents 
Abstract.............................................................................................................................2 
List of Tables.....................................................................................................................8 
List of Figures....................................................................................................................9 
List of Figures....................................................................................................................9 
Acknowledgement...........................................................................................................12 
Author’s declaration ........................................................................................................13 
Abbreviations ..................................................................................................................14 
1  Introduction .............................................................................................................15 
1.1  Overview of Urinary Incontinence....................................................................15 
1.2  Prevalence of Urinary Incontinence..................................................................17 
1.3  Clinical Signs and Complications Associated with Urinary Incontinence..........19 
1.4  Urodynamic Categorisation of Urinary Incontinence........................................21 
1.4.1  In the Woman...........................................................................................21 
1.4.2  In the Man................................................................................................24 
1.4.3  In the Bitch...............................................................................................25 
1.4.4  In the Dog.................................................................................................26 
1.5  The Anatomy of the Urinary Bladder and Urethra ............................................27 
1.6  Innervation of the Lower Urinary Tract............................................................35 
1.7  Cellular Basis of Contraction............................................................................37 
1.8  Muscarinic Receptors of the Urinary Bladder...................................................40 
1.9  Adrenoceptors in the Urinary Bladder ..............................................................44 
1.10  Non-Adrenergic, Non-Cholinergic Mechanisms of Bladder Control.................46 
1.11  Reproductive Hormones in the Woman ............................................................48 
1.12  Reproductive Hormones in the Bitch................................................................52 
1.12.1  The Role of Reproductive Hormones in Urinary Incontinence in the Bitch55 
1.13  An Overview of the Treatment Options for Urinary Incontinence.....................57 
1.14  Conclusions and Aims......................................................................................63 
2  Validation of Equipment and Protocols....................................................................64 
2.1  Introduction......................................................................................................64 
2.2  Materials and Methods .....................................................................................65 
2.2.1  Animals....................................................................................................65 
2.2.2  Preparation of Tissue................................................................................65 
2.2.3  Carbachol Concentration Response Protocol.............................................66 
2.2.4  KCl Concentration Response Protocol......................................................67 
2.2.5  Electrical Field Stimulation Protocol.........................................................67 
2.2.6  Data Analysis ...........................................................................................68 
2.3  Results .............................................................................................................69 
2.4  Discussion and Conclusion...............................................................................71 
3  Validation of Canine Tissue Bath Protocols .............................................................73 
3.1  Introduction......................................................................................................73 
3.2  Materials and Methods .....................................................................................75 
3.2.1  Animals....................................................................................................75 
3.2.2  Preparation of Tissue................................................................................75 
3.2.3  Assessment of Carbachol-Induced Contraction.........................................76 
3.2.4  Assessment of KCl-Induced Contraction...................................................76 
3.2.5  Data Analysis ...........................................................................................77 
3.3  Results .............................................................................................................78 
3.4  Discussion and Conclusion...............................................................................83 
4  Effects of Neutering on the in vitro Responses of Canine Detrusor Muscle Strips to 
KCl, Carbachol and Electrical Stimulation...............................................................87 
4.1  Introduction......................................................................................................87 6 
4.2  Materials and Methods .....................................................................................90 
4.2.1  Animals....................................................................................................90 
4.2.2  Preparation of Tissue................................................................................90 
4.2.3  Assessment of KCl-Induced Contraction...................................................91 
4.2.4  Basic Carbachol Concentration Response Protocol ...................................91 
4.2.5  Basic Neurogenic Electrical Field Stimulation Protocol............................91 
4.2.6  Non-Adrenergic, Non-Cholinergic Neurogenic Electrical Field Stimulation 
Protocol....................................................................................................92 
4.2.7  Data Analysis ...........................................................................................92 
4.3  Results .............................................................................................................93 
4.3.1  Response to KCl Stimulation....................................................................93 
4.3.2  Response to Carbachol Stimulation...........................................................94 
4.3.3  Response to Neurogenic Field Stimulation................................................96 
4.3.4  The Non-Adrenergic, Non-Cholinergic System.........................................98 
4.4  Discussion......................................................................................................100 
5  Morphometric Analysis of the Canine Urinary Bladder – The Effect of Neutering on 
Percentage Collagen...............................................................................................106 
5.1  Introduction....................................................................................................106 
5.2  Materials and Methods ...................................................................................108 
5.2.1  Animals..................................................................................................108 
5.2.2  Preparation of Tissue..............................................................................108 
5.2.3  Morphometric Analysis ..........................................................................109 
5.2.4  Statistical Analysis..................................................................................109 
5.3  Results ...........................................................................................................111 
5.4  Discussion......................................................................................................114 
6  Pharmacological Characterisation of Muscarinic Receptors in Canine Urinary Bladder
  ..............................................................................................................................118 
6.1  Introduction....................................................................................................118 
6.2  Materials and Methods ...................................................................................120 
6.2.1  Animals..................................................................................................120 
6.2.2  Preparation of Tissue..............................................................................120 
6.2.3  Muscarinic Antagonist Preparations........................................................121 
6.2.4  Carbachol Concentration Response Protocol with Muscarinic Antagonists ...
  ...............................................................................................................121 
6.2.5  Data Analysis .........................................................................................122 
6.3  Results ...........................................................................................................123 
6.4  Discussion......................................................................................................129 
7  Effects of Acute Incubation with Reproductive Hormones on In Vitro Responses of 
Canine Detrusor Muscle Strips to Muscarinic and Electrical Stimulation................135 
7.1  Introduction....................................................................................................135 
7.2  Materials and Methods ...................................................................................138 
7.2.1  Animals..................................................................................................138 
7.2.2  Preparation of Tissue..............................................................................138 
7.2.3  Hormone Preparations ............................................................................139 
7.2.4  Carbachol Concentration Response Protocol with GnRH, LH or FSH.....140 
7.2.5  Carbachol Concentration Response Protocol with Oestrogen..................140 
7.2.6  Neurogenic Electrical Field Stimulation Protocol with GnRH, LH or FSH....
  ...............................................................................................................141 
7.2.7  Neurogenic Electrical Field Stimulation Protocol with Oestrogen...........141 
7.2.8  Data Analysis .........................................................................................142 
7.3  Results ...........................................................................................................145 
7.3.1  Acute Effects of Incubation with GnRH, LH or FSH on Responses to 
Carbachol Stimulation ............................................................................145 7 
7.3.2  Effects of Acute Exposure to Elevated GnRH, LH or FSH on Responses to 
Neurogenic Field Stimulation .................................................................146 
7.3.3  Effects of Oestrogen on Detrusor Muscle Responses to Carbachol 
Stimulation.............................................................................................147 
7.3.4  Effects of Oestrogen on Detrusor Muscle Responses to Neurogenic Field 
Stimulation.............................................................................................148 
7.4  Discussion and Conclusion.............................................................................150 
8  mRNA Expression of M1, M2 and M3 Receptors in the Canine Urinary Bladder – 
Effects of Neutering...............................................................................................153 
8.1  Introduction....................................................................................................153 
8.2  Materials and Methods ...................................................................................155 
8.2.1  Animals..................................................................................................155 
8.2.2  Preparation of Tissue..............................................................................155 
8.2.3  mRNA Extraction...................................................................................156 
8.2.4  Reverse Transcription.............................................................................156 
8.2.5  Polymerase Chain Reaction ....................................................................157 
8.2.6  Gel Electrophoresis.................................................................................158 
8.2.7  Purification of DNA from Agarose Gel...................................................158 
8.2.8  DNA Sequencing....................................................................................159 
8.2.9  Real Time PCR.......................................................................................159 
8.2.10  Statistical Analysis..................................................................................160 
8.3  Results ...........................................................................................................162 
8.3.1  PCR for M1, M2 and M3..........................................................................162 
8.3.2  Gels........................................................................................................163 
8.3.3  Sequences...............................................................................................164 
8.3.4  Real Time PCR.......................................................................................166 
8.4  Discussion......................................................................................................173 
9  Neutering affects mRNA expression levels for the LH- and GnRH- receptors in the 
canine urinary bladder............................................................................................176 
9.1  Introduction....................................................................................................176 
9.2  Materials and Methods ...................................................................................178 
9.2.1  Animals..................................................................................................178 
9.2.2  Preparation of Tissue..............................................................................178 
9.2.3  mRNA Extraction...................................................................................179 
9.2.4  Reverse Transcription.............................................................................179 
9.2.5  Real Time PCR.......................................................................................179 
9.2.6  Statistical Analysis..................................................................................179 
9.3  Results ...........................................................................................................180 
9.3.1  Validation of qPCR primer probes combinations to study hormone receptor 
gene expression ......................................................................................180 
9.3.2  Comparison of LH and GnRH receptor gene expression between groups.182 
9.3.3  Real time PCR for FSH receptor mRNA.................................................183 
9.3.4  Relationship between receptor mRNA expression and tissue contractility.....
  ...............................................................................................................183 
9.4  Discussion......................................................................................................186 
10  Thesis Overview ....................................................................................................191 
Appendix  - Publications................................................................................................206 
List of References..........................................................................................................207 8 
List of Tables 
 
 
Table 1-1. Common causes of urinary incontinence in bitches and women.......................16 
 
Table 1-2.  Table showing the main properties and locations of the muscarinic receptor 
subtypes in the mammalian body .....................................................................................41 
 
Table 3-1.  Maximum (Emax) and Log EC50 values for Carbachol and KCl in isolated 
strips of canine detrusor muscle at different resting tensions. ...........................................78 
 
Table 4-1. Maximum (Emax) and Log EC50 values for Carbachol in isolated strips of 
detrusor muscle from entire and neutered male and female canines, and neutered female 
canines known to be suffering from acquired urinary incontinence ..................................95 
 
Table 6-1.  Affinity estimates (pKB) at each concentration for muscarinic antagonists in 
bladder smooth muscle from entire and neutered canines...............................................126 
 
Table 6-2.  Antagonist affinity constants (log affinity constants of pKB values) for 
mammalian muscarinic receptors and for bladder smooth muscle from entire and neutered 
canines.  Data are from a variety of mammalian species (Caulfield et al., 1998).............127 
 
Table 8-1.  Mean ± s.e.mean values for age and weight in groups of entire and neutered 
male and female canines plus neutered females known to be suffering from acquired 
urinary incontinence ......................................................................................................162 
 
Table 8-2.  β-Actin PCR primers....................................................................................163 
 
Table 8-3.  M1 PCR primers...........................................................................................163 
 
Table 8-4.  M3 PCR primers...........................................................................................163 
 
Table 8-5.  Partial sequence of M1 receptor in the canine. ..............................................165 
 
Table 8-6.  Partial sequence of M3 receptor in the canine. ..............................................165 
 
Table 8-7.  β–actin rtPCR primers and probe..................................................................166 
 
Table 8-8.  Canine M1 receptor rtPCR primers and probe...............................................166 
 
Table 8-9.  Canine M2 receptor rtPCR primers and probe...............................................166 
 
Table 8-10.  Canine M3 receptor rtPCR primers and probe.............................................166 
 
Table 9-1.  Mean ± s.e.mean values for age and weight in groups of entire and neutered 
male and female canines and neutered female animals known to be suffering from acquired 
urinary incontinence. .....................................................................................................180 9 
List of Figures 
Figure 1-1.  Schematic showing the link between the urodynamic causes of urinary 
incontinence in women, the clinical signs noted by the patient and the classification of the 
condition..........................................................................................................................22 
 
Figure 1-2.  Radiograph showing a, lateral view of the abdomen of a bitch and b, an 
anterior-posterior view of the abdomen of a woman, demonstrating the normal position of 
the organs of the urinary system.......................................................................................28 
 
Figure 1-3.  Schematic diagram of the bladder and urethra.  The trigone area is marked on 
a cut away diagram viewed from the inside of the bladder in the area shown....................30 
 
Figure 1-4.  Photograph showing the different layers and orientations of the muscle fibres 
that make up the detrusor muscle of the canine bladder....................................................32 
 
Figure 1-5.  Schematic diagram showing the innervation of the lower urinary tract.  SNS is 
the Sympathetic Nervous System, whilst PNS is the Parasympathetic Nervous System....35 
 
Figure 1-6.  Schematic diagram showing the major hormonal events of the average 
menstrual cycle and the phases in which they occur.........................................................49 
 
Figure 1-7.  Schematic summary of hormonal changes considered typical of a non-
pregnant ovarian cycle in a bitch......................................................................................53 
 
Figure 2-1.  Photograph of the tissue bath and electrical stimulator set up........................66 
 
Figure 2-2.  Cumulative dose response curves to a, carbachol and b, KCl in isolated rat 
urinary bladder strips.......................................................................................................69 
 
Figure 2-3.  Frequency response curves in isolated strips of rat bladder............................70 
 
Figure 2-4.  A typical section of trace showing control stimulations and the inhibitory 
effect of tetrodotoxin in isolated strips of rat urinary bladder............................................70 
 
Figure 3-1.  A representative section of trace showing the contractile response to carbachol 
in an isolated strip of canine detrusor muscle...................................................................78 
 
Figure 3-2  A representative section of trace showing the contractile response to KCl in 
isolated strips of canine detrusor muscle. .........................................................................79 
 
Figure 3-3  Cumulative concentration response curves to a, carbachol and b, KCl in 
isolated strips of canine detrusor muscle. .........................................................................80 
 
Figure 3-4.  Cumulative concentration curves to a, carbachol and b, KCl in isolated strips 
of canine detrusor muscle at 1 day, 2 days, and 3 days post harvesting of tissue...............82 
 
Figure 4-1. Cumulative concentration response curves to KCl in isolated canine urinary 
bladder smooth muscle strips...........................................................................................94 
 
Figure 4-2. Cumulative concentration response curves to carbachol in isolated canine 
urinary bladder smooth muscle strips...............................................................................95 10 
Figure 4-3. Frequency response curves to neurogenic field stimulation in isolated canine 
urinary bladder smooth muscle strips...............................................................................97 
 
Figure 4-4. Graph showing the correlation between maximal tensions produced in response 
to carbachol and neurogenic field stimulation. .................................................................97 
 
Figure 4-5.  Graph showing the atropine resistant component of the electrical field 
stimulation induced contractile response of isolated strips of canine urinary bladder smooth 
muscle. ............................................................................................................................98 
 
Figure 4-6.  Graph showing the α-, β- ATP sensitive component of the non-adrenergic, 
non-cholinergic mediated contractile response of isolated strips of canine urinary bladder 
smooth muscle to electrical field stimulation....................................................................99 
 
 Figure 5-1.  Representative sections of bladder wall from each group stained with Masson 
Trichrome Orange G to allow visualization of collagen and smooth muscle...................111 
 
Figure 5-2.  Summary data of percentage of collagen within the canine urinary bladder 
wall from entire and neutered male and female canines and neutered female canines 
suffering from acquired urinary incontinence.................................................................112 
 
Figure 5-3.  Graph showing overall negative correlation between maximal tension 
produced in response to carbachol stimulation against percentage collagen within the 
bladder wall...................................................................................................................113 
 
Figure 6-1. Cumulative concentration response curves to carbachol in isolated canine 
urinary bladder smooth muscle strips over time..............................................................123 
 
Figure 6-2. Effects of Pirenzepine, Methoctramine and 4-DAMP on cumulative 
concentration response curves of carbachol in isolated strips of canine detrusor muscle.124 
 
Figure 6-3.  Schild plots for antagonism of the carbachol response by Pirenzepine, 
Methoctramine and 4-DAMP in isolated strips of detrusor muscle.................................125 
 
Figure 6-4.  Affinity of subtype-selective antimuscarinics for inhibiting carbachol induced 
contraction of strips of detrusor muscle from entire and neutered canines. .....................128 
 
Figure 7-1.  Time control cumulative concentration response curves to carbachol in 
isolated canine urinary bladder smooth muscle for GnRH, LH and FSH studies.............143 
 
Figure 7-2.  Time control cumulative concentration response curves to carbachol in 
isolated canine urinary bladder smooth muscle strips for oestrogen studies....................143 
 
Figure 7-3.  Time control frequency response curves to neurogenic field stimulation in 
isolated canine urinary bladder smooth muscle strips for GnRH, LH and FSH studeis ...144 
 
Figure 7-4.  Time control frequency response curves to neurogenic field stimulation in 
isolated canine urinary bladder smooth muscle strips for oestrogen studies....................144 
 
Figure 7-5. Cumulative concentration response curves to carbachol in isolated canine 
urinary bladder smooth muscle strips following a 2 hour incuabtion with hormones.......145 
 
Figure 7-6.  Frequency response curves to neurogenic field stimulation in isolated canine 
urinary bladder smooth muscle strips following 2 hour incubation with hormones.........146 11 
Figure 7-7.  Cumulative concentration response curves to carbachol in isolated canine 
urinary bladder smooth muscle strips following a 2 hour incubation with varying 
concentrations of oestrogen............................................................................................147 
 
Figure 7-8.  Cumulative concentration response curves to carbachol in isolated canine 
urinary bladder smooth muscle strips following a 24 hour incubation with varying 
concentrations of oestrogen............................................................................................148 
 
Figure 7-9.  Frequency response curves to neurogenic field stimulation in isolated canine 
urinary bladder smooth muscle strips following a 2 hour incubation with varying 
concentrations of oestrogen............................................................................................149 
 
Figure 7-10.  Frequency response curves to neurogenic field stimulation in isolated canine 
urinary bladder smooth muscle strips following a 24 hour incubation with varying 
concentrations of oestrogen............................................................................................149 
 
Figure 8-2.  Linearity assessment of mRNA expression for a., M1, b, M2 and c, M3 
receptor, using serial dilutions of input cDNA reverse transcribed from canine urinary 
bladder...........................................................................................................................168 
 
Figure 8-3.  Gene amplification assessment of a, M1, b, M2 and c, M3 receptor against the 
housekeeping gene β-actin.............................................................................................169 
 
Figure 8-4.  Mean (± s.e.mean) mRNA expression for: a, M1 receptor, b, M2 receptor and 
c, M3 receptor, in entire and neutered male and female canines and neutered female canines 
identified as suffering from acquired urinary incontinence.............................................170 
 
Figure 8-5.  Mean (± s.e.mean) maximal tension values in response to carbachol in isolated 
strips of detrusor muscle from entire and neutered male and female canines and neutered 
female canines identified as suffering from acquired urinary incontinence. Data is for 
canines for which both maximal contraction to carbachol and mRNA expression levels for 
muscarinic receptors are available..................................................................................171 
 
Figure 8-6.  Correlation between maximal tensions produced by detrusor muscle strips in 
vitro in response to muscarinic stimulation and mRNA expression levels for: a, M1 
receptor, b, M2 receptor and c, M3 receptor....................................................................172 
 
Figure 9-1.  Linearity assessment of mRNA expression for a, LH receptor and b, GnRH 
receptor, using serial dilutions of input cDNA reverse transcribed from canine bladder..181 
 
Figure 9-2.  Gene amplification assessment of a, LH receptor and b, GnRH receptor 
against the housekeeping gene β-actin............................................................................181 
 
Figure 9-3.  Mean (± s.e.mean) mRNA expression for: a, LH receptor and b, GnRH 
receptor, in isolated strips of detrusor muscle from entire and neutered male and female 
canines and neutered female canines identified as suffering from acquired urinary 
incontinence...................................................................................................................183 
 
Figure 9-4.  Mean (± s.e.mean) maximal tension values in response to carbachol in isolated 
strips of detrusor muscle from entire and neutered male and female canines and neutered 
female canines identified as suffering from acquired urinary incontinence. Data is for 
canines for which both maximal contraction to carbachol and mRNA expression levels for 
GnRH and LH are available...........................................................................................184 
 12 
Acknowledgement 
There are many people who have helped, supported and encouraged me throughout this 
thesis and to all I owe a great dept of gratitude.  Firstly, I would like to thank my 
supervisors, Neil Evans and Fiona Dowell, for their guidance, help and advice in the 
planning and completion of these studies, and for giving me the freedom to make my own 
hypotheses and decisions.   
 
I would also like to thank a number of people from Glasgow University Veterinary School 
who have helped me along the way.  To Ian Gibson who patiently imparted his knowledge 
of tissue bath protocols to me alongside teaching me to solder and keeping me company 
over long hours in the lab, to Christine Whitelaw who taught me microbiology protocols 
and was always willing to help me troubleshoot various equipment malfunctions and to 
Lynne Stevenson and Ian MacMillan for providing their skills and experience in the area of 
histopathology.  Sally-Anne Argyll of Edinburgh University Veterinary School helped me 
with analysis of Schild plots and muscarinic antagonists and gave freely of her time, for 
which I am very grateful.  Thanks also go to Jane Robinson who assisted my path into 
research and provided an ever cheerful face along the way.  
 
I thank the staff of the cell-sciences division at Glasgow University Veterinary School for 
their advice, interest and encouragement.  Richard Irving for his post-mortem and 
photography skills, Adrian Philbey for his comments and suggestions, Maureen Bain for 
her time and cheerful encouragement and Monika Mihm for inviting me to share her office 
and giving me practical advice.  
 
On the home front I would like to thank my parents who have always believed in me, 
supported and encouraged me, no matter how wild or mundane the adventure, and my 
husband who has been so supportive of my studies and who has kept me smiling 
throughout. 
 
I wish to thank Petplan and Pfizer for their sponsorship of my PhD, but also Glasgow 
University Veterinary School for helping me throughout my studies.  Finally, special 
thanks go to all the owners who kindly agreed to allow their pet to be included in this 
study.   
 13 
Author’s declaration 
 
 
This dissertation is not substantially the same as any other I have submitted for a degree, 
diploma or any other qualification at any other institution.  It is the result of my own work 
and includes nothing that is the outcome of work done in collaboration with others, except 
where stated. 
 
 
 
 
Victoria Ann Coit 
November 200814 
Abbreviations 
 
 
ACh    Acetylcholine 
ATP    Adenosine triphosphate 
AUI    Acquired urinary incontinence 
cAMP   Cyclic adenosine-3’,5’-monophosphate 
CI    Confidence interval 
CNS    Central nervous system 
DAG    Diacylglycerol 
4-DAMP  4-diphenyl-acetoxy-N-methyl piperidine methiodide 
DO    Detrusor overactivity 
FE    Entire female canine(s) 
FN    Neutered female canine(s) 
FN AUI  Neutered female canine(s) known to be suffering from acquired urinary 
incontinence 
FSH    Follicle stimulating hormone 
GnRH   Gonadotrophin releasing hormone 
IDI    Idiopathic detrusor instability 
IP3    Inositol triphosphate 
KCl    Potassium Chloride 
LH    Luteinising hormone 
ME    Entire male canine(s) 
MLCK   Myosin light-chain kinase 
MLCP   Myosin light-chain phosphatase 
MN    Neutered male canine(s) 
PNS    Parasympathetic nervous system 
SNS    Sympathetic nervous system 
Ttx    Tetrodotoxin 
UI    Urinary incontinence 
 15 
1  Introduction 
1.1 Overview of Urinary Incontinence  
Urinary incontinence is defined as the involuntary and unconscious loss of urine from a 
patient, and can occur at anytime whether the patient is awake (enuresis) or sleeping 
(nocturnal enuresis) (Abrams et al., 2002).  Although there can be many varied causes of 
urinary incontinence including ectopic ureters, neoplasia of the bladder and / or urethra, 
trauma of the spinal cord, inflammatory diseases and physiological disorders (Table 1-1) 
there are only two populations known to be at significant risk of developing urinary 
incontinence: women and bitches.  In these populations the majority of urinary 
incontinence is thought to be due to hormonal and / or age related changes.  In women the 
risk of developing urinary incontinence increases after the menopause and in the bitch, 
after neutering (Abrams et al., 2002; Holt et al., 1993; Thom et al., 1998; Thrusfield, 
1985).  Urinary incontinence is thought to have a multimodal aetiology and pathogenesis.  
It has been more closely defined and subcategorised in women and in this population falls 
under two main syndromes; urge incontinence, where the bladder contracts out-with 
conscious and voluntary patient control and stress incontinence where the tone within the 
urethral sphincters is insufficient to overcome any increases in pressure within the bladder, 
such as when sneezing occurs (Abrams et al., 2002).  It is recognised that many women 
suffer concurrently from these syndromes which can act in synergy with each other to 
cause an increase in the frequency or severity of the condition; this is defined as mixed 
urinary incontinence (Abrams et al., 2002).  In the canine only one form of urinary 
incontinence has been widely reported, variously known as post-neutering urinary 
incontinence, urethral sphincter mechanism incompetence and acquired urinary 
incontinence, the latter of which will be used in this thesis.  Acquired urinary incontinence 
has mainly been likened to stress incontinence in women, whereby overt leakage of urine 
occurs mainly when the bitch is lying down or excited and actively moving (Arnold et al., 
1989; Hotston Moore, 2001).  Despite this, some owners report that their bitch appears 
agitated just before an episode of urinary incontinence or inappropriate urination and that 
some bitches will try and get to their usual toileting place immediately before or during an 
episode, suggesting that some bitches may suffer from an undiagnosed form of urge 
incontinence. 
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Type  Example 
Congenital  Ectopic ureter(s) 
  Patent urachus 
Gynaecological  Pregnancy and parturition 
  Atrophy / pelvic floor muscle weakness 
  Bladder outflow obstruction 
Urological  Detrusor overactivity  
  Urethral incompetence  
  Urinary tract infections 
  Bladder calculi 
  Neoplasia of urinary tract 
Medical  Diabetes 
  Chronic Renal Failure 
  Hypothyroidism 
Functional  Arthritis (restricted mobility) 
  Post-surgical immobility 
Iatrogenic  Ovariohysterectomy / ovariectomy 
  Drugs (e.g. steroids, tricyclic antidepressants) 
  Complication of vaginal / urethra surgery 
Neurogenic  Spinal cord lesion 
  Diabetic neuropathy 
Psychogenic  Dementia 
Table 1-1. Common causes of urinary incontinence in bitches and women.   
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1.2 Prevalence of Urinary Incontinence 
Urinary incontinence is a widespread problem in both bitches and women, although the 
exact prevalence of the condition is likely to be underestimated due to the fact that many 
patients and owners fail to report the problem (Knight-Klimas, 2004).  This failure to 
report the condition is likely due to a number of reasons including embarrassment, lack of 
knowledge of urinary incontinence, low expectation of treatment options and the erroneous 
thinking that it is a normal part of aging.  Currently urinary incontinence is estimated to 
affect between 10 and 40% of women (Parsons et al., 2003), however this figure rises to 50 
to 70% in institutionalised elderly patients (Ouslander et al., 1982) where self reporting is 
not required.  The prevalence of urinary incontinence in women increases with age 
(Parsons et al., 2003), obesity (Dwyer et al., 1988; Han et al., 2006), parturition and 
hysterectomy (Thom et al., 1997), the menopause (Hunskaar et al., 2000) and is affected 
by race (Graham et al., 2001).  Similar factors also predispose bitches to acquired urinary 
incontinence as increasing ideal adult body weight, obesity and breed all contribute to the 
predisposition to urinary incontinence (Arnold et al., 1989).  There is a strong correlation 
between increasing body weight and increasing risk of developing urinary incontinence, 
with bitches weighing greater than 20kg having a 30% risk and bitches weighing less than 
10kg having a 10% risk for developing urinary incontinence (Arnold et al., 1989; Holt et 
al., 1993).  It is also reported that in the bitch there is a direct relationship between tail 
docking and neutering, with bitches that are docked having a higher incidence of urinary 
incontinence then their full tailed counterparts, possibly due to neurological changes 
brought about by trauma to the nerve roots as they leave the spinal canal (Holt et al., 
1993).  This latter fact should play a diminishing role in the disease prevalence in the UK 
over the coming years as tail docking has now been effectively banned in all breeds for 
cosmetic purposes.  As the breeds reported to be most affected by acquired urinary 
incontinence in the only published UK study of the disease prevalence are traditionally 
docked breeds (rottweiler, dobermann pinscher and boxer) (Holt et al., 1993) it remains to 
be seen if the breed distribution of predisposition to acquired urinary incontinence will 
change over the coming years.  Although the development of urinary incontinence can also 
be linked to mechanical damage of the urinary tract, following a difficult parturition or 
accidental trauma, this is only true for a minority of bitches.  In the bitch the largest 
contributing factor to the development of acquired urinary incontinence is neutering, with 
up to 20% of neutered bitches (Arnold et al., 1989), compared to <1% of intact bitches 
(Holt et al., 1993) subsequently reported to develop acquired urinary incontinence.  A 
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(Thrusfield, 1985) which is proposed to occur as a consequence of hormonal, vascular or 
neurological changes (Thrusfield et al., 1998), rather than mechanical damage of the lower 
urinary tract sustained during surgery (Gregory, 1994). 
Due to the relationship between neutering and the development of acquired urinary 
incontinence in bitches, there has been debate as to the best time to neuter a non-breeding 
bitch, be it before or after her first season.  Traditionally it has been recommended to 
neuter a bitch before her first season as this is known to lower the risk of her developing 
mammary tumours in later life (Dorn et al., 1968); conversely it was thought that this may 
increase the risk of her developing acquired urinary incontinence (Thrusfield et al., 1998).  
A study at the start of this century concluded that bitches neutered before their first oestrus 
may actually be at lower risk of developing acquired urinary incontinence than those 
neutered after their first oestrus (Stocklin-Gautschi et al., 2001).  The same study also 
concluded that there was no difference in the prevalence of development of acquired 
urinary incontinence in bitches neutered via ovariohysterectomy, the mainstay of neutering 
in Britain, and ovariectomy, the procedure of choice in mainland Europe.  This latter 
finding lends weight to the hypothesis that it is the removal of the ovaries and the 
subsequent hormonal changes that occur that is responsible for the development of 
acquired urinary incontinence in the bitch and not the surgery per-se, unlike in the woman 
where hysterectomy is a recognised risk factor in the development of urinary incontinence 
(Thom et al., 1997). 
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1.3 Clinical Signs and Complications Associated with 
Urinary Incontinence 
Regardless of the aetiology of urinary incontinence the clinical signs of overt leakage of 
urine are the same.  The condition in both humans and canines is debilitating, causes many 
social and economical problems and has a severe negative impact on the health of affected 
individuals and their quality of life (Hotston Moore, 2001; Kelleher et al., 1997).  The 
majority of women that suffer from urinary incontinence alter their lifestyle in some way 
and employ incontinence pads to aid in management of their condition which can lead to a 
decrease in their self confidence and severely curtail the activities that they partake in, 
decreasing their quality of life (Getliffe et al., 2007; Miller et al., 2003).  In some 
communities to suffer from urinary incontinence is to become a social outcast and, in parts 
of the third world, women are thrown out of their families and communities if it is found 
that they suffer from the condition.  In canines the social stigmatism seen in humans that 
accompanies urinary incontinence does not affect them but may be directed against their 
owners and can cause significant mental anguish for those involved.  This is often due to 
the fact that the use of incontinence pads is unsuitable in most bitches and thus animals 
frequently contaminate their bedding, as well their environment, with urine.  This 
environmental contamination is a potential health threat, as well as being socially 
unacceptable to many owners and may lead to alterations in the management of the 
affected canine and on occasions to their euthanasia.  The management and lifestyle 
alterations that are undertaken by patients or the owners of bitches suffering from urinary 
incontinence are often costly both in terms of quality of life and economically and it is this 
latter issue which puts a large financial strain on individuals and in the case of women, the 
health service provider (Klotz et al., 2007; Wilson et al., 2001).   
As well as the economic and social impact of urinary incontinence there are many ethical 
and welfare concerns for those affected (Hotston Moore, 2001).  The constant leakage of 
urine can lead to scalding of the skin causing significant irritation and discomfort to the 
patient, potentially leading to secondary infections of the skin which, if left untreated, can 
become life-threatening (Holt, 1983; Kelleher, 2001).  Along with the risk of skin 
infections there is also an increased incidence of cystitis among urinary incontinent 
patients, due to retrograde infections, which can progress to pylonephritis and kidney 
damage over time (Kelleher, 2001).  In women, it is possible for prolapse of the vagina, 
bladder and urethra to occur in incontinent patients which is a severe condition usually 
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incontinence also has a psychological impact on the patient and those caring for them, and 
can lead to severe psychosomatic problems such as anxiety, stress related disorders and 
depression (Miner, 2004; Zorn et al., 1999).   
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1.4 Urodynamic Categorisation of Urinary Incontinence  
The mechanisms that underlie urinary incontinence are more defined in women than in 
canines, as indicated earlier, due to the relative ease of urodynamic studies and the 
following subclassification of the condition in this species.  The characteristics and known 
urodynamic causes of urinary incontinence in women and canines are reviewed below. 
 
1.4.1 In the Woman 
As previously stated, in women there are three main classifications of urinary 
incontinence; urge incontinence, stress incontinence, and mixed incontinence (Fig. 1-1).  
These classifications are based on the symptoms experienced by the patient and although 
these can be linked to possible mechanisms of disease do not necessarily relate to the 
underlying cause(s) of the disease.  Urge urinary incontinence is the complaint of 
involuntary leakage of urine accompanied by or immediately preceded by urgency or the 
strong desire to void (Abrams et al., 2002); it is frequently associated with overactive 
bladder syndrome which includes detrusor activity + / - impaired contractility of the 
bladder.  Stress urinary incontinence is the complaint of involuntary leakage of urine on 
effort or exertion, or on sneezing or coughing (Abrams et al., 2002) and is usually 
associated with urethral closure incompetence.  Mixed urinary incontinence is the 
complaint of involuntary leakage of urine associated with urgency and also with exertion, 
effort, sneezing or coughing (Abrams et al., 2002) and is associated with both overactive 
bladder syndrome and urethral closure incompetence. Victoria A. Coit, 2008     Chapter 1, 22 
 
Figure  1-1.    Schematic  showing  the  link  between  the  urodynamic  causes  of  urinary 
incontinence in women, the clinical signs noted by the patient and the classification of the 
condition. 
 
Detrusor overactivity is a urodynamic observation characterised by involuntary detrusor 
contractions during the filling phase of micturition (Parsons et al., 2003).  Detrusor 
overactivity can occur with or without a feeling a urgency, approximately a third of 
patients have an overactive bladder with urgency, termed overactive bladder wet, whilst 
the rest of patients do not suffer from feelings of urgency and this condition is termed 
overactive bladder dry (Tubaro, 2004). The amount of urine lost following detrusor 
overactivity is usually large and symptoms may include urgency, increased frequency of 
urination and nocturia (Knight-Klimas, 2004).  Detrusor overactivity due to neurogenic 
disease is termed neurogenic detrusor activity or hyperreflexic bladder and any neural 
lesion or condition that stops the cortical inhibition of detrusor contractions such as spinal 
cord injury or multiple sclerosis can cause it (Abrams et al., 2002).  More commonly a 
specific cause of detrusor overactivity cannot be found and the condition is then termed 
idiopathic detrusor activity or detrusor instability (Abrams et al., 2002; Knight-Klimas, 
2004; Parsons et al., 2003).  Whatever the cause of detrusor overactivity, the involuntary 
detrusor contractions can be spontaneous or provoked.  Spontaneous detrusor overactivity 
can be sub-defined as phasic or terminal.  Phasic detrusor overactivity is characterised by 
spontaneous contractile activity but does not always lead to clinical urinary incontinence.  
Phasic detrusor overactivity is defined by a characteristic waveform of contractile pressure 
mimicking the normal voiding cycle during cystometry.  Terminal detrusor overactivity is 
again spontaneous and is defined as a single involuntary detrusor contraction at 
Urge Incontinence  Mixed Incontinence  Stress Incontinence 
Urgency 
Nocturia 
Frequency 
Large volumes lost 
No urgency 
Associated with physical activity 
Small volumes lost 
Phasic DO  Terminal DO 
Detrusor Overactivity (DO) 
Idiopathic / Neurogenic 
Urethral Incompetence  Impaired 
Contractility 
Urodynamic 
Cause 
Classification 
Clinical 
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cystometric capacity, which cannot be suppressed and which leads always to clinical signs 
of urinary incontinence (Abrams et al., 2002; Parsons et al., 2003).  Provoked detrusor 
overactivity occurs in response to either physical or psychological provocation of the 
bladder such as laughing or hearing running water and may be learnt (Parsons et al., 2003).  
As toilet training in humans and canines is the learning of cortical inhibition of detrusor 
contractions, it has been postulated that idiopathic detrusor overactivity is an un-learning 
or altered learning of this control; therefore altered mental status can allow uninhibited 
normal detrusor contractions to occur giving the presenting clinical signs of detrusor 
overactivity without any underlying bladder pathology. 
A further condition which can complicate urge incontinence, possibly as a separate entity, 
or possibly as an end stage of detrusor overactivity is low bladder contractility, often 
termed impaired detrusor contractility (Elbadawi et al., 1993a; Parsons et al., 2003; 
Resnick et al., 1987; Zhu et al., 2001).  In this condition, the strength of the contractile 
force of the detrusor is decreased along with a decrease in the sustainability of the 
contractions (Griffiths et al., 2002).  This in turn can lead to an increase in the residual 
volume of urine left within the bladder after voiding (Griffiths et al., 2002; Resnick et al., 
1987), which can cause irritation of the urinary bladder and a propensity to develop 
secondary bacterial infections, both of which can add to the clinical signs of urinary 
incontinence.   
Stress urinary incontinence is the involuntary leakage of urine through the urethra during 
periods of raised intra-abdominal pressure, such as coughing or laughing, in the absence of 
a detrusor contraction and can only be accurately diagnosed after performing urodynamic 
studies (Abrams et al., 2002; Parsons et al., 2003).  Stress urinary incontinence differs 
symptomatically from overactive bladder syndrome in that the amount of urine lost is often 
small, nocturia is often absent and there is a lack of urgency (Sarkar et al., 2000).  
Normally, the urethra remains closed during the filling phase of micturition, maintaining a 
positive urethral closure pressure even in the presence of raised intra-abdominal pressure, 
although detrusor overactivity may overcome it (Abrams et al., 2002).  An incompetent 
urethra, however, often considered to be caused by sphincter deficiencies, does not manage 
to maintain this tight seal, even in the absence of a detrusor contraction and allows the free 
passage of urine.  In women, weak pelvic floor muscles are thought to contribute to the 
incompetence of the urethra and damage to the levator ani muscles and pubo-urethral 
ligaments can allow passage of the bladder neck and proximal urethra into the vagina when 
intra-abdominal pressure increases, thus taking them out of the intra-abdominal pressure 
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include multiple childbirths, difficult childbirths, obesity, pelvic surgery and chronic cough 
(Knight-Klimas, 2004; Parsons et al., 2003; Wilson et al., 2003).    
Mixed urinary incontinence is a combination of urge and stress incontinences which can 
act in synergy with each other to cause a more severe and frequent clinical condition.  The 
causes of mixed urinary incontinence are the same as those for the individual syndromes 
(Abrams et al., 2002; Knight-Klimas, 2004).  The condition requires accurate diagnosis, 
often via cystometry and urodynamic studies and treatment often requires to be tailored to 
the individual depending on which syndrome predominates. 
 
1.4.2 In the Man 
Although urinary incontinence is less prevalent in men than in women the clinical signs 
and decreased quality of life that patients suffer are comparable.  The pathophysiology of 
urinary incontinence in men differs slightly from that of women, mainly due to the varying 
anatomy of the urethra and accessory sex glands such as the prostate, however, 
urodynamically there are a number of similarities between incontinence in men and 
women.  In men urge incontinence due to detrusor overactivity predominates; stress 
incontinence is rarely seen and then usually in patients who have had prostate surgery or 
abdominal trauma (Johnson et al., 1999).  Reported symptoms of urgency and urge 
incontinence may be particularly difficult to interpret clinically in men because they might 
indicate detrusor instability or bladder outlet obstruction causing uninhibited contractions 
(Hyman et al., 2001; Johnson et al., 1999). 
Detrusor overactivity in men has many similarities to that of women with men suffering 
from both neurogenic and idiopathic detrusor overactivity, the latter being termed detrusor 
instability.  Detrusor instability can be accompanied by low bladder compliance which can 
lead to residual urine retention, the feeling of incomplete bladder emptying upon urination 
and increased frequency of urination, as well as the sensation of urgency (Hyman et al., 
2001).  The feeling of incomplete bladder emptying and increased frequency of urination 
can also be due to bladder outlet obstruction, however, a condition that has been reported 
to occur in the presence and absence of detrusor instability (Hyman et al., 2001).  In man, 
the most common cause of bladder outlet obstruction is prostate disease which causes an 
increase in the size of the prostate which in turn constricts the lumen of the urethra causing 
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prostate in men is benign prostatic hyperplasia, a condition that occurs with aging, 
although tumours and infection of the prostate cause the same urodynamic symptoms 
(Ourad et al., 2003).  
In cases of severe prostate enlargement, especially due to neoplasia, the prostate may be 
surgically resected or removed, which may leaded to development of initial urge 
incontinence, followed by long term iatrogenic stress incontinence (Fowler et al., 1995; 
Penson et al., 2008; Rassweiler et al., 2006).  Although the type of surgery (radical 
prostatectomy versus transurethral resection) can influence the likelihood of urinary 
incontinence developing, with the more extensive surgeries having the highest incidence of 
post surgical incontinence, the urodynamic findings are the same, with unconscious urine 
leakage, especially at times of physical effort, being reported by the patient.   
 
1.4.3 In the Bitch 
Although there are a number of underlying reasons for urinary incontinence in the canine, 
as shown above, and whilst multiple causes of urinary incontinence have been 
characterised in humans, the majority of research into the condition in canines has focused 
on the role of the urethra.  This has led to urethral incompetence, often referred to as 
urethral sphincter mechanism incompetence, being considered the principle mechanism 
behind urinary incontinence in the canine (Holt, 1987).  In urethral sphincter mechanism 
incompetence, the resting tone, and therefore resistance produced by the urethra, is 
decreased and is insufficient to overcome any increases in pressure within the bladder, 
resulting in urine leakage (Gregory et al., 1996; Rosin et al., 1981).  It has been 
demonstrated, using microtransducers, that urethral closure pressures in incontinent bitches 
are much lower than in continent bitches and that the urethral closure pressures of  bitches 
decrease significantly after spaying (Reichler et al., 2004; Rosin et al., 1981). The exact 
reason for this decrease in urethral tone is as yet not known but is hypothesised to be 
hormonally related as regardless of the procedure used to neuter a bitch her ovaries are 
removed thus altering her reproductive and sexual hormone production.   
Although the urethra appears to play a significant role in the development of urinary 
incontinence in the neutered bitch, a low urethral resting tone is not a defining 
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may be involved.  Given the similarities between neutered bitches and post-menopausal 
women it is feasible that these further complicating factors involve the urinary bladder. 
 
1.4.4 In the Dog 
Urinary incontinence in the dog is rarely reported and is believed to be uncommon (Aaron 
et al., 1996).  There is very little published research into the condition but that which is 
available has focused on the role of the urethra, claiming similarities with urethral 
sphincter mechanism incompetence in the bitch (Aaron et al., 1996).  As in bitches, male 
canines suffering from urethral incompetence have clinical signs of stress incontinence 
with urine leakage occurring at times of increased intra-abdominal pressure (Aaron et al., 
1996; Power et al., 1998). There is also a reported link between neutering and the 
development of urinary incontinence in the male canine.  The mechanism(s) by which it is 
thought that neutering leads to acquired urinary incontinence however varies between the 
sexes (Holt, 1983) as in the male canine castration is associated with a small prostate 
which may lead to the development of an intra-pelvic bladder and shorter urethra (Power et 
al., 1998).  Both of these anatomical variations lead to a decrease in the urethral closure 
pressure leading to clinical signs of urinary incontinence (Power et al., 1998).  As in men, 
the prostate can also become enlarged in entire canines, and this can occasionally lead to 
bladder outlet obstruction and associated urinary incontinence (Holt, 1983). 
 
To begin to fully understand and appreciate the mechanisms responsible for the 
development of urinary incontinence in both bitches and women it is necessary to have an 
understanding of the anatomy and innervation of the lower urinary tract, and a perception 
of the main receptors responsible for normal micturition.  The sections that follow give an 
overview of these areas in the bitch, with differences in the woman recorded where 
appropriate. 
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1.5 The Anatomy of the Urinary Bladder and Urethra 
The urinary system comprises of the paired kidneys that form urine by filtration of the 
blood; the ureters that convey the urine away from the kidneys; the bladder which is the 
main storage reservoir for urine; and the urethra along which the urine is discharged.  As 
previously discussed, urinary incontinence can be caused by malfunction of any part of the 
urinary system; however, only the bladder and urethra have been implicated in the 
development of acquired urinary incontinence, therefore, this review will focus on these 
organs. 
The urinary bladder is a hollow musculomembranous organ that can change shape, size 
and position depending on the quantity of urine stored within it (Evans et al., 1993), and 
the amount of faeces within the rectum (Gray, 2000).  The urinary bladder can nominally 
be split into two sections, an intrapelvic neck region which is continuous with the urethra, 
and the larger globular body portion that will change relative position within the abdomen 
depending on the degree of distension with urine.  The area of the body of the bladder 
found most cranially is often referred to as the apex or cranial vertex of the bladder (Jacob, 
2007).  When empty, the urinary bladder is small and globular, with a very substantial wall 
(up to 2cm thick) and a negligible lumen (Dyce et al., 2002).  The contracted bladder rests 
on the pubic bones and is entirely intrapelvic in position (Gray, 2000; Smith, 1999).  When 
the bladder relaxes and distends with urine the walls become thinner (down to 2mm thick) 
and it protrudes cranially, assuming a rough pear shape.  As the bladder distends the neck 
area, which joins to the urethra, remains fixed within the pelvic cavity whilst the body and 
apex of the bladder extends cranially; in the canine, ventrally, in the human, forwards into 
the abdomen (Gray, 2000) (Fig. 1-2).  The extent of this cranial extension depends on the 
degree of bladder fill, with an exceptionally full bladder able to reach as far forward as the 
umbilicus in the canine (Dyce et al., 2002; Evans et al., 1993).  When distended, the dorsal 
(canine) or posterior (human) portion of the bladder is in contact with the jejunum, 
descending colon and either the cervix and uterine body in the female or the deferent ducts 
in the male (Evans et al., 1993; Gray, 2000; Jacob, 2007; Smith, 1999).  In the canine, the 
ventral portions of the bladder lie on the visceral and parietal layers of the peritoneum as 
they overlie the ventral abdominal wall, with the greater omentum occasionally moving 
caudally to sit between the peritoneal layers (Dyce et al., 2002).  In the human, the anterior 
portions of the bladder rest against the pelvic bones and the anterior abdominal wall (Gray, 
2000; Jacob, 2007). Victoria A. Coit, 2008     Chapter 1, 28 
 
 
 
 
 
Figure  1-2.    Radiograph  showing  a,  lateral  view  of  the  abdomen  of  a  bitch 
(pneumocystogram)  and  b,  an  anterior-posterior  view  of  the  abdomen  of  a  woman 
(intravenous  pylogram  /  excretory  urogram),  demonstrating  the  normal  position  of  the 
organs  of  the  urinary  system.    Photos  by  kind  permission  of  Glasgow  University’s 
Diagnostic Imaging Department. 
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The urinary bladder is covered with a serosal layer (peritoneum) which extends into three 
reflections or folds that attach the bladder to the abdominal and pelvic walls and are known 
as the ligaments of the bladder (Gray, 2000).  These are made up of double layers of 
peritoneum between which are blood vessels, nerves, lymphatics, adipose tissue, ureters, 
ductus deferens and vestiges of embryonic structures (Evans et al., 1993).  The largest fold 
is the median ligament of the bladder, or median vesicular fold, which runs ventrally from 
the bladder to the symphysis pelvis and the mid-ventral line of the abdominal wall as far 
cranially as the umbilicus.  The ligament is triangular in shape being widest caudally and 
narrowing as it moves cranially (Gray, 2000).  In the foetus, the median ligament contains 
the urachus, which normally disappears shortly after birth leaving only the peritoneal fold.  
The paired lateral ligaments of the bladder or lateral vesical folds, run dorsolaterally from 
the lateral bladder wall to attach to the abdominal and pelvic walls (Dyce et al., 2002; 
Evans et al., 1993; Jacob, 2007).  These ligaments contain the round ligaments of the 
bladder in the adult (umbilical artery in the foetus) and the ureters.  In utero the umbilical 
arteries, branches of the internal iliac arteries, carry blood from the foetus to the placenta 
and form part of the umbilical cord.  When the cord is severed at birth the arteries retract 
and contract to become fibrous cords between the bladder and the umbilicus.  In the adult, 
the narrow patent lumen of each vessel still carries blood from the internal iliac artery to 
the cranial portions of the bladder (Dyce et al., 2002).  In the human, the bladder is also 
connected to the pelvic wall by the fascia endopelvina.  In front, this fascial attachment is 
strengthened by a few muscular fibres, the pubovesicales, which run from the pubic bones 
to the front of the bladder; at the back, more muscular fibres run from the neck of the 
bladder to the sides of the rectum and constitute the rectovesicales (Gray, 2000).   
The bladder body can be further divided into the domed apex and the body proper (Fig. 1-
3).  The ureters enter obliquely into the caudal bladder body on its dorsal surface.  If an 
imaginary line was to be drawn between these openings and then from each opening 
towards the urethra a triangle would be formed.  This triangle is known as the trigone area 
and is thought to have a different embryonic origin from the remainder of the bladder wall 
(Dyce et al., 2002).  The mucosa of the bladder is only loosely attached to the underlying 
muscularis and has an enormous capacity to stretch with distension of the bladder.  The 
mucosa lining the trigone is thrown into ill-defined ridges that are directed towards the 
urethra and which form the median urethral crest that continues into the pelvic urethra for a 
short distance. These ridges are not abolished by distension, unlike the numerous mucosal 
folds that cover the rest of the bladder’s internal surface (Gray, 2000; Smith, 1999).   
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Figure 1-3.  Schematic diagram of the bladder and urethra.  The trigone area is marked on a 
cut away diagram viewed from the inside of the bladder in the area shown. 
  
  
The bladder is composed of four coats or sections, the tunica serosal (outermost), tunica 
muscularis, tela submucosa and the tunica mucosa which is the inner most layer (Gray, 
2000; Henrikson, 1993).  The outer tunica serosal is derived from the peritoneum and is the 
structure reflected onto the abdominal and pelvic walls as discussed above.  The tunica 
muscularis consists of three smooth muscle layers, collectively called the detrusor muscle, 
with some collagen fibres interspersed. Gap junctions between bladder smooth muscle 
cells allow for transmission of nerve impulses from cell to cell (Andersson et al., 2004a; 
Christ et al., 2003).  Originally the layers of muscle bundles within the bladder wall were 
thought to merge at the bladder neck and form an internal urethral sphincter (Wrobel et al., 
1993), however, it is now thought that some of the muscle bundles from the bladder wall in 
the human run directly towards the bladder neck, therefore expanding the urethral opening 
when they contract (Gray, 2000).  This is consistent with the finding in the canine that the 
proximal urethra may form part of the urine reservoir, expanding when the bladder is 
distended (Dyce et al., 2002).  This means that continence and urethral closure depends on 
the tension passively exerted by the elastic component of the urethral mucosa, and on the 
external urethral sphincter formed by the striated urethralis muscle.  The tela submucosa 
consists of a layer of areolar tissue with collagen and elastic fibres, as well as 
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myofibroblasts (Fry et al., 1997), within it.  This layer connects the muscular and mucous 
coats and is intimately linked to the latter (Gray, 2000; Henrikson, 1993).  The inner most 
coat is the tunica mucosa, a thin lining of the bladder formed by transitional epithelium 
called urothelium (Henrickson, 1993).  It is continuous with the ureters and lining 
membrane of the renal tubules, as well as with the urethra (Gray, 2000). 
The detrusor muscle is the component of the urinary bladder responsible for the 
mechanical actions of contraction and relaxation.  The detrusor muscle is made up of 
smooth muscle cells arranged into 3 distinct layers which are arranged in an outer and 
inner longitudinal layer with a middle circular layer (Dyce et al., 2002; Gray, 2000). These 
muscle bundles may interweave with each other (Henrickson, 1993).  In the human 
detrusor, bundles of muscle cells of varying diameter are surrounded by connective tissue 
rich in collagen.  The bundles of muscle cells in the human detrusor are large and are often 
composed of several smaller sub-bundles (Andersson et al., 2004a).  Within the main 
bundles of both species the muscle fibres are grouped into small functional units or 
fascicles (Dyce et al., 2002).  The orientation and interaction between the smooth muscle 
cells in these bundles are important as this will determine some of the properties of the 
bladder wall and its behaviour, such as the shape of the bladder and its intraluminal 
pressure (Andersson et al., 2004a).  In smaller animals, such as the rat, the muscle bundles 
are less complex and the patterns of arrangement simpler than in the human detrusor 
(Gabella et al., 1990).  There have been no comparison studies in the canine looking at the 
fine structure of the urinary bladder; however it is hypothesised to be similar to that of the 
human.  Figure 1-4 shows the gross structure of the canine urinary bladder wall, 
demonstrating the arrangement of the muscle layers and bundles which appears to be 
similar to that described for the human. 
The individual smooth muscle cells that make up the detrusor muscle in humans and 
canines are typical of urinary smooth muscle cells throughout the mammalian body.  They 
are long, spindle shaped cells with a central nucleus.  The cytoplasm is packed with 
myofilaments, and the membranes contain regularly spaced dense bands with membrane 
vesicles between them.  Mitochondria and a few elements of sarcoplasmic reticulum are 
also present, mainly near the nucleus (Andersson et al., 2004a; Henrikson, 1993). 
During filling of the bladder, in the storage phase of micturition, the smooth muscle cells 
have to relax and to elongate and rearrange in the wall of the bladder over a significant 
period of time (hours).  During the emptying phase of micturition, the smooth muscle cells 
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manner to allow fast and smooth bladder contraction.  These activities of the detrusor 
muscle require regulation of both contraction and relaxation via nervous and hormonal 
control systems (see sections 1.6-1.11). 
 
 
Figure 1-4.  Photograph showing the different layers and orientations of the muscle fibres 
that make up the detrusor muscle of the canine bladder.  Photo courtesy of Richard Irving, 
Division of Pathological Sciences, Glasgow Vet School. 
 
Early work on smooth muscle organs divided smooth muscle into two distinct classes 
termed single-unit and multiunit on the basis of contractile behaviour (Bozer, 1941).  
Single-unit smooth muscles are arranged in bundles with many points of close contact 
between the cell membranes, gap junctions.  Gap junctions are low resistance pathways 
through which ions can pass from one cell to another, thereby rapidly spreading an 
electrical signal throughout a tissue.  A small number of fibres in a single-unit muscle will 
spontaneously depolarise generating an action potential, these are called pacemaker cells 
(Andersson et al., 2004a).  In single-unit smooth muscles these pacemaker cells can often 
be stimulated to produce an action potential when the muscle is stretched.  Multiunit 
smooth muscles are composed of discrete muscle bundles and fibres that operate 
independently from each other.  They tend to be well innervated by the autonomic nervous 
system and are controlled mainly by direct nerve signals, therefore, they rarely show 
spontaneous contractions (Bozer, 1941).  The detrusor muscle exhibits characteristics of 
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both single-unit and multiunit muscles, with electrical coupling between cells and 
spontaneous action potentials developing, yet being densely innervated and requiring 
nervous coordination to achieve voiding (Andersson et al., 2004a). 
In the female the urethra runs caudally from the bladder neck to the external body surface 
along the pelvic floor.  It passes through the vaginal wall at an oblique angle and opens 
ventrally at the vaginal-vestibule junction (Gray, 2000).  In the male the urethra runs from 
the bladder neck to an external orifice at the free extremity of the penis and can be split 
into two sections: an internal pelvic portion and an external or spongy part, the latter 
named for the very vascular tissue that surrounds the urethra on its leaving the pelvic 
cavity.  The first part of the urethra in the male is surrounded entirely by the prostate and is 
penetrated by the opening of the deferent ducts and the numerous pores that drain the 
prostate (Dyce et al., 2002; Gray, 2000).  The urethral lumen widens caudal to the prostate 
but gradually narrows again as it approaches the ischial arch over which it exits the pelvic 
region (Dyce et al., 2002). 
The urethra has a similar structure to that of the bladder with a transitional epithelial lining, 
a middle muscular layer and an outer serosal layer.  As the urethra progresses towards the 
external urethral orifice the transitional epithelium gives way to stratified squamous 
epithelium (Gray, 2000). The muscle bundles are less well arranged than that of the 
bladder but contain both longitudinal and circular components (Henrickson, 1993).  In both 
the female and the male, the smooth muscle gradually gives way to skeletal (striated) 
muscle, the urethralis muscle, along the length of the urethra, the change happening more 
distally in the female than in the male (Smith, 1999; Wrobel et al., 1993).  The external 
urethral sphincter is formed of this skeletal muscle and as such is near the junction of the 
urethra and the vestibule in female, and is found along the length of the urethra from just 
caudal of the prostate to the root of the penis in males (Smith, 1999).  Mixed in with these 
fibres are muscle fibers from the rhabdosphincter, a striated muscle that sits in a horseshoe 
shape around and under the urethra and that helps to close the urethral lumen when it is 
contracted (Strasser et al., 2000).  The urethral submucosa contains a complex venous 
network that is thought to constitute a form of erectile tissue in the female as well as the 
male; this may help improve continence by assisting mucosal apposition and abolishing the 
lumen of the urethra during the storage phase of micturition (Dyce et al., 2002; Gray, 
2000). 
The pelvic floor or pelvic diaphragm is found in all animals and although is not a true part 
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women (Rogers, 2008).  The pelvic diaphragm is composed of muscle fibers of the levator 
ani muscles, the coccygeus muscle and associated connective tissue which span the area 
posterior the pelvis; it separates the pelvic cavity cranially from the perineal region 
caudally (Jacob, 2007).  The right and left levator ani lie across the floor of the pelvis and 
are separated by a narrow gap that transmits the urethra, vagina and anal canal. The levator 
ani is usually considered in three parts: pubococcygeus, puborectalis, and iliococcygeus 
(Dyce et al., 2002). The pubococcygeus is the main part of the levator ani and runs from 
the body of the pubis to the coccyx, incorporating some fibers into the prostate, urethra and 
vagina (Gray, 2000).  The right and left puborectalis unite behind the anorectal junction to 
form a muscular sling which some experts regard as part of the external anal sphincter 
(Gray, 2000).  The iliococcygeus, the most posterior part of the levator ani, is often poorly 
developed.  The coccygeus, situated behind the levator ani is frequently composed of 
tendinous as well as muscular fibers; it extends from the ischial spine to the lateral margin 
of the sacrum and coccyx (Gray, 2000).  Damage to any part of the pelvic diaphragm, for 
example during parturition or pelvic surgery, can result in both urinary and faecal 
incontinence, as well as prolapse of the abdominal organs. 
The blood supply to the bladder is through the cranial and caudal vesical arteries (Evans et 
al., 1993; Gray, 2000; Smith, 1999).  The cranial vesical artery is a branch of the umbilical 
artery and supplies the cranial portion of the bladder including the apex and part of the 
dome (Dyce et al., 2002; Evans et al., 1993).  The caudal vesical artery is a branch of the 
vaginal or prostatic artery from the internal iliac artery and supplies the caudal part of the 
dome and the neck of the bladder (Dyce et al., 2002; Smith, 1999).  There is a venous 
plexus on the surface of the bladder that drains primarily into the internal pudendal veins 
(Evans et al., 1993; Gray, 2000; Smith, 1999). 
The blood supply to the urethra varies slightly with the sexes as the urethra travels 
caudally.  The cranial portion in both sexes, which extends to the whole of the urethra in 
females, is supplied by the paired urethral arteries that are branches of the vaginal or 
prostatic artery, themselves branches of the internal iliac artery (Dyce et al., 2002; Evans et 
al., 1993; Gray, 2000).  A branch of the artery of the penis supplies the penile portion of 
the male urethra; it is a terminal branch of the internal pudendal artery (Dyce et al., 2002).  
The venous drainage is via the satellite veins of the aforementioned arteries (Dyce et al., 
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1.6 Innervation of the Lower Urinary Tract  
Micturition and urine storage depend on coordinated action between two functional units in 
the lower urinary tract; a reservoir (the urinary bladder) and an outlet (the bladder neck and 
the smooth and striated muscle of the urethra) (de Groat et al., 2001).  During voiding, the 
muscles at the bladder outlet relax and the bladder smooth muscle contracts, raising the 
intravesical pressure and inducing urine flow.  During urine storage, the bladder outlet is 
closed and the bladder smooth muscle is quiescent, allowing the intravesical pressure to 
remain low over a wide range of bladder volumes. These changes are coordinated by three 
sets of nerves (parasympathetic, sympathetic, and somatic) that emerge from the sacral and 
thoracolumbar spinal cord (Andersson, 1993) (Fig. 1-5). 
 
Figure 1-5.  Schematic diagram showing the innervation of the lower urinary tract.  SNS is 
the Sympathetic Nervous System, whilst PNS is the Parasympathetic Nervous System. 
 
The hypogastric nerve, originating from spinal cord segments of L1 through L4, supplies 
sympathetic innervation to the bladder and urethra, as well as the rhabdosphincter (Creed, 
1979; Cunningham, 1992; Evans et al., 1993).  The pelvic nerve, originating from the 
spinal cord segments S2 through S4, supplies parasympathetic (cholinergic) innervation to 
the detrusor muscle and transmits sensory impulses from the bladder (Cunningham, 1992; 
Evans et al., 1993; Smith, 1999). Somatic innervation of the muscle of the external urethral 
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sphincter is distributed via the pudendal nerve, originating from spinal cord segments S1 
through S3 (Evans et al., 1993; Smith, 1999).  The pudendal nerve also innervates muscles 
of the anal sphincter and perineal region (Dyce et al., 2002).  The spinal cord carries 
messages to and from the brain to accomplish voluntary control over micturition. The 
micturition reflex centre has been localized in the pontine-mesencephalic reticular 
formation in the brainstem (de Groat, 1998). There are interconnections from the 
micturition reflex centre to the frontal lobes and other areas in the cortex and subcortical 
areas (de Groat, 1990).  
The sympathetic and somatic nervous systems dominate during the storage phase of 
micturition (Evans et al., 1993; Longhurst et al., 2001; Smith, 1999).  Sympathetic 
stimulation via β-adrenoceptors in the detrusor muscle results in bladder relaxation to 
accommodate filling.  Sympathetic stimulation via α-adrenoceptors in the neck of the 
bladder results in contraction and closure of the sphincter that maintains continence (de 
Groat, 1998).  Sympathetic pathways, acting via tonic inhibitory systems in the micturition 
centre of the rostal pons, also inhibit parasympathetic bladder innervation during storage 
(de Groat, 1998).  Stimulation of the pudendal nerve results in increased tone of the 
external urethral sphincter, contributing to continence (Creed, 1995).  External urethral 
sphincter tone can also increase in response to sudden increases in abdominal pressure 
(during coughing or barking) to maintain continence (Brading, 1999; Kamo et al., 2003; 
Thuroff et al., 1982). 
When the bladder is filled with urine, sensation from tension receptors, volume receptors 
and nociceptors in the bladder wall is transmitted via afferent nerve fibres in the pelvic 
nerve to the sacral spinal cord and subsequently the brainstem (Andersson, 2002).  
Voluntary control of urination originates from the cerebral cortex (Blok, 2002; de Groat, 
1990; Sugaya et al., 2005).  During the emptying phase of micturition, parasympathetic 
(cholinergic) stimulation of the detrusor muscle results in bladder contraction via 
muscarinic receptors (Andersson et al., 2004a; Evans et al., 1993; Smith, 1999).  
Simultaneous inhibition of sympathetic nerves and somatic stimulation of the urethral 
smooth and skeletal muscle, along with stimulation of muscarinic receptors in the urethra 
causing nitric oxide release, results in urethral relaxation (Chess-Williams, 2002; Evans et 
al., 1993; Smith, 1999; Van der Werf et al., 2002).  Following complete emptying of the 
bladder or voluntary cessation of urination, the storage phase begins again. 
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1.7 Cellular Basis of Contraction 
Contraction of the smooth muscle of the detrusor is initiated by an increase in the
 
intracellular Ca
2+ concentration. It is understood that Ca
2+ can either enter the cytoplasm 
through the cell membrane,
 via Ca
2+ channels, or be released from the sarcoplasmic 
reticulum (Andersson et al., 2004a). These pathways for Ca
2+ translocation can be seen in 
Figure 1-6. 
 
 
Figure 1-6.  Signal pathways (1–4) involved in activation of detrusor contraction via 
muscarinic M3 receptors. ACh, acetylcholine; PLC, phospholipase C; DAG, diacylglycerol; 
PKC, protein kinase C; MLC, myosin light chain; IP3, inositol trisphosphate; SR, 
sarcoplasmic reticulum; CIC, calcium-induced calcium release. There seem to be 
differences between species in the contribution of the different pathways in contractile 
activation.  In human detrusor, Ca
2+ influx (3) is of major importance.  Taken from Urinary 
Bladder Contraction and Relaxation: Physiology and Pathophysiology: Physiol Rev, Jul 
2004; page 958.  Copyright The American Physiological Society, used with permission. 
 
The release of Ca
2+ from the sarcoplasmic reticulum is an important step in activation
 of 
the detrusor muscle.  The release of Ca
2+ is triggered by inositol trisphosphate (IP3)
 via IP3 
receptors.  IP3 is one of the breakdown products of phosphatidylinositol, a phosphorylated 
membrane phospholipids; diacylglycerol (DAG) is the other breakdown product.  The 
breakdown is initiated by activation of the muscarinic receptor on the cell wall and the Victoria A. Coit, 2008     Chapter 1, 38 
ensuing G-protein-coupled mechanism which in turn activates phospholipase C.  IP3 can 
diffuse and bind to specific receptors on the sarcoplasmic reticulum and release Ca
2+ stored 
within the organelle into the sarcoplasm (Andersson et al., 2004a). 
The Ca
2+ activation of the contractile proteins is known
 to occur via a phosphorylation 
pathway where Ca
2+ binds to a soluble protein calmodulin,
 and the Ca
2+/calmodulin 
complex activates the myosin light-chain
 kinase (MLCK) which catalyzes the 
phosphorylation of the myosin regulatory light chains (Fry et al., 2002).  
Dephosphorylation of the regulatory
 light chain is performed by a myosin light-chain 
phosphatase
 (MLCP).  
Relaxation of the smooth muscle cells occurs when the intracellular Ca
2+ concentration is 
reduced back to the resting level by reuptake via an adenosine triphosphate (ATP)-
consuming Ca
2+ pump (SERCA), into the sarcoplasmic reticulum (Fry et al., 2002). 
Despite these mechanisms it is known that some Ca
2+ is lost across the cell membrane, 
possible via a Ca
2+ pump, powered by ATP hydrolysis and an exchange of Ca
2+ for Na
+ by 
a Na
+-Ca
2+ counter exchanger (Wu et al., 2001).  This lost Ca
2+ must be replenished by 
subsequent Ca
2+ entry into the cell to ensure a steady state with respect to cellular Ca
2+.  
The replenishment of this intracellular Ca
2+ is thought to occur by a number of mechanisms 
including influx via voltage-activated Ca
2+ channels and Na
+-Ca
2+ exchange (Fry et al., 
2002).  This influx of Ca
2+ is exceptionally important as without it the calcium stores of the 
cell will diminish and contraction of the muscle will no longer be possible. 
Although the main mechanisms of contraction of the smooth muscle cells of the detrusor 
involve Ca
2+ release from the sarcoplasmic reticulum and influx of calcium via Ca
2+ 
channels and Na
+-Ca
2+ exchange it is understood that inhibition of the MLCP can lead to 
Ca
2+ sensitization and improved contraction of the cell (Andersson et al., 2004a).   
One main pathway for inhibition of the MLCP involves a specific kinase (Rho-associated
 
kinase), which is activated via small G proteins of the Rho
 superfamily, in the case of the 
detrusor RhoA (Symons M, 1996). Activation of Rho-associated
 kinase leads to 
phosphorylation of the myosin binding subunit
 of the MLCP and inhibits this enzyme.  A 
further pathway for modulating the Ca
2+ sensitivity
 of contraction is via the protein kinase 
C (PKC) (Jensen et al., 1996).  This is thought to act via CPI-17 which is strongly 
phosphorylated by PKC and which in turn inhibits the action of MLCP (Eto et al., 1999). Victoria A. Coit, 2008     Chapter 1, 39 
In conclusion, although there are many pathways that can cause contraction of the smooth 
muscle cells of the detrusor, the concentration of calcium within the cell is the determining 
factor in cellular contraction.  The release of calcium from the sarcoplasmic reticulum, and 
the influx of calcium into the cell, is the main factor involved in determining cellular 
contraction, and the primary receptor responsible for initiating calcium release is the 
muscarinic receptor, although other receptors such as purinergic receptors also have a role 
to play. 
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1.8 Muscarinic Receptors of the Urinary Bladder 
As has been previously discussed, the parasympathetic nervous system, acting via the 
muscarinic receptors, is the main motor drive to the urinary bladder during micturition 
(Chess-Williams, 2002).  Defects in this system, involving the muscarinic receptors, are 
hypothesised to be involved in the development of urinary incontinence in women (Chess-
Williams, 2002), and thus potentially in canines.  Muscarinic receptors are activated via 
acetylcholine (ACh), the neurotransmitter released by the parasympathetic neurones.  They 
are found throughout the bladder but predominate within the smooth muscle layer 
(Andersson et al., 2004b). 
There are five muscarinic receptor subtypes, encoded by five distinct genes (Caulfield, 
1993).  The five gene products correspond to pharmacologically defined receptors and M1 
– M5 are used to describe both the molecular and pharmacological subtypes (Caulfield et 
al., 1998).  Muscarinic receptors are all coupled to G proteins, although the signal 
transduction systems vary.  M1, M3 and M5 receptors are coupled preferentially to Gq/11 
proteins which activate phospholipase C leading to mobilisation of intracellular calcium.  
M2 and M4 receptors are coupled to pertussis toxin sensitive Gi/0 proteins which inhibit 
adenylyl cyclase (Andersson et al., 2004b).  Muscarinic receptors are found throughout the 
body, however, not all receptors have been demonstrated in all tissues (Table 1-2), and the 
functional role of the receptors in certain tissues has not been fully elucidated.  Data from 
the rat would suggest that receptor abundance is directly associated with contractile ability 
as it is known that in the rat the density of muscarinic receptors is greatest in the dome of 
the bladder and lowest in the neck region of the bladder (Saito et al., 1997) and the greatest 
contraction following muscarinic receptor stimulation occurs in the dome (Levin et al., 
1988).  Within the wall of the human urinary bladder, muscarinic receptors can be found 
on the detrusor muscle itself (Chess-Williams, 2002), where they cause contraction of the 
bladder, on the urothelium (Chess-Williams, 2002) where they are thought to cause the 
release of a diffusible factor that may inhibit contraction and on autonomic nerve endings 
where they alter transmitter release (Chess-Williams, 2002).  There have been no reported 
studies looking at the distribution of muscarinic receptors in the canine bladder; although 
given the distribution in other species such as the rat (Saito et al., 1997) it can be 
hypothesised that muscarinic receptors in the canine urinary bladder will closely mimic 
those in their human counterparts. 
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  G-protein  Cellular response  Main locations 
M1  Gq/11  ↑ IP3, DAG 
Excitation 
CNS (cerebral cortex) 
Glands (gastric, salivary etc) 
M2  Gi/0  ↓ cAMP 
Inhibition 
CNS (widely distributed) 
Heart 
Smooth muscle (bladder, gastrointestinal tract) 
M3  Gq/11  ↑ IP3 
Stimulation 
CNS (widely distributed) 
Glands (gastric, salivary etc) 
Smooth muscle (bladder, airways, 
gastrointestinal tract, eye) 
Endothelium 
M4  Gi/0  ↓ cAMP 
Inhibition 
CNS (cortex, hippocampus) 
M5  Gq/11  ↑ IP3 
Excitation 
CNS (Substantia nigra) 
Iris / ciliary muscle 
Table  1-2.    Table  showing the  main properties  and  locations  of the  muscarinic  receptor 
subtypes in the mammalian body.  IP3, inositol triphosphates; DAG, diacylglycerol; cAMP, 
cyclic adenosine-3',5'-monophosphate; CNS, central nervous system. 
 
The muscarinic receptor subtypes reported within the bladder vary between species and 
between studies, however all five receptor subtypes have now been demonstrated within 
the human bladder (Sigala et al., 2002) whilst the M1-M4 receptor subtypes have been 
reported in the rat urinary bladder (Braverman et al., 1998a), and only the M2 and M3 
receptor subtypes have been demonstrated in the pig (Maeda et al., 1988; Yamanishi et al., 
2000) and rabbit (Wang et al., 1995).  In most species so far studied, the M2 receptor 
subtype outnumber the M3 receptor subtype in the urinary bladder by 3:1, however, in the 
rat this ratio is increased to 9:1 (Chess-Williams, 2002).   
Despite this disparity in receptor numbers it is the M3 receptor subtype that is thought to be 
the main functional receptor responsible for bladder contraction during micturition (Chess-
Williams, 2002).  This has been demonstrated in pharmacological characterisation studies 
in normal bladder tissue from humans (Chess-Williams et al., 2001), pigs (Sellers et al., 
2000), rats (Braverman et al., 1998a; Braverman et al., 1998b; Longhurst et al., 2000), 
rabbits (Barras et al., 1999) and monkeys (Lai et al., 1998).  However there is thought to 
be a minor role played by the more numerous M2 receptors in bladder contraction, as 
shown by the decreased responsiveness of detrusor muscle strips to muscarinic stimulation 
in vitro in tissue collected from M2 knock-out mice (Stengel et al., 2000).  In vivo it has Victoria A. Coit, 2008     Chapter 1, 42 
also been shown via intravesicular pressure measurements in muscarinic antagonist treated 
anesthetised rats that M2 receptors are involved in micturition (Hegde et al., 1997), 
however, their exact role in normal micturition has not yet been determined.  In animals 
with a low M2:M3 receptor ratio such as the pig or human it has been postulated that M2 
receptors may regulate smooth muscle tone under certain conditions such as high 
sympathetic activity (Eglen et al., 1994).  Therefore, while sympathetic activity usually 
causes relaxation of the bladder via β-adrenoceptors to facilitate urine storage (Levin et al., 
1988), activation of M2 receptors may effectively switch off the sympathetic inhibitory 
mechanisms mediated by the β-adrenoceptors leading to improved emptying of the 
bladder.  Furthermore M2 receptors may become more important where there is M3 
receptor dysfunction, for example it has been shown in rats that there is an increase in the 
density of M2 receptors within the bladder in certain disease states such as diabetes (Tong 
et al., 1999) and denervation (Braverman et al., 1999a; Braverman et al., 1998b), however, 
a similar phenomenon has not been reliably demonstrated in the human bladder (Uchiyama 
et al., 2004). 
All of the subtypes of muscarinic receptor have been demonstrated in the urothelium of 
humans (Bschleipfer et al., 2007), however, none of the subtypes have been found in the 
rat urothelium (Gunasena et al., 1995; Saito et al., 1997) which suggests that species 
differences in the distribution of muscarinic receptors and their control of micturition may 
occur.  It has been shown that the urothelium has an afferent innervation (Wakabayashi et 
al., 1993) and it is suggested that at least part of this is a parasympathetic motor 
innervation (Wakabayashi et al., 1995).  The exact role of this innervation with regard to 
micturition has yet to be elucidated but the ACh released has been hypothesised to play a 
role in the release of the urothelium-derived inhibitory factor described by Hawthorn et al. 
(2000) which is thought to aid in relaxation of the bladder.  It has also recently been 
demonstrated that there is a non-neuronal cholinergic system within the human bladder 
urothelium that produces ACh (Yoshida et al., 2006).  A role for this non-neural ACh has 
not been demonstrated although a number of hypothesis have been put forward, including 
an action on the muscarinic receptors within the detrusor muscle to enhance contraction.  It 
is considered more likely, however, that this non-neuronally secreted ACh may stimulate 
the urothelial muscarinic receptors and affect the sensory pathway during the storage phase 
of micturition (Yoshida et al., 2006), potentially via the urothelium-derived diffusible 
inhibitory factor that has been shown to inhibit contraction of the underlying detrusor 
muscle to a variety of contractile agents in both pigs (Hawthorn et al., 2000) and humans 
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Finally, muscarinic receptors have also been demonstrated presynaptically on both the 
parasympathetic and sympathetic nerve endings within the bladder (Chess-Williams, 
2002).  Stimulation of the prejunctional muscarinic receptors on the parasympathetic 
nerves have been shown to have both inhibitory and facilitatory effects in a number of 
species including rats and rabbits (Braverman et al., 1998a; D'Agostino et al., 1997; 
Inadome et al., 1998; Somogyi et al., 1994).  The facilitatory effect is mediated via 
prejunctional M1 receptors which increase ACh release (Somogyi et al., 1999), whilst the 
inhibitory mechanism decreases ACh release and is mediated via the M2 or M4 receptors 
(Braverman et al., 1998a; D'Agostino et al., 1997).  Whether the inhibitory or facilitatory 
mechanism predominates at any given time will depend on a number of factors including 
stimulation parameters (Somogyi et al., 1999), and may therefore have a role to play in the 
development of urinary incontinence. 
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1.9 Adrenoceptors in the Urinary Bladder 
The body of the bladder receives only a sparse innervation by noradrenergic nerves from 
the sympathetic nervous system.  The density of these neural inputs increases towards the 
bladder neck and urethra, especially in the male (Gosling et al., 1999).  The functional 
significance of these nerves, which also occur in the lamina propria of the bladder have not 
yet been fully established. 
Both α-adrenoceptors and β-adrenoceptors have been reported within the urinary bladder 
of humans (Andersson et al., 2004a); however, the functional importance of the α-
adrenoceptors is undetermined.  Stimulation of the α-adrenoceptors causes contraction of 
the detrusor, whilst stimulation of the β-adrenoceptors causes relaxation (Andersson, 
1993).  It is possible to provoke contraction of the detrusor with sufficiently high 
concentrations of drugs that act exclusively on the α-adrenoceptors in a number of species, 
however, the number of α-adrenoceptors in the human bladder is low and the β-
adrenoceptors predominate (Goepel et al., 1997).  This means that the normal response of 
the human isolated detrusor muscle to noradrenalin is relaxation (Andersson, 1993).  This 
may mean that the α-adrenoceptors have no significant role in normal bladder contraction 
in the human, however, it is hypothesised that this may change in certain disease states 
such as bladder outlet obstruction and overactive bladders, although the results of studies 
looking at this have not been conclusive (Andersson et al., 2004a).   
Noradrenalin is released by electrical stimulation of the adrenergic nerves in detrusor tissue 
(Mattiasson et al., 1987) and since β-adrenoceptors predominate over α-adrenoceptors 
post-junctionally in the human bladder relaxation ensues (Andersson, 1993; Nomiya et al., 
2003).  There are three subtypes of β-adrenoceptor; β1-, β2- and β3-adrenoceptors.  All 
three of these have been demonstrated in the urinary bladder of the human, as well as a 
number of other species including the monkey (Takeda et al., 2002), ferret (Takeda et al., 
2000a), canine and rat (Takeda et al., 2003).  The functional subtype, however, appears to 
vary with species with the guinea-pig having relaxation mediated via the β1-adrenoceptor 
(Li et al., 1992), the rat via β1-, β2- and β3-adrenoceptors (Longhurst et al., 1999; Takeda et 
al., 2000b) and the human by β3-adrenoceptors. 
These findings suggest that β-adrenoceptor stimulation may help keep the bladder relaxed 
during filling.  There have, however, been no reported functional studies in vivo to test this 
hypothesis and the importance of sympathetic input for human bladder control is 
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effect on bladder filling and neither does blockade of the β-adrenoceptors, therefore the 
sympathetic nervous system may not be essential for urine storage in humans, although it 
may play a role in various disease states (Andersson, 1986).  In addition a study in rats has 
demonstrated that a selective β3-adrenoceptor agonist can increase the voiding interval and 
decrease the number of spontaneous contractions during the filling phase of micturition in 
certain models of induced bladder overactivity, leading to the hypothesis that activation of 
the β3-adrenoceptor can directly inhibit smooth muscle contractility in this species, with 
this condition (Woods et al., 2001). Whether or not this will hold true for other species, 
and whether or not activation of β3-adrenoceptors is an effective way of treating detrusor 
overactivity has not yet been reported. 
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1.10 Non-Adrenergic, Non-Cholinergic Mechanisms of 
Bladder Control 
It is known that in most mammalian species part of the neuronally induced bladder 
contraction is resistant to atropine (Andersson, 1993), a competitive antagonist of the 
muscarinic receptors.  This atropine resistant component of contraction is termed the non-
adrenergic, non-cholinergic mediated response, and its proportion to the total contraction 
varies with both species and the frequency of stimulation used in in vitro studies.  It has 
been reported that atropine can block up to 25% of the contractile response in isolated 
strips of detrusor muscle from rats (Andersson et al., 2004a), but in rabbits and pigs this 
figure rises to 40 and 75% respectively (Brading et al., 1991).  There have been no 
reported studies looking at the role of non-adrenergic, non-cholinergic mechanisms in 
bladder contraction in canines. 
In the human bladder the role of the non-adrenergic, non-cholinergic mechanism is still 
disputed (Andersson et al., 2004a).  There have been a number of studies looking at the 
role of acetylcholine in the electrically induced contraction of isolated strips of detrusor 
muscle that have variously concluded that the non-adrenergic, non-cholinergic mechanism 
is responsible for between 0 and 50% of the nerve mediated contraction of the urinary 
bladder in the human (Cowan et al., 1983; Sibley, 1984).  This dramatic difference is likely 
due to differences in the experimental protocols used, as a further study demonstrated that 
with an experimental protocol involving only the minimal electrical field stimulation 
required to produce consistent and reproducible tissue responses, atropine blocked only 
70% of the contractile response (Luheshi et al., 1990).  With a stimulation protocol 
involving long trains of large pulses, however, the same study demonstrated 100% atropine 
sensitivity, demonstrating the need for minimal electrical field stimulation in this type of 
research and for accurate comparisons between studies to be made, acknowledging what 
the stimulation parameters for each study are.  Further studies looking at human bladder 
contractility have consistently demonstrated an atropine-resistant, tetrodotoxin-sensitive 
component to nerve-mediated contraction (Bayliss et al., 1999; O'Reilly et al., 2002; Palea 
et al., 1993).  The contribution of non-adrenergic, non-cholinergic mechanisms to 
contraction of the normal human bladder is, however, thought it be small. 
There have been a number of reported studies looking at the role of the non-adrenergic, 
non-cholinergic mechanism in bladder contraction in certain disease states in humans, 
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results but agree that in bladder outlet obstruction and detrusor overactivity there is an 
atropine-resistant component of between 25 and 65% of electrically induced contraction 
(Andersson et al., 2004b), much greater than the 0 to 25% demonstrated in their control 
tissues.  Part of this atropine-resistant component may be due to direct muscle stimulation 
of hypertrophied detrusor muscle (Tagliani et al., 1997), however, at least some of the 
atropine-resistant responses were tetrodotoxin sensitive, suggesting a nerve-mediated 
response (Andersson et al., 2004b).   
The functional neurotransmitter(s) responsible for the non-adrenergic, non-cholinergic 
mechanism have not yet been identified, however, a number of potential compounds have 
been identified.  These include adenosine-5'-triphosphate (ATP), nitric oxide, various 
neuropeptides and prostanoids.  Of these, ATP has been the most extensively studied and 
demonstrates the most compelling evidence for involvement in the non-adrenergic, non-
cholinergic mechanism of bladder contraction (Andersson et al., 2004a). 
It has been shown by a number of studies that the atropine-resistant contractile component 
of nerve-mediated detrusor contraction in humans and guinea-pigs can be blocked by α, β- 
methylene ATP, an agent known to stimulate and
 then to desensitize P2-purinoceptors, 
which suggests that ATP is the non-adrenergic, non-cholinergic mediator in these species 
(Andersson et al., 2004a; O'Reilly et al., 2002; Palea et al., 1993).  It is known that ATP 
works via stimulation of P2X receptors (Andersson et al., 2004a), and it has been shown 
that the P2X receptor subtypes are present in the human bladder (Hardy et al., 2000; 
O'Reilly et al., 2002).  Further studies have shown that other animals, such as the rat, 
mouse, rabbit and cat have multiple purinergic excitatory receptors present within the 
bladder as well (Andersson, 1993).  It is hypothesised that ATP mediates detrusor 
contraction via activation of a ligand-gated cation channel (the P2X receptor) that 
promotes the influx of extracellular Ca
2+ (Andersson et al., 2004a).  Changes in the P2X 
receptor subtypes including selective loss of the P2X3 and P2X5 receptor subtypes have 
been reported in idiopathic detrusor overactivity (Moore et al., 2001), and the amount of 
P2X1 receptor, the predominant purinoceptor subtype in the human bladder, has been 
shown to be greater in patients with obstructed bladders compared to normal bladders 
(O'Reilly et al., 2002).  This all suggests that ATP may contribute to excitatory 
neurotransmission within the bladder, and that the purinergic system, as part of the non-
adrenergic, non-cholinergic mechanism may have a greater role to play in certain disease 
states.  
 Victoria A. Coit, 2008     Chapter 1, 48 
1.11 Reproductive Hormones in the Woman 
In the woman, cyclic ovarian function, often referred to as menstrual cycles, occur between 
puberty and menopause, which are increasing and decreasing periods of ovarian activity 
respectively.  The average length of each menstrual cycle is 28 days; however, there is a 
large range both between and within individual women with a range of 25-32 days 
considered to be normal.  The greatest variability in cycle length occurs in the years 
following the onset of menarche and proceeding menopause (Vollman, 1956).  Menarche, 
the onset of menstrual bleeding and cyclicity, is one of the later stages of puberty in girls 
and the average age of onset is 12 years, however, factors such as genetics, diet, obesity 
and overall health can accelerate or delay the onset of menarche (Kaprio et al., 1995).  
Menopause is the cessation of menstrual cycles at the end of a woman’s reproductive life 
and the average age of menopause is around 50 years, although the exact age is influenced 
by a number of factors including genetics, chronic disease, certain surgeries and various 
medical treatments which can delay or hasten its onset (Kato et al., 1998).   
The sequence of events in the menstrual cycle is determined by the relative hormone 
concentrations at each stage of the cycle.  Menstrual cycles are counted from the first day 
of menstruation and can be divided into 3 main phases or events; the follicular phase, 
ovulation and the luteal phase (Fig. 1-7).  Each phase of the cycle corresponds with 
significant events in hormone concentrations, follicular development and endometrial 
pathology. 
The follicular phase of the menstrual cycle spans the first day of menstruation until 
ovulation.  The aim of the follicular phase is to develop a viable follicle capable of 
undergoing ovulation.  The early events of the follicular phase are initiated by a rise in 
FSH concentrations, early in the cycle, which is caused by the decrease in progesterone 
and oestrogen concentrations at the end of the previous cycle, and the subsequent removal 
of inhibition of FSH secretion by these ovarian hormones (Sherman et al., 1975).  FSH 
stimulates the development of 15-20 follicles each month and stimulates follicular 
secretion of oestradiol by up-regulating secretion of androgens by the theca externa and by 
activating receptors on granulosa cells (Ganong, 2005).  As oestradiol concentrations 
increase, under the influence of FSH, oestradiol inhibits the further secretion of FSH and 
FSH concentrations decrease (Abraham et al., 1972; Sherman et al., 1975). 
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Figure  1-7.    Schematic  diagram  showing  the  major  hormonal  events  of  the  average 
menstrual cycle and the phases in which they occur. 
 
Under normal circumstances, one follicle evolves into the dominant follicle, destined for 
ovulation, while the remaining follicles undergo atresia (van Santbrink et al., 1995).  The 
exact selection process of the dominant follicle has not been reported, however, it is known 
that the dominant follicle always expresses an abundance of FSH receptors (Hillier, 1994).  
As FSH concentrations decrease towards the end of the follicular phase, the developing 
follicles must compete for the remaining FSH and the dominant follicle, with its high 
concentration of FSH receptors, remains responsive (Hillier, 1994).  The dominant follicle 
can then continue to synthesize oestradiol, which is essential for its complete maturation.  
The remaining, poorly FSH receptor-endowed follicles can not produce the required 
oestradiol, cease to develop and ultimately undergo atresia.  As the dominant follicle 
matures, it secretes increasing amounts of oestrogen, the concentrations of which peak 
towards the end of the follicular phase (Abraham et al., 1972).  At this critical moment, 
oestrogen exerts positive feedback on GnRH and thus LH secretion, generating a dramatic 
preovulatory LH surge (Abraham et al., 1972).   
Menstruation occurs at the start of the follicular phase and is characterised by menstrual 
bleeding, during which the apoptosed functionalis portion of the endometrium is shed 
along with blood from the spiral arteries of the endometrium (Ferenczy et al., 1991).  The 
increasing concentrations of oestrogen that occur during the follicular phase end menses 
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and induce proliferation of the new functionalis from stem cells of the basalis of the 
endometrium.  Proliferation of endometrial glands and stromal connective tissue occurs 
towards the end of the follicular phase and continues through ovulation and into the luteal 
phase (Ferenczy et al., 1991).  
The LH surge triggers ovulation by causing final maturation of the dominant follicle and 
weakening the wall of the follicle in the ovary (Chappel et al., 1991; Hillier, 1994).  The 
luteal phase is defined by the luteinization of the components of the follicle which were not 
ovulated and begins at ovulation and lasts until the menstrual phase of the next cycle.  The 
granulosa cells, theca cells, and some surrounding connective tissue are all converted into 
the corpus luteum, which eventually undergoes atresia (Ganong, 2005).  The major effects 
of the LH surge, apart from ovulation, are the conversion of granulosa cells from 
predominantly androgen-converting cells to predominantly progesterone-synthesizing 
cells, the expression of new LH receptors which fosters increased progesterone synthesis, 
and reduced affinity of granulosa cells for oestrogen and FSH (Ganong, 2005).  Combined, 
these changes promote increased progesterone secretion with some oestrogen secretion 
(McNatty et al., 1979; McNatty et al., 1980).  Progesterone secretion by the corpus luteum 
peaks between five and seven days post-ovulation (Abraham et al., 1972).  High 
progesterone concentrations exert negative feedback on GnRH and subsequently GnRH 
pulse frequency decreases.  As GnRH pulse frequency decreases, FSH and LH secretion 
also decreases (Ganong, 2005).  The corpus luteum further loses its FSH and LH receptors 
and, lacking stimulation by FSH and LH, after 14 days, the corpus luteum undergoes 
atresia and begins evolving into the corpus albicans (Ganong, 2005).  With the decline of 
both oestrogen and progesterone concentrations, an important negative feedback control on 
FSH is removed and FSH concentrations rise once again to initiate the next menstrual 
cycle (Abraham et al., 1972). 
The menopause marks the end of reproductive capabilities of a woman and the end of 
menstrual cyclicity.  The menopausal transition is considered to have been initiated when 
changes in cycle frequency or in menstrual flow first occur, and during this period, which 
lasts an average of 4 years, there are changes in the endocrinology of the pituitary-ovarian 
axis (McKinlay et al., 1992).  Up until the age of approximately 40 years there is a steady 
and roughly linear decline in follicle numbers within the ovary, however, over the 
following 10 years there is markedly accelerated decline in follicles, up until the 
menopause, where the ovary no longer contains follicles and therefore no longer contains 
granulosa cells (Burger, 1996).  This sharp decline in follicles is thought to be linked to the 
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considered to be cycling regularly (Reyes et al., 1977; Sherman et al., 1975).  Other than 
an overall average increase in FSH concentrations during the menopausal transition there 
are no other consistent hormonal changes with fluctuations in LH and oestrogen, as well as 
occasionally FSH being recorded by a number of studies (Hee et al., 1993; Metcalf, 1988; 
Metcalf et al., 1981).  It is likely that these fluctuations are due to irregular maturation and 
ovulation of declining follicles. 
The exact timing of true menopause and the cessation of menstrual periods in an individual 
can only be determined retrospectively, with no clear endocrine change occurring at the 
time of the last cycle (Burger, 1996).  In the first 6-12 months following the last cycle, up 
to 40% of women have oestrogen concentrations consistent with functioning follicles; 
however, progesterone concentrations suggest that no ovulation takes place (Rannevik et 
al., 1986).  By 12-24 months after the menopause, serum oestradiol concentrations are 
known to be significantly lower than those pre-menopause (Rannevik et al., 1986).  Serum 
gonadotrophin concentrations increase significantly after the menopause and by 12 months 
post-menopause, serum FSH concentrations are 10-15 fold higher than follicular phase 
concentrations in young cycling women, whilst LH concentrations are approximately 3 
fold higher (Burger, 1996; Chakravarti et al., 1976).  Serum gonadotrophin concentrations 
subsequently slowly decline with increasing age (Rossmanith, 1995). 
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1.12 Reproductive Hormones in the Bitch 
Although there has been much debate as to the aetiology and pathophysiology of acquired 
urinary incontinence in the bitch it is accepted that neutering (either via 
ovariohysterectomy or ovariectomy) significantly increases the risk of a bitch developing 
this condition.  This is thought to be due to changes in reproductive hormones that occur 
post neutering.  To understand how these hormones may change after neutering, 
knowledge of the normal reproductive hormone patterns and the regulation of hormone 
secretion in the intact bitch is necessary.   
The reproduction biology of the domestic bitch is unique.  Unlike the more extensively 
studied species such as the rat and ovine, the bitch is usually classified as monoestrus with 
an inter-oestrus period of approximately 6 months regardless of pregnancy status.  During 
the normal reproductive cycle of the bitch there are various known hormonal changes 
orchestrated by the hypothalamus and pituitary gland which in turn act on the ovaries; this 
is termed the hypothalamo-pituitary-ovarian axis.  The bitch’s oestrus cycle is commonly 
divided into 4 distinct stages, each with characteristic hormonal, behavioural and 
reproductive tract changes.  These stages are pro-oestrus, oestrus, metoestrus and anoestrus 
(Fig. 1-8).  
Pro-oestrus is associated with follicular development that is stimulated by Follicle 
Stimulating Hormone (FSH) and Luteinizing Hormone (LH), which in turn are controlled 
by Gonadotrophin Releasing Hormone (GnRH) released from the hypothalamus.  This 
phase lasts for approximately 10 days.  As the follicles develop they produce oestrogen in 
increasing quantity, which stimulates pheromone secretion and causes the bitch to become 
attractive to dogs, although she will not accept mounting (Concannon, 1986b).  Although 
FSH is folliculotrophic it does not increase in concentration as dramatically as LH 
(Concannon, 1993), presumably because the developing follicles secrete inhibin, a 
selective inhibitor of FSH secretion (Olson et al., 1982).  The cells of the developing 
follicle begin to undergo luteinization before ovulation (Concannon et al., 1977).  This 
allows the cells to produce progesterone in low concentrations before ovulation, when 
oestradiol is the main follicular steroid, and it is understood to be this increase in 
progesterone and the fall in the oestrogen:progesterone ratio that triggers the LH and FSH 
surge and therefore ovulation (Concannon et al., 1977; Concannon et al., 1975; Olson et 
al., 1982; Smith et al., 1974).  The LH surge is the central event in the oestrous cycle; it 
lasts for 1-3 days and occurs 0-3 days after the oestrogen peak (Concannon et al., 1977). Victoria A. Coit, 2008     Chapter 1, 53 
 
Figure 1-8.  Schematic summary of hormonal changes considered typical of a non-pregnant 
ovarian cycle in a bitch.  Taken from Canine pregnancy and parturition, Veterinary Clinics of 
North  America: Small  Animal Practice, volume 16:3, page 454, Copyright Elsevier (1986), 
used with permission. 
 
Oestrus refers to the behavioural changes expressed by the bitch, namely the change from 
the proceptive behaviour of pre-oestrous, to receptive behaviour  (Beach et al., 1982).  The 
exact timing of the onset of oestrus when compared to the LH peak varies between 
individual bitches but tends to be within one day of the LH surge (Concannon et al., 1989).  
The rapidly decreasing oestrogen concentrations in the presence of the rising progesterone 
concentrations bring about these behavioural changes (Concannon et al., 1977).  The LH 
surge causes ovulation and further luteinization of the ruptured follicles to become corpora 
lutea, allowing the cells to switch from producing oestrogen to progesterone (Concannon et 
al., 1977). 
Metoestrus is deemed to have commenced when a bitch refuses to stand to be mated and is 
usually 6-8 days after the onset of oestrus, or 8-10 days after the LH peak (Jeffcoate, 
1998).  There are no discrete endocrine changes that mark the onset of metoestrus, 
although the plasma progesterone will have been increasing since just prior to the pre-
ovulatory LH peak and will continue to rise.  This rise in progesterone is considered a 
useful indicator of ovulation, and plasma progesterone concentrations of around 10ng/ml Victoria A. Coit, 2008     Chapter 1, 54 
clearly coincide with the most fertile period in the bitch, about 3-5 days after the LH peak 
(Jeffcoate et al., 1997).  The progesterone concentration reaches a plateau approximately 2 
weeks after the LH peak (Concannon, 1983; Weilenmann et al., 1993) after which 
concentrations of progesterone gradually decline over the next 60-120 days (Austad et al., 
1976).  This decline is thought to be due to luteal regression, which is poorly understood in 
the canine.  No luteolytic mechanisms have been found in the bitch (Hoffmann et al., 
2004), and it is postulated that regression could be due to ageing of the corpora lutea.  In 
the bitch, progesterone is produced by the corpora lutea, progesterone production is 
supported in the first half of the luteal period by LH (Concannon, 1980; Okkens et al., 
1986) but prolactin is the predominant luteotrophic factor in the second half of the luteal 
period (Concannon et al., 1987; Jochle et al., 1989; Okkens et al., 1986).  Prolactin 
concentrations typically rise from approximately day 30 to day 65 in non-pregnant bitches 
and then begin to fall (Concannon, 1993; Jeffcoate, 1998).  Oestradiol concentrations 
increase very slightly near the start of metoestrus and remain at this level during the luteal 
phase, falling again towards the start of anoestrus (Onclin et al., 2002).  
Anoestrus is defined as the interval between the end of the luteal phase and the start of pro-
oestrus.  Determining the end of the luteal phase is difficult, as it is not marked by any 
obvious hormonal or behavioural changes.  Progesterone concentrations tend to be lower 
than 1ng/ml at the start of anoestrus (Jeffcoate, 1998) and remain low throughout anoestrus  
(Concannon, 1986b; Weilenmann et al., 1993).  FSH, in contrast, is high throughout 
anoestrus (Olson et al., 1982) and there is evidence that FSH concentrations increase 
towards the end of anoestrus and that this increase in circulating FSH should be considered 
a critical event required for ovarian folliculogenesis (Kooistra et al., 2001).  LH 
concentrations are on average low throughout most of the cycle, except during the pre-
ovulatory LH surge (Concannon et al., 1977; Concannon, 1993).  It has now been shown 
that LH secretion is pulsatile throughout the entire cycle (Hegstad et al., 1993; Hoffmann 
et al., 1993; Jeffcoate, 1993) and that pulse frequency increases during anoestrus to a 
maximum in late anoestrus and then decreases in pro-oestrus, although mean 
concentrations in plasma were high during proestrus (Concannon, 1993).  During the 
transition into anoestrus oestradiol concentrations are still raised above basal but fall to 
basal concentrations before rising considerably approximately a month before the LH peak 
(Jeffcoate, 1993).  Prolactin concentrations fall in early anoestrus and increase slightly 
during pro-oestrus although the reasons for this remain unclear (Jeffcoate, 1993). 
 There has been much interest in the mechanism that maintains such a long inter-oestrus 
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effect of photoperiod (Bouchard et al., 1991).  The high concentrations of sex steroids 
during metoestrus exert a negative feedback control on the hypothalamus and pituitary 
suppressing FSH and LH production, however, as the concentrations of the sex steroids 
wane towards anoestrus this negative feedback is removed and FSH and LH production 
increases.  The high FSH and pulsatile LH seen throughout anoestrus suggest that there is 
no lack of gonadotrophin production so research has concentrated on an ovarian 
insensitivity mechanism to explain the lack of follicular activity during anoestrus.  To date 
the best explanations seem to be an effect of luteal remnants on follicular gonadotrophin 
sensitivity (Jeffcoate, 1993) or follicular insensitivity to FSH caused by FSH receptor 
splice variants found at this stage of the cycle which may prevent the follicular response to 
FSH stimulation (McBride et al., 2001). 
The main effect of neutering a bitch is the irreversible termination of her reproductive 
cyclicity, with a neutered bitch staying in what is often considered to be a permanent state 
of anoestrus.  This is caused by the lack of oestrogen and progesterone production due to 
the removal of her ovaries (Concannon, 1993).  It also is known that neutering leads to a 
rapid and persistent increase in the circulating plasma concentrations of LH and FSH, due 
to the lack of negative feedback on the pituitary and hypothalamus by gonadal steroids 
(Burger, 1996; Olson et al., 1992; Reichler et al., 2004).   
 
1.12.1  The Role of Reproductive Hormones in Urinary 
Incontinence in the Bitch 
Initially, the development of acquired urinary incontinence post-neutering in the bitch was 
thought to be caused by the lack of oestrogen (Finco et al., 1974), and treatment with 
supplemental exogenous oestriol is still a current pharmacological treatment for acquired 
urinary incontinence in the bitch (Angioletti et al., 2004).  Despite this, it is unlikely that 
oestrogen deficiency alone is responsible for acquired urinary incontinence as oestrogen 
replacement therapy is ineffective in about 25% of cases (Arnold et al., 1989) and the 
serum oestradiol concentration of spayed incontinent bitches is similar to that of intact 
bitches during anoestrus (Richter et al., 1985).  Due to this, a new hypothesis has been 
formed that the increase in gonadotrophins may be at least partially responsible for the 
development of acquired urinary incontinence, especially as studies have demonstrated the 
presence of receptors for the gonadotrophins in the urinary bladder (Ponglowhapan et al., 
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steroid removal is provided by a recent study in neutered canines suffering from acquired 
urinary incontinence which reported that administration of GnRH analogues to decrease 
serum LH and FSH concentrations aided continence (Reichler et al., 2006b).  If increased 
concentrations of gonadotrophins are involved in the development of acquired urinary 
incontinence then the success of replacement oestrogen therapy in the bitch may be partly 
due to the suppression of plasma LH and FSH by oestrogen administration (Concannon, 
1993). 
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1.13 An Overview of the Treatment Options for Urinary 
Incontinence 
The aim of treatment of urinary incontinence is curing or lessening the clinical signs of 
overt inappropriate urination, preventing complications and secondary infections, and 
improving the quality of life for the patient.  Treatment of urinary incontinence can be 
either pharmacological or non-pharmacological.  Non-pharmacological measures include 
increased scheduled opportunities to void, bladder training, pelvic floor exercises, 
biofeedback / electrical stimulation, periurethral injection therapy, surgery, catheters and 
incontinence pads, although not all measures are suitable for both women and bitches. 
As many patients afflicted by urinary incontinence, both human and canine, suffer from 
episodic incontinence, shortening the inter-voiding time can help to decrease the number of 
episodes of incontinence.  This can be especially useful in canines who suffer most from 
inappropriate urination overnight where the inter-voiding interval can be as long as 10 
hours.  Scheduled toileting and bladder training are completely non-invasive management 
options suitable mainly for use in women where the patient practices voiding on a schedule 
and consciously suppresses sensory urges to urinate in an attempt to train the bladder and 
brain to coordinate urination, as occurs with initial toilet training (Holroyd-Leduc et al., 
2004b).  This can be effective in a number of cases of mild urinary incontinence; however, 
it does require good cognitive function on behalf of the patient (Moore, 2000; Thakar et 
al., 2000).   
Pelvic floor exercises are a mainstay of treatment for urinary incontinence in women and 
are effective in strengthening the pelvic floor muscles, and this is particularly important in 
women with stress incontinence, but again is not a feasible option in canines with acquired 
urinary incontinence.  These exercises help increase a woman’s awareness of her pelvic 
muscles and studies suggest they can increase the strength and duration of pelvic muscle 
contractions, decrease the volume of urine leakage and decrease the number of incontinent 
episodes a day (Thakar et al., 2000).  Vaginal cones and weights can also be inserted into 
the vagina as a means to strengthen pelvic floor muscles and are often recommended as an 
adjunct to pelvic floor exercises (Holroyd-Leduc et al., 2004b; Thakar et al., 2000).  
Electrical stimulation therapy involves the electrical stimulation of pelvic floor muscles in 
women using either a probe wired to a device for controlling the electrical stimulation, or 
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the pudendal nerve will improve urethral closure by activating the pelvic floor musculature 
(Holroyd-Leduc et al., 2004a).  In addition, electrical stimulation is thought to improve 
partially denervated urethral and pelvic floor musculature by enhancing the process of 
reinnervation.  Variation in the amplitude and frequency of the electrical pulse is used to 
mimic and stimulate the different physiologic mechanisms of the voiding response, 
depending on the type and aetiology of incontinence, e.g., either overactive bladder, stress 
incontinence, or a mixed pattern, although best results seem to obtained with patients 
suffering from overactive bladder incontinence (Brubaker et al., 1997; Wang et al., 2004).  
Periurethral injection therapy has been used successfully to treat urinary incontinence in 
both women and bitches (Barth et al., 2005; Thakar et al., 2000).  In this procedure an inert 
sclerosing agent such as gluteraldehyde cross-linked bovine collagen is injected into the 
urethra to physically decrease the urethral lumen.  The procedure is repeatable if required 
and carries a high success rate coupled with a low complication rate (Barth et al., 2005; 
Thakar et al., 2000).  Although the procedure is commonly practiced in human medicine it 
is not widely available in veterinary practice, with only a handful of veterinary hospitals 
offering the treatment in America and mainland Europe, and none offering the procedure in 
Britain, as yet. 
Colposuspension is an established surgical technique for the treatment of stress 
incontinence in women and urethral sphincter mechanism incompetence in the bitch 
(Holroyd-Leduc et al., 2004a; Holt, 1990).  In both species, the surgery is similar and 
involves placing non absorbable sutures from the bladder and cranial vagina to the body 
wall at the level of the pubic bone to draw the bladder neck out of the pelvic inlet and into 
the abdomen.  This means that any increases in intra-abdominal pressure can act 
simultaneously on the bladder and urethra.  Thus, any increase in intravesical pressure is 
counteracted by an increase in urethral resistance (Holt, 1990).  Although the procedure 
claims to have a high long-term success rate and low complication rate, it is a very 
invasive procedure and careful evaluation of the patient is required prior to surgery so that 
only those patients with genuine stress incontinence and an intrapelvic bladder are 
selected, as these are the patients that respond most favourably to this treatment (Holroyd-
Leduc et al., 2004a; Holt, 1990).  In women, a laparoscopic colposuspension technique has 
been reported that is less invasive and gives shorter recovery times, however it appears to 
be 20% less effective than open surgery (Thakar et al., 2000). 
Tension free vaginal tape is a surgical technique for the treatment of genuine stress 
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through the urogenital diaphragm to pass laterally to the urethra and behind the pubic bone 
to perforate the rectus sheath.  This means that the tape comes to rest in a U shape around 
the mid-urethra and is then adjusted so that it provides tension free support to the urethra.  
Good success rates have been recorded with improvement in up to 95% of patients, at least 
in short term studies (Moran et al., 2000; Ulmsten et al., 1999).  Due to the ease of the 
surgical technique, a relatively low incidence of serious complications and the short post-
operation recovery time, this procedure has increased in popularity and is considered an 
excellent alternative to colposuspension in many patients (Thakar et al., 2000).  This 
procedure has been described in the bitch (Nickel et al., 1998), however, the number of 
complications, coupled with a relatively poor success rate when used alone, means that this 
procedure is not in common use in the bitch. 
There are several other surgical procedures documented for treatment of urinary 
incontinence including urethral reconstruction, ileocytoplasty and artificial urinary 
sphincter placement (Thakar et al., 2000).  Although none of these are routine procedures, 
artificial urinary sphincter placement is indicated in a number of women such as those with 
sphincteric dysfunction in which other procedures have not significantly improved the 
condition.  These are not procedures that are utilised in the canine (Elliott et al., 1998; 
Petrou, 2002). 
As previously mentioned there are a number of pharmacological treatments for urinary 
incontinence in both the woman and the bitch.  In the woman there are specific therapies 
suitable for treating urinary incontinence due to an overactive bladder, and separate 
treatments for stress incontinence which concentrate on treating urethral dysfunction.  In 
the bitch the only reported and licensed therapies are for treating urinary incontinence due 
to decreased resting urethral tone.  In both species it is often found, however, that 
combination therapy, especially involving a mix of medical, behavioural and non-specific 
treatments gives the best and most sustainable cure for the patient. 
In the bitch the most commonly used pharmacological treatments in the United Kingdom 
are oestrogens (Incurin, Invervet) and alpha-adrenergic drugs, the most common being 
phenylpropanolamine (Propalin, Vétoquinol).  They both act by increasing the resting 
urethral tone, therefore are of limited use in patients with incontinence due to causes other 
than sphincteric dysfunction.  Both drugs seem to be well tolerated by animals, however, 
there is a risk of side effects with both drugs, the main symptoms being increased 
attractiveness to male dogs and increased risk of mammary cancer with oestrogens 
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increased blood pressure with phenylpropanolamine (Carofiglio et al., 2006; Mandigers et 
al., 2001).  Although widely used, these treatments do not always affect a cure and many 
bitches become refractory to them over time (Mandigers et al., 2001; Richter et al., 1985).  
Recently, a long acting GnRH analogue has been trialled in the bitch as a treatment for 
acquired urinary incontinence and it appears, at least in the short term, to offer good 
clinical improvement in urinary incontinence in this species, although the exact mechanism 
of action has not been described (Reichler et al., 2006b). 
In women, the mainstay of medical management for stress incontinence has also been 
hormonal treatment with oestrogen and progestins and with alpha-agonists such as 
phenylpropanolamine, however, side effects can be great and these are no longer 
recommended for long term treatment of urinary incontinence.  Oestrogens were used for 
stress incontinence, as weakened pelvic floor muscles due to decreased concentrations of 
oestrogen post-menopause are considered one of the main contributing factors to 
development of urinary incontinence.  Oestrogen has been shown to have a direct effect on 
urethral mucosa and periurethral tissues, increasing urethral closure pressure (Sarkar et al., 
2000); however, side effects of long term use include significantly increased risk of breast 
cancer, ovarian cancer, cholecystitis, cardiovascular disease and stroke (Chen et al., 2002b; 
Grady et al., 2002; Hulley et al., 2002; Lacey et al., 2002; Nelson et al., 2002).  This 
means that the long term risks of systemic treatment with oestrogen in women outweigh 
the advantages of treatment and it is no longer a recommended therapy.  Topical oestrogen 
vaginal creams, the oestrogen vaginal ring and oestrogen patches are associated with few 
side effects, however, and appear to be as effective as systemic treatment and therefore are 
recommended for a number of patients (Robinson et al., 2003). 
Other therapies for stress incontinence in women include the α-adrenoceptor agonists 
phenylpropanolamine and pseudoephedrine and also the selective serotonin and 
noradrenalin reuptake inhibitor duloxetine.  Phenylpropanolamine has recently been 
withdrawn from the market due to a slight but significant increase in the risk of 
haemorrhagic stroke associated with its use (Norton et al., 2006).  Pseudoephredine is still 
available and works by increasing the urethral sphincter tone, however, it also acts upon 
other body systems to give side effects such as insomnia, restlessness, nervousness and 
headaches and can cause fatal complications in patients suffering from cardiac 
arrhythmias, hypertension and angina and therefore has limited applications (Norton et al., 
2006).  Duloxetine is a relatively new therapy that has undergone a number of clinical 
trials in which it has shown good efficacy in treating stress incontinence in women with a 
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and nausea (Hurley et al., 2006).  Although new therapies are coming onto the market to 
treat stress incontinence in women it is likely that behavioural approaches and pelvic floor 
exercises are just as effective in treating stress incontinence in the majority of women as 
pharmacological agents. 
Pharmacological treatments for urge incontinence caused by an overactive bladder in the 
woman are more promising and offer an improved benefits/risk ratio than those for stress 
incontinence.  Anticholinergic and antispasmodic agents such as oxybutynin and 
tolterodine are the most common choices for the treatment of urge incontinence and act by 
decreasing muscarinic-mediated detrusor contractions and allowing the bladder to fill 
properly.  Oxybutynin is an antimuscarinic agent and also has a direct antispasmodic effect 
on smooth muscle whereas tolterodine is purely a muscarinic receptor antagonist.  Both 
agents are effective at improving continence and quality of life for patients (Diokno et al., 
2003; Norton et al., 2006).  Side effects of both drugs are primarily anticholinergic and 
dose related and include xerostomia, xerophthalmia, constipation, sedation, blurred vision, 
urinary retention, insomnia, tachycardia, confusion and delirium.  A large number of 
studies, many associated with drug companies, have looked at the effects of immediate and 
sustained release oxybutynin and tolterodine and have produced many contradictory 
claims.  In general, it has been concluded that immediate release oxybutynin is as effective 
as immediate release tolterodine, however, the latter has the least incidence of dry mouth 
due to the fact that it is more selective for receptors in the bladder than in the parotid gland 
(Harvey et al., 2001; Malone-Lee et al., 2001).  The results for the sustained release 
preparations of oxybutynin and tolterodine have shown that both agents work well, with 
oxybutynin being slightly more effective in increasing the number of patients with no 
clinical signs of incontinence at 12 weeks, however, oxybutynin was also reported to 
produce a higher incidence of dry mouth (Diokno et al., 2003).  To further reduce the 
anticholinergic side effects of these drugs a transdermal oxybutynin product has been 
trialled and manufactured which appears to have similar efficacy to oral immediate-release 
oxybutynin but with lower anticholinergic side effects, however, the cost of this treatment 
is significantly more than oral therapies and there are reported application site reactions 
with this mode of delivery (Davila, 2006; Davila et al., 2001; Dmochowski et al., 2002).  
There have been no reported trials of muscarinic receptor antagonists for urinary 
incontinence in the bitch therefore efficacy and safety of these drugs in canines is at 
present unknown. 
Tricyclic antidepressants can also be used for urge incontinence in women.  These agents 
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contractility (Yoshimura et al., 2002).  The tricyclics that have been used include 
nortriptyline, desipramine, imipramine, doxepin and amitriptyline, however, the latter 
should be avoided in elderly or frail patients as it is associated with increased 
anticholinergic effects than the other tricyclics (Yoshimura et al., 2002).  There are no 
reported studies looking at the use of these drugs in the bitch, however amitriptyline has 
been used for behaviour modification therapy and is known to have severe cardiac effects 
including causing ventricular tachycardia in some animals (Ansel et al., 1993).  These 
agents are likely best used when the patient has a concomitant depression or neuropathy. 
In conclusion there are many treatment options for urinary incontinence in both women 
and bitches, however, not all treatments are suitable for all patients, therefore, a careful and 
thorough work-up leading to accurate diagnosis of the condition is required, along with a 
general clinical exam to diagnose any other existing medical conditions, before a specific 
treatment option is recommended.  In most patients a combination of therapies will give 
the best outcome, with behavioural therapy and modifications to lifestyle being the first 
step in formulating an individual treatment plan.  Due to the potential side effects of both 
surgery and medical treatments these options should only be considered after less invasive 
therapies have been exhausted.  In the bitch, behavioural therapy will often not result in a 
complete cure of the disease, therefore medical therapy should be considered alongside 
modifications to lifestyle.  In both women and bitches surgery should only be offered after 
other treatments have failed and only after a thorough counselling of patient or owner as to 
the potential side effects and complications of the procedure.  In all cases patients and 
owners should be warned that with current therapeutic options the condition may not be 
totally resolved despite a multi-modal treatment regime, in which case the use of 
incontinence pads and other sanitary devices may be required.  
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1.14 Conclusions and Aims 
It is possible to see that there are many similarities between post neutering urinary 
incontinence in the bitch and stress incontinence in the woman, with both conditions 
centring on a decreased resting urethral tone that is insufficient to overcome increases in 
pressure within the bladder.  It has also been shown that the bladder has an important role 
to play in the development of urinary incontinence in the woman, especially in cases of 
urge incontinence caused by an overactive bladder, and in cases of decreased bladder 
contractility.  In the bitch the role of the bladder in the development of urinary 
incontinence has not been reported, although it is understood that a decreased resting 
urethral tone is not a defining characteristic of acquired urinary incontinence in the bitch 
(Reichler et al., 2006b).  This has lead to the hypothesis that the bladder may be involved 
in the development of urinary incontinence in the bitch and as such could provide a new 
target for treatment of this debilitating and embarrassing problem. 
The aim of the studies in this thesis therefore, were to investigate the functional, structural 
and molecular changes that occur within the bladder of a canine post neutering that may 
lead it to develop, or predispose it to, urinary incontinence.  
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2  Validation of Equipment and Protocols  
2.1 Introduction 
The ultimate aim of this project was to determine and characterise the changes that occur 
within the urinary bladder of canines post neutering that may predispose a bitch to develop 
acquired urinary incontinence.  As there have been no published in vitro reports of canine 
detrusor muscle function, the aim of this preliminary study was to validate our in vitro 
organ bath equipment, experimental technique and protocols by replicating the robust 
experimental approach previously described for use in the rat (Rattus rattus) (Kories et al., 
2003; Longhurst et al., 2000).  Using this approach, strips of rat urinary bladder are placed 
in organ baths under standard physiological conditions, tensioned until stable at the 
designated optimal resting tension (2g), and then subjected to standard concentration 
dependent carbachol and KCl response protocols.  Carbachol is a non-selective muscarinic 
agonist that causes contraction of smooth muscle preparations via stimulation of the 
muscarinic pathway whilst KCl causes contraction of smooth muscle preparations by direct 
action on the cell membrane causing depolarisation.  As contractile responses of urinary 
bladder strips in this experimental set up have proven to be consistent when used by a 
number of different research groups, similar responses in this study would validate our 
equipment and demonstrate reliable and consistent technique by personnel.  
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2.2 Materials and Methods 
2.2.1 Animals 
Age matched adult male (n = 10) Wistar rats (200 - 300g, out bred) obtained from Harlan 
(Oxfordshire, UK) were used for this study.  All animals received food and water ad 
libitum.  The protocols used for this investigation were approved by the Glasgow 
University Veterinary School Ethics Committee. 
 
2.2.2 Preparation of Tissue 
Rats were humanely killed through stunning followed by exsanguination by severance of 
the carotid arteries, in accordance with the Animals (Scientific Procedures) Act 1986.  The 
urinary bladder was immediately removed and placed in ice-cold Krebs buffer of the 
following composition: NaCl 118mM, KCl 4.8mM, CaCl2 2.5mM, MgSO4 1.2mM, 
KH2PO4 1.2mM, NaHCO3 24mM, glucose 11mM.  The dome of the bladder was dissected 
free at the level of the ureteral orifices, cleared of fat and cut into strips (2mm x 10mm). 
The bladder strips were mounted in 15ml tissue baths (Scotia Glassware Ltd, 
Grangemouth, UK), bathed at 37°C in Krebs solution and continually aerated with 95% O2 
/ 5% CO2.  Muscle tension was measured with BIOPAC TSD125C isometric force 
microtransducers (BIOPAC Systems Inc, California) and results displayed on a computer 
screen using the BIOPAC data acquisition software (AcqKnowledge 3.8) (Fig. 2-1).  
Bladder strips were mounted under 2g resting tension (Longhurst et al., 2000) and the 
contractile response to KCl (40mM) was examined to determine tissue viability.  Strips 
that did not produce a minimum of 0.5g active tension were discarded, replaced and new 
strips tested.  After testing all strips were repeatedly washed and allowed to equilibrate for 
30 minutes, during which time the resting tension was adjusted to 2g every 10 minutes. 
In all cases experiments were performed on the same day as the bladders were harvested. 
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2.2.3 Carbachol Concentration Response Protocol 
Once muscle tension in the strips was stable at 2g resting tension a standard 
Carbamylcholine Chloride (carbachol, Sigma, UK) concentration response protocol was 
performed and the resultant muscle tensions recorded.  Briefly, carbachol was made up to a 
1M stock solution and aliquots stored (-20°C) from which serial dilutions were prepared on 
the day of each experiment.  Carbachol was added to the baths in a stepwise manner to 
give cumulative bath concentrations of 1nM – 30µM (log -9M to -4.5M), increasing in half 
log increments after the response to the previous concentration had reached a maximum. 
 
 
 
 
Figure 2-1.  Photograph of the tissue bath and electrical stimulator set up. 
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2.2.4 KCl Concentration Response Protocol 
Following completion of the cumulative response protocol to carbachol, the strips were 
washed repeatedly and allowed to equilibrate for 1 hour, during which time the resting 
tension was adjusted to 2g every 10 minutes.  Once tension in the strips of urinary bladder 
were stable at 2g resting tension, KCl (Sigma, UK) (2M) was added to the baths in a 
stepwise manner to give final cumulative bath concentrations of 10mM – 80mM.  This was 
performed using 10mM increments with each further concentration applied after the 
response to the previous concentration had reached a maximum. 
 
2.2.5 Electrical Field Stimulation Protocol 
In a separate series of experiments, strips of urinary bladder were mounted in Ag-AgCl 
ring electrodes (manufactured by Mr I. Gibson, Glasgow University Veterinary School), 
washed repeatedly and tensioned until stable at 2g resting tone.  Once stable the 
supramaximal voltage (at 20Hz) was determined for each strip by applying stimulations at 
increasing voltages until the maximal contractile response was seen, the voltage required to 
produce approximately 70% of this response was considered the supramaximal voltage of 
that strip.  Any strips that did not respond at this stage were discarded, replaced and the 
supramaximal voltage determined as before.  A train of three stimulations at the 
supramaximal voltage for each strip was then conducted; to ensure that the response seen 
to that voltage was stable. 
Bladder strips were then washed, re-tensioned to 2g resting tension and allowed to 
equilibrate for 30 minutes, during which time the strips were re-tensioned to 2g every 10 
minutes.  Once muscle tension was stable, electrical field stimulation (0.5-100Hz, 100 
pulses) was delivered from a Digitimer Ltd MultiStim System-D330 stimulator 
(Hertfordshire, UK) at a pulse width of 0.5ms and at supramaximal voltage.  Stimulations 
were applied at five minute intervals to allow the re-establishment of normal resting tone 
between stimulations.  Frequency dependent contractions were observed.  To allow 
confirmation that the observed responses to electrical field stimulation were neurogenic, at 
the end of the each experiment the tissue strips were incubated with the neurotoxin 
Tetrodotoxin (1µM) (Sigma, UK) and stimulated at 20Hz every 5 minutes for 3 
stimulations.  Tetrodotoxin is a neurotoxin that prevents action potentials forming and Victoria A. Coit, 2008     Chapter 2, 68 
spreading through a muscle by blocking the sodium gated voltage channels on nerve cells 
thereby preventing any nerve mediated contractions (Narahashi, 1974). 
 
2.2.6 Data Analysis 
All data are expressed as g/mg of wet tissue and results as mean ± s.e.mean where 
applicable (n = number of animals).   
The results from all strips collected from each animal (minimum 4 / animal) were meaned, 
and the value obtained used as the result for that animal in further analysis.  The LogEC50 
values (log of the concentration of carbachol required to produce a response equal to half 
of the maximal tension produced) were calculated by GraphPad Prism® v.5 software from 
the mean data for each animal.  
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2.3 Results 
Carbachol induced concentration dependent contraction of the isolated urinary bladder 
strips in all animals (Fig. 2-2a).  The threshold for response was approximately 30nM and 
maximum response was observed at approximately 10µM.   
KCl induced a dose dependent contraction of all isolated urinary bladder strips (Fig. 2-2b), 
the maximal contraction produced was lower (37%) than that produced by carbachol.  The 
threshold for response was approximately 20mM and maximum response was observed at 
approximately 50mM. 
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Figure 2-2.  Cumulative dose response curves to a, carbachol and b, KCl in isolated rat 
urinary bladder strips.  Each point is the mean ± s.e.mean of observations from 10 animals.   
 
 
Electrical field stimulation of the isolated strips of urinary bladder produced frequency 
dependent contraction (Fig. 2-3).  The maximal contraction was seen at 20Hz in all 
animals.  Tetrodotoxin abolished the response of the tissue to electrical field stimulation 
and thus confirmed that responses seen were neurogenic in origin.  The effects of 
tetrodotoxin are shown in the data record for a representative strip in Figure 2-4.   
 
 Victoria A. Coit, 2008     Chapter 2, 70 
0.01 0.1 1 10 100
-0.1
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Frequency (Hz)
T
e
n
s
i
o
n
 
P
r
o
d
u
c
e
d
 
(
g
/
m
g
)
 
Figure 2-3.  Frequency response curves in isolated strips of rat bladder.  Each point is the 
mean ± s.e.mean of observations from 10 animals.   
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Figure 2-4.  A typical section of trace showing control stimulations (upper trace) and the 
inhibitory effect of tetrodotoxin (1µM; lower trace, addition denoted by arrow) in isolated 
strips of rat urinary bladder.  Stimulation parameters were 20Hz, 5 sec, and 0.5msec pulse 
width. 
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2.4 Discussion and Conclusion 
In this study, the strips of rat urinary bladder were found to respond in a similar manner 
and with a similar magnitude of response to that reported previously, thus validating both 
our experimental tissue bath set-up and the methodology as suitable for the study of rat 
urinary bladder (Frazier et al., 2007; Kories et al., 2003; Longhurst et al., 2000), and 
therefore reasonable for the study of canine detrusor muscle function.  
There was concentration dependant contraction of the rat urinary bladder strips to 
carbachol.  This is as expected as carbachol is a non-selective muscarinic agonist that 
works via the cholinergic system, binding to and activating the muscarinic receptors within 
the bladder (Rang et al., 2007).  As the muscarinic receptors are known to mediate the 
contractile response of the urinary bladder (Longhurst et al., 2001) then addition of 
carbachol can be expected to produce contraction in a concentration dependant manner.  
Although carbachol acts at the muscarinic receptors by mimicking acetylcholine, it is not 
hydrolysed by acetylcholinesterase and therefore is not broken down or removed (Rang et 
al., 2007), hence the contraction produced by each dose of carbachol does not diminish but 
remains stable over time.  Carbachol is thought to act mainly at the M3 receptors in the 
bladder, which are the receptors deemed responsible for the majority of the contractile 
action of the bladder during micturition (Chess-Williams, 2002); however, it is possible 
that at higher concentrations carbachol may act on the M2 and nicotinic receptors causing a 
change of state of the cation channels on the muscle cell membrane (Andersson et al., 
2004a; Rang et al., 2007), and potentially altering both K
+ and Ca
2+ conductance across the 
cell membrane.  The change in state of K
+ ion channels, in particular, may explain why at 
higher concentrations, carbachol was seen to invoke concentration dependant relaxation of 
the rat urinary bladder strips in this present study (Oh et al., 2003). 
In response to KCl, there was concentration dependant contraction, followed by 
concentration dependant relaxation of the rat urinary bladder strips.  KCl is a metal halide 
that disassociates in solution to form K
+ (the major cation of cells) and Cl
- ions, both of 
which are essential to many body systems and functions including conductance of nerve 
impulses, acid-base balance and carbohydrate metabolism.  KCl is not specific for any 
receptor but is thought to act directly upon the cell membrane (Foster et al., 1983).  When 
added to the extracellular environment KCl, at low concentrations, causes depolarisation of 
the cell membrane thereby leading to formation of action potentials and contraction of 
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concentrations of K
+, Ca
2+, Na
+ and Mg
2+ ions may cause the hyperpolarisation of the cell 
membrane and activation of various ion channels thereby inhibiting further contraction 
(Foster et al., 1983; Kravtsov et al., 1995), and eventually leading to relaxation. 
In response to electrical field stimulation, there was frequency dependant contraction of the 
urinary bladder strips which was blocked by the neurotoxin tetrodotoxin.  Tetrodotoxin is a 
neurotoxin that prevents action potentials forming and spreading through a muscle by 
blocking the sodium gated voltage channels on nerve cells thereby preventing any nerve 
mediated contractions (Narahashi, 1974).  Using this neurotoxin demonstrated that the 
responses obtained in the experiments previously described were neurogenic in origin, 
therefore, they mimicked the in vivo contractile responses to parasympathetic neuronal 
stimulation of the bladder during the emptying phase of micturition.  This contraction 
during the emptying phase is thought to be mediated mainly through muscarinic receptor 
stimulation (Andersson et al., 2004a; Andersson et al., 2004b; Creed et al., 1983; 
D'Agostino et al., 1989) via acetylcholine released from the nerve terminals.  As free 
acetylcholine around the nerve terminal is rapidly broken down by the enzyme 
acetylecholinesterase (Andersson et al., 2004a) the contraction evoked by electrical field 
stimulation cannot be maintained over time, hence the need to allow sufficient time for the 
tissue to recover between stimulations. 
The responses of the rat bladder to carbachol, KCl and electrical field stimulation showed 
little variation both between strips for an individual animal and between individual 
animals.  This was to be expected as the study population was uniform in terms of weight, 
age and strain of animal used, and confirms that error due to personnel or equipment was 
minimal.  These results confirm that the techniques and equipment are suitable to 
investigate changes in bladder function in the canine, and demonstrate that any differences 
in function of detrusor muscle recorded in the canine are not due to personnel or equipment 
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3  Validation of Canine Tissue Bath Protocols  
3.1 Introduction 
Acquired urinary incontinence in the bitch is an increasingly recognised condition that 
affects up to 20% of all neutered bitches (Arnold et al., 1989).  The role of the urethra in 
the condition has been extensively studied (Gregory, 1994; Holt, 1988; Reichler et al., 
2004; Rosin et al., 1981), however, decreased urethral tone is not considered a defining 
characteristic and the exact aetiology and pathophysiology of the condition remain 
unknown.  Studies in women, to investigate post menopausal urinary incontinence, have 
demonstrated that the bladder has a pivotal role to play in the development of urinary 
incontinence in this patient group (Elbadawi et al., 1993a; Elbadawi et al., 1993b; Resnick 
et al., 1987).  The overall aim of this thesis was to determine and characterise the changes 
that are induced within the urinary bladder of canines post neutering that may predispose 
them to develop acquired urinary incontinence.  As there are no published in vitro reports 
of canine detrusor muscle function, the aim of this part of the study was to validate 
protocols for use with this tissue within a classical in vitro tissue bath system. 
The equipment and protocols to be used with the canine urinary bladder tissue had 
previously been validated using bladder tissue from a species in which similar studies have 
been conducted, namely the rat, (chapter 2).  The results in the rat indicated that the 
responses to carbachol, KCl and electrical field stimulation were highly repeatable between 
tissue strips from the same animal, and between animals.  This finding is critical to the 
proposed canine studies as it means that any variation seen is likely to be due to biological 
variation and not to equipment or personnel.  Prior to the use of the chosen experimental 
approach to study differences in detrusor function as a consequence of neutering in the 
canine, a series of studies were necessary to determine the exact experimental conditions 
required to optimise the conditions for use with this tissue.  Due to the lack of reported data 
on canine detrusor muscle function, a length tension study on isolated strips of canine 
urinary bladder smooth muscle was conduced to determine the optimum resting tension for 
this tissue.  These studies were also considered important as the canine bladder is 
significantly larger than that of the rat, and its function is different as domestic canines are 
‘housetrained’ and thus require a significant storage function in addition to contractile 
micturition and thus may require different study conditions than that of the rat.  
Optimisation of the resting tension also allows more accurate assessment of the 
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tension is too low then the filaments overlap, and if the tension is too high the filaments are 
not able to interact with each other properly, thus the contractile force of the stimulated 
muscle is decreased. 
As all of the canine tissue was donated, with full owner consent, it was recognised that 
there would not be a constant or regular supply of tissue, and that tissue would often be 
donated late in the evening or at weekends.  Given the larger size of the canine urinary 
bladder and to be able to utilise the tissue obtained fully, a further aim of the initial 
characterisation studies was to investigate the effect of storage of the tissue to determine if 
experiments could be run up to 3 days post harvesting, instead of on the day of harvesting 
as in the rat.  It was hypothesised that changes would occur in the muscle tissue upon 
storage and that the contractility of muscle would diminish over time due to the build-up of 
waste products of metabolism and the depletion of oxygen and glucose within the storage 
solution by the tissue, all leading to degradation of the muscle tissue.  The time course for 
these changes has not been previously reported, therefore tissue was used from the same 
animal on days 1, 2 and 3 post harvesting, with day of harvesting considered as day 0, and 
statistical analysis of the results performed to determine if tissue could reliably be used for 
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3.2 Materials and Methods 
3.2.1 Animals 
The study was approved by The University of Glasgow Veterinary School’s ethical review 
committee.  Tissue from a total of 22 canines was included in the study, with a mean age of 
6 years (range 1-14 years) and a mean weight of 24.4kg (range 8-45kg).  The majority of 
canines included in this study were cross bred, with no pedigree breeds appearing more 
than once.  In all cases tissue was collected within 2 hours of euthanasia (intravenous 
overdose of pentobarbatone), with full, informed, owner consent.  In all cases, euthanasia 
occurred for reasons other than scientific investigation.  The majority of animals were 
destroyed for severe behavioural problems, the remainder for a number of different 
complaints, none of which involved the urinary system.   
 
3.2.2 Preparation of Tissue 
A full, detailed history of each animal was taken and a gross post-mortem of the entire 
urinary tract performed, before the urinary bladder was harvested, sectioned across the 
level of the ureters and the dome of the bladder placed in Krebs solution (NaCl 118mM, 
KCl 4.8mM, CaCl2 2.5mM, MgSO4 1.2mM, KH2PO4 1.2mM, NaHCO3 24mM, glucose 
11mM) and stored at 4°C.  Any animal with a history of, or gross pathological signs of, 
urinary tract disease, other than acquired urinary incontinence, were excluded from the 
study. 
The domes of the bladders were cleared of any fat and the lining urothelium removed.  
Bundles of smooth muscle fibres could then be identified and up to 28 strips of smooth 
muscle (2mm x 10mm) were produced from the resultant detrusor muscle sheet.  The 
detrusor muscle strips were mounted in 15ml tissue baths (Scotia Glassware Ltd, 
Grangemouth, UK), bathed at 37°C in Krebs solution and continually aerated with 95% O2 
/ 5% CO2.  Muscular tension was measured with BIOPAC TSD125C isometric force 
microtransducers (BIOPAC Systems Inc, California) and displayed on a computer screen 
using the BIOPAC data acquisition software (AcqKnowledge 3.8).  To determine optimal 
resting tension, detrusor muscle strips from each animal were mounted under 2, 4, 6 or 8g 
resting tension.  Tissue strips were washed (repeatedly) and allowed to equilibrate for 60 Victoria A. Coit, 2008     Chapter 3, 76 
minutes, during which time the resting tension was adjusted on a per strip basis to achieve 
the intended passive muscle tension.  
Initially, to assess tissue viability, muscle strips were exposed to a KCl challenge (40mM) 
and tissue strips that did not respond were discarded and replaced; however, it was found 
that response, or more frequently lack of response, to this initial dose of KCl did not 
accurately correlate to later contractile responses to carbachol and therefore this practice 
was stopped and no further test doses used.  Tissues were then subjected to an assessment 
of carbachol induced contraction (3.2.3) followed by KCl induced contraction (3.2.4). 
To study the effects of storage on the viability of tissue the bladder domes were kept in 
Krebs solution at 4°C for up to 3 days post harvesting.  As it was hypothesised that muscle 
strip contractility would decrease over time due in part to utilisation of the components of 
the Krebs solution, and due to build up of waste products from metabolism the Krebs 
storage solution was refreshed daily.  On days 1, 2 and 3 bundles of smooth muscle were 
dissected out as described above and subjected to an assessment of carbachol-, followed by 
KCl- induced contraction as described below. 
 
3.2.3 Assessment of Carbachol-Induced Contraction 
Once tension in strips was stable at the intended levels a carbachol concentration response 
protocol was performed.  Carbachol (as per chapter 2) was added to the baths in a stepwise 
manner to give cumulative bath concentrations of 1nm – 30µM (log -9M to -4.5M), 
increasing in half log increments after the response to the previous concentration had 
reached a plateau. 
 
3.2.4 Assessment of KCl-Induced Contraction 
Following completion of the cumulative response protocol to carbachol, the detrusor 
muscle strips were washed repeatedly and allowed to equilibrate for 1 hour, during which 
time the resting tension was adjusted as necessary every 10 minutes to achieve the intended 
resting muscle tension for each strip.  Once the strips of urinary bladder were stable at their 
designated resting tension, KCl was added to the baths in a stepwise manner to give final 
cumulative bath concentrations of 10mM – 80mM.  This was performed using 10mM Victoria A. Coit, 2008     Chapter 3, 77 
increments with each further concentration applied after the response to the previous 
concentration had reached a plateau. 
3.2.5 Data Analysis 
Results were normalised relative to tissue weight and results presented as g/mg of wet 
tissue.  Data are expressed as mean ± s.e.mean (n = number of canines).  
Results from a minimum of 2 strips of bladder tissue per animal were analysed and the 
mean of these strips used in further calculations where applicable.  Data were graphed and 
statistical analysis was performed using either GraphPad Prism® v.5, or GraphPad InStat 3 
software.  Comparisons between maximal tensions produced and age and weight of the 
animal were made using analysis of variance (ANOVA).  Comparisons between day 1, 2 
and 3 data were made using repeated analysis of variance (ANOVA) with Bonferroni post-
test.  A probability (P) less than or equal to 0.05 was considered significant.   Victoria A. Coit, 2008     Chapter 3, 78 
3.3 Results 
Carbachol induced concentration dependent contraction of the isolated strips of detrusor 
muscle from all animals (Fig. 3-1).  Contraction was measurable at 10nM and reached a 
maximum at 3µM in all groups after which there was dose dependant relaxation seen in a 
number of strips (Fig. 3-1).  The highest maximal contraction and lowest LogEC50 value 
were seen in the strips placed at 4g resting tension (Table 3-1).  Although the results for 4g 
were not significantly greater compared to the other tensions studied, it was noted that 
more strips at 6g and 8g resting tension either broke or failed to respond during the 
protocol (17% and 12% of strips respectively) compared to those at 2g and 4g resting 
tension (4% and 5% respectively).  Analysis of variance showed no affect of age or weight 
of animals on the results obtained. 
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Figure 3-1.  A representative section of trace showing the contractile response to carbachol 
in an isolated strip of canine detrusor muscle.  Arrows denote addition of carbachol. 
 
 
  Resting Tension 
  2g  4g  6g  8g 
Carbachol – Emax  0.73 ± 0.12  0.94 ± 0.14  0.85 ± 0.13  0.83 ± 0.12 
Carbachol – LogEC50  -6.77 ± 0.14  -6.88 ± 0.14  -6.78 ± 0.13  -6.75 ± 0.12 
KCl – Emax  0.16 ± 0.02  0.30 ± 0.06  0.25 ±0.06  0.28 ± 0.06 
Table 3-1.  Maximum (Emax) and Log EC50 values for Carbachol and KCl in isolated strips of 
canine detrusor muscle at different resting tensions.  Data are expressed as g/mg of wet 
tissue with results given as mean ± s.e.mean.  In all groups n = 22 animals. 
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KCl induced a dose dependent contraction of all isolated urinary bladder strips (Fig. 3-2). 
The mean maximal contraction produced by the strips of detrusor muscle in response to 
KCl was lower than that produced in response to carbachol (31%).  Contraction was 
measurable at 10mM and reached a maximum at 30mM, in all groups (Fig 3-3b), after 
which there was dose dependant relaxation.  The highest maximal contraction was seen in 
detrusor strips placed at 4g resting tension (Table 3-1).  As with carbachol the number of 
detrusor strips that either broke or did not respond to the protocol was higher in the strips 
at 6g (11%) and 8g (24%), compared to 4g (7%) and 2g (10%) resting tension.  Analysis of 
variance again showed no affect of age or weight of animal on the results gained. 
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Figure 3-2   A representative section of trace showing the contractile response to KCl in 
isolated strips of canine detrusor muscle.  Arrows denote addition of KCl. 
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Figure 3-3  Cumulative concentration response curves to a, carbachol and b, KCl in isolated 
strips of canine detrusor muscle.  Each point is the mean ± s.e.mean of observations from 
22 animals.  ■ 2g resting tension, ▲ 4g resting tension, ▼ 6g resting tension, ♦ 8g resting 
tension. 
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As strips placed under 4g resting tension gave the best results in the length tension studies, 
only these results were used to compare the affect of storage on contractile responses.  
Carbachol produced concentration dependant contraction of strips on all days studied (Fig. 
3-4a).  The maximal responses to carbachol on days 1 and 2 were similar (1.063 ± 
0.289g/mg and 1.021 ± 0.344g/mg respectively), however, the maximal responses seen on 
day 3 (0.365 ± 0.107g/mg) were significantly lower than those seen on days 1 and 2 (P < 
0.001).  There was no significant difference between the LogEC50 values on any of the 
days studied. 
As for the length tension study, KCl produced concentration dependant contraction of 
detrusor muscle strips on all days studied (Fig. 3-4b).  The pattern in maximal contraction 
to KCl was comparable to that of carbachol, with the maximal contraction on days 1 and 2 
being similar (0.421 ± 0.040g/mg and 0.429 ± 0.065g/mg respectively) but being 
significantly decreased (P < 0.001), on day 3 (0.095 ± 0.015g/mg) compared to days 1 and 
2. Victoria A. Coit, 2008     Chapter 3, 82 
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Figure 3-4.  Cumulative concentration curves to a, carbachol and b, KCl in isolated strips of 
canine detrusor muscle at 1 day ●, 2 days ■, and 3 days ▲ post harvesting of tissue. Each 
point is the mean ± s.e.mean of observations from 5 animals. *** P<0.001 compared to other 
groups. 
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3.4 Discussion and Conclusion 
Canine detrusor muscle responded to carbachol in a manner similar to that of other species 
studied (Fetscher et al., 2002; Hawthorn et al., 2000; Schneider et al., 2004), in that there 
was concentration dependant contraction of the smooth muscle strips.  By plotting the 
concentration dependant contractile responses to carbachol on a logarithmic scale a 
classical sigmoid curve was produced which allowed comparison between responses in 
terms of maximal contractile response seen and LogEC50 values, which gave an indication 
of the sensitivity of the tissue to the agonist.  When comparing the responses of the canine 
detrusor muscle to carbachol under differing resting tensions, it was found that although 
the maximal responses seen differed for the various resting tensions, the LogEC50 values 
were comparable between groups.  This similarity in LogEC50 values is to be expected as 
all strips were being tested against the same muscarinic agonist, and would therefore be 
expected to show similar sensitivities as the binding properties and receptor responses 
should be equal in all strips. 
Carbachol is thought to act mainly at the M3 receptors in the bladder, which are the 
receptors deemed responsible for the majority of the contractile action of the bladder 
during micturition (Chess-Williams, 2002); however, it is possible that at higher 
concentrations carbachol may act on the M2 and nicotinic receptors causing a change of 
state of the cation channels on the muscle cell membrane (Andersson et al., 2004a; Rang et 
al., 2007), and potentially altering both K
+ and Ca
2+ conductance across the cell 
membrane.  The change in state of K
+ ion channels, in particular, may explain why at 
higher concentrations (10µM and 30µM), carbachol was seen to invoke concentration 
dependant relaxation of the urinary bladder strips in this present study (Oh et al., 2003). 
Response of the canine detrusor muscle to KCl in this system was also as for other species 
studied (Chaiyaprasithi et al., 2003; Hawthorn et al., 2000).  KCl is a metal halide that 
disassociates in solution to form K
+ (the major cation of cells) and Cl
- ions, both of which 
are essential to many body systems and functions including conductance of nerve 
impulses, acid-base balance and carbohydrate metabolism.  KCl is not specific for any 
receptor but is thought to act directly upon the cell membrane (Foster et al., 1983).  When 
added to the extracellular environment KCl, at low concentrations, causes depolarisation of 
the cell membrane thereby leading to formation of action potentials and contraction of 
smooth muscle cells.  At higher concentrations (>40mM) it is possible that alterations in 
relative concentrations of K
+, Ca
2+, Na
+ and Mg
2+ ions may cause the hyperpolarisation of Victoria A. Coit, 2008     Chapter 3, 84 
the cell membrane and activation of various ion channels thereby inhibiting further 
contraction (Foster et al., 1983; Kravtsov et al., 1995), and eventually leading to 
relaxation. 
When comparing the responses of the canine detrusor muscle to KCl, under differing 
resting tensions, it was found that although the maximal responses seen differed between 
the groups, the overall shape of the graphs was similar, with maximal response seen at 
30mM KCl, followed by gradual concentration dependant relaxation at higher 
concentrations.  This suggests that the overall mechanisms responsible for contraction and 
relaxation of the detrusor muscle strips are similar for all resting tensions studied. 
The difference in maximal response to both carbachol and KCl seen between differing 
resting tensions is due to the effects of muscle length on the ability of the actin and myosin 
filaments within the thick and thin filaments to interact.  The interactions between these 
filaments cause shortening of the muscle fibre when the muscle is stimulated (Andersson et 
al., 2004a), which is evident as contractile tension in our system.  There is an optimum 
arrangement of these thick and thin filaments, which, when stimulated, produces maximal 
contraction of the muscle.  The resting tension at which this optimum alignment of thick 
and thin filaments within the smooth muscle will occur may vary between species and 
between different muscular organs as the in vivo passive tension normally placed upon the 
muscle will vary depending on species and organ.  If the resting tension is too low, the 
thick and thin filaments overlap to such a degree that further shortening of the muscle fibre 
to produce contraction is inhibited (Andersson et al., 2004a).  This is seen in this study by 
the fact that the group under 2g resting tension had the lowest maximum response and at 
this resting tension a number of strips failed to response to carbachol or KCl.  If the resting 
tension is too high, the thick and thin filaments are too far apart and therefore cannot 
interact properly to cause shortening of muscle fibres and contraction of the muscle when 
stimulated.  This was evident in the 6g and 8g groups in this study, which showed a lower 
maximal response than the 4g group.  The 6g and 8g groups also showed a greater number 
of strips breaking during contraction than the 2g and 4g groups.  For canine detrusor 
muscle it would therefore appear that 4g resting tension is the optimal tension for further in 
vitro studies, as this was the tension that gave the maximal response to both carbachol and 
KCl, with the lowest number of strips breaking or failing to respond to treatment.  This is 
in contrast to the 1-2g standard resting tension used in rat, rabbit and guinea pig (Kories et 
al., 2003; Longhurst et al., 2000; Longhurst et al., 2001), but within the range of 1-4g 
resting tension suggested for use in studying human detrusor function in vitro (Yoshida et 
al., 2006).  This similarity to human tissue is unsurprising as the canine urinary bladder Victoria A. Coit, 2008     Chapter 3, 85 
shows greater similarity in terms of size and function to that of the human compared to that 
of rats, rabbits and guinea-pigs. 
As canine tissue was donated supply was unpredictable, therefore, to optimise the system, 
a further study was conducted to determine the length of time, post tissue harvesting, that 
canine detrusor muscle would reliably and reproducibly respond in the above protocols.  
The results obtained demonstrated that tissue is viable for up to three days post harvesting 
but that contractile responses to stimulation significantly decrease on the third day.  These 
results also demonstrated that responses to stimulation to both carbachol and KCl were 
similar on the first and second day post harvesting.  From this it has been concluded that 
tissue may be stored and strips dissected out daily for use in protocols for two days after it 
has been harvested without affecting the responsiveness of the tissue.  This allowed 
maximal use of all tissue donated for use in further studies. 
As in the rat study in chapter 2, within-animal variation in the canine study was low; 
however, in contrast to the rat study, inter-animal variation was seen to be much higher in 
the canine.  As the techniques and equipment used were validated by the study in the rat 
(chapter 2) the variation in response between canines is not due to equipment or personnel 
but due to the animals themselves.  The rat population was consistent in terms of weight, 
age and strain of animal used, however, due to the constraints of the study this was not the 
case in the canine.  Analysis of variance showed that there were no significant effects of 
age or weight of the animal on the maximal contraction of the detrusor muscle strips to 
either carbachol or KCl, therefore the variation between animals cannot be due to these 
factors.  Although the breed of the animal may have a role to play in the variation seen, the 
majority of canines in the study were cross bred, thereby keeping specific breed variation 
to a minimum.  Previous studies in the rat have suggested that there may be functional 
changes in the bladder due to gender or ovariectomy (Fleischmann et al., 2002; Longhurst 
et al., 2000) therefore it was hypothesised that the variation seen between animals could be 
due to gender and neutering as male and female, entire and neutered animals were included 
in the study.  
In conclusion the study showed that 4g initial resting tension is the optimum resting 
tension for use in tissue bath studies that use the canine detrusor muscle, and that strips of 
this smooth muscle can be used for two days post harvesting without affecting the results 
gained.  Furthermore, high inter-animal variation in the responses of isolated strips of 
detrusor muscle to carbachol and KCl stimulation seen in this study suggest significant Victoria A. Coit, 2008     Chapter 3, 86 
differences in tissue responsiveness and sensitivity exist between canines, possibly due to 
gender or gonadal differences.  87 
4  Effects of Neutering on the in vitro Responses of 
Canine Detrusor Muscle Strips to KCl, Carbachol 
and Electrical Stimulation 
4.1 Introduction 
Urinary incontinence is defined as the involuntary loss of urine (Abrams et al., 2002), and 
is a severely debilitating condition that has significant welfare implications for affected 
patients.  In the canine, the most commonly seen form of urinary incontinence is acquired 
urinary incontinence also known as post neutering incontinence, as it is seen most 
frequently in bitches after they have been neutered.  Indeed, acquired urinary incontinence 
is seen in up to 20% of all neutered bitches (Arnold et al., 1989) whilst less than 1% of 
entire bitches and males are affected (Holt et al., 1993).  Acquired urinary incontinence has 
been directly linked to being neutered (Thrusfield, 1985), although mechanical damage of 
the lower urinary tract, during surgery, is not implicated in the aetiology (Gregory, 1994).  
A number of other hypotheses for the causes of post-neutering acquired urinary 
incontinence have also been put forward, including vascular, neurological and hormonal 
changes, the later of which is currently the subject of research.  Acquired urinary 
incontinence in the bitch is thought to have a similar aetiology to that of post menopausal 
incontinence in women, although the exact pathophysiology of the condition in these two 
groups is not well enough understood to allow determination of commonality of cause. 
It has been shown in women that although the resting tone of the urethra may be involved 
in post menopausal urinary incontinence, the urinary bladder also has a significant role to 
play.  Studies have shown that there is impaired contractility of the bladder in women 
suffering from post menopausal urinary incontinence (Elbadawi et al., 1993a) and that this 
is frequently found in conjunction with idiopathic detrusor instability (Elbadawi et al., 
1993b; Resnick et al., 1987).  In patients suffering from impaired bladder contractility a 
change in responsiveness and contractility of the detrusor muscle to muscarinic stimulation 
has been demonstrated in vitro (Mills et al., 2000) and these finding have been replicated 
in neutered female rats (Fleischmann et al., 2002; Zhu et al., 2001).  These aspects of 
bladder function in the canine have never been reported.   
Interestingly, during the validation studies reported in chapters 2 and 3 it was noted that 
there was a greater degree of variation in responsiveness of the detrusor muscle strips to Victoria A. Coit, 2008     Chapter 4, 88 
both carbachol and KCl stimulation in canines than in the rat.  Although there will be a 
degree of biological variation in response due to the diversity of the canine population 
studied, I hypothesise that a significant proportion of the variation seen in the canine study 
may be due to gonadal and / or gender differences in the study population.  As discussed 
above, in vitro studies have shown that gonadal status influences bladder contractility in 
both the human and the rat and that this change in contractility has been hypothesised to be 
linked to urinary incontinence in postmenopausal women (Mills et al., 2000).  A similar 
change in contractility of the detrusor in the canine may, therefore, be involved in the 
development of acquired urinary incontinence in neutered bitches.  It is of note that in the 
majority of the studies so far reported looking at the role of gonadal status on the function 
of the detrusor muscle in all species; the emphasis has been on the female, with only a few 
studies considering the changes that may occur in the bladder of male subjects after 
gonadectomy.  In particular, there are no studies looking at the contractility of the urinary 
bladder after gonadectomy in the male to see if similar functional changes occur as have 
been reported in the female. 
It is known that the muscarinic pathway is the primary pathway responsible for bladder 
contraction in the mammal (Chess-Williams, 2002).  Studies looking at the contractility of 
the detrusor muscle in vitro therefore seek to stimulate the muscarinic pathway either via 
muscarinic agonists, such as carbachol, or via neurogenic field stimulation.  It is also 
known, however, that part of the neuronally induced bladder contraction is resistant to 
atropine (Andersson et al., 2004a) and is therefore out-with cholinergic control.  This 
atropine resistant component of contraction is termed the non-adrenergic, non-cholinergic 
response and its proportion relative to the total contraction of the detrusor varies with 
species and disease state (Andersson et al., 2004a).  In humans this non-adrenergic, non-
cholinergic mediated response can contribute up to 65% of the total contraction in patients 
suffering from urinary incontinence due to detrusor overactivity, over twice that of control 
patients (Andersson et al., 2004b).  It is thought that the non-adrenergic, non-cholinergic 
response may be mediated by ATP, at least in the human (Andersson et al., 2004a; Palea et 
al., 1993).  There have been no reported studies looking at the role of the non-adrenergic, 
non-cholinergic system in the canine detrusor however. 
In this study the hypothesis that gonadal status and / or gender will alter the in vitro 
contractility and responsiveness of isolated strips of canine detrusor muscle to non-
specific, muscarinic and electrical field stimulation was tested.  The further hypothesis that 
the non-adrenergic, non-cholinergic system has a role to play in detrusor contractility in the 
canine was also tested.  Based on data from the human and the rat it was expected that the Victoria A. Coit, 2008     Chapter 4, 89 
responsiveness and contractility of the detrusor would be lowest in neutered animals and 
that the role of the non-adrenergic, non-cholinergic system would be greatest in 
gonadectomised animals. 
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4.2 Materials and Methods 
4.2.1 Animals 
The study was approved by The University of Glasgow Veterinary School’s ethical review 
committee.  Tissue from a total of 63 canines was included in the study, although not all 
animals were included in each protocol.  The study population had a mean age of 5.9 ± 0.5 
years (range 1-14 years) and a mean weight of 22.9 ± 1.3kg (range 8-48kg).  The canines 
were split into five groups depending on gender, gonadal status and incidence of acquired 
urinary incontinence: entire and neutered males, entire and neutered females, plus neutered 
females known to be suffering from acquired urinary incontinence (determined by history 
and signs of urine scalding around perineum).  The majority of canines were cross bred, 
with no pedigree breeds appearing more than once.  In all cases, tissue was collected 
within 2 hours of euthanasia (intravenous overdose of pentobarbatone), with full informed 
owner consent, for reasons other than scientific investigation.  The majority of animals had 
been euthanized for severe behavioural problems, the remainder for a number of different 
complaints, none of which involved the urinary system. 
 
4.2.2 Preparation of Tissue 
A full, detailed history of each animal was taken and a gross post-mortem of the entire 
urinary tract performed before the urinary bladder was harvested, sectioned across the level 
of the ureters, the dome of the bladder placed in Krebs solution (NaCl 118mM, KCl 
4.8mM, CaCl2 2.5mM, MgSO4 1.2mM, KH2PO4 1.2mM, NaHCO3 24mM, glucose 11mM) 
and stored at 4°C.  Any animal with a history of, or gross pathological signs of, urinary 
tract disease, other than acquired urinary incontinence, was excluded from the study. 
For all tissue bath protocols bladder tissue was used within 2 days of euthanasia of the 
animal (see chapter 3).   
Preparation of detrusor strips was as for chapter 3 with the addition of strips of detrusor 
muscle being mounted in Ag-AgCl ring electrodes (manufactured by Mr I. Gibson, 
Glasgow University Veterinary School) for electrical stimulation protocols (4.2.5 and 
4.3.6), as well as on fixed hooks for KCl and carbachol concentration response protocols 
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4.2.3 Assessment of KCl-Induced Contraction 
This was as described in chapter 3, with the exception that all strips of detrusor muscle 
were placed under 4g resting tension as this was deemed to be optimal (chapter 3). 
 
4.2.4 Basic Carbachol Concentration Response Protocol 
This was as described in chapter 3, with the exception that all strips of detrusor muscle 
were placed under 4g resting tension as this was deemed to be optimal (chapter 3). 
 
4.2.5 Basic Neurogenic Electrical Field Stimulation Protocol 
Strips of detrusor muscle were dissected as previously described, mounted on a fixed hook 
and passed through an Ag-AgCl ring electrode.  Strips were washed repeatedly with 
oxygenated Krebs as in the Carbachol and KCl protocols and tensioned until stable at 4g 
resting tension.  Once stable, the supramaximal voltage (at 20Hz) was determined for each 
strip by application of electrical stimulation (100 pulses) with increasing voltages until the 
maximal contractile response was seen; the voltage required to produce approximately 
70% of this response was considered the supramaximal voltage of that strip.  A train of 
three stimulations at this voltage was then conducted to test that the response seen at that 
voltage was stable. 
Strips were then washed, re-tensioned to 4g resting tension and allowed to equilibrate for 
30 minutes, during which time the strips were re-tensioned to 4g every 10 minutes.  Once 
stable, electrical field stimulation (0.5-100 Hz, 100 pulses) was delivered from a Digitimer 
Ltd MultiStim System-D330 stimulator at a pulse width of 0.5ms and at supramaximal 
voltage.  Stimulations were applied at five minute intervals to allow the re-establishment of 
normal resting tone between stimulations.  Frequency dependant contractions were 
observed.  To confirm that the observed responses to electrical field stimulation were 
neurogenic, at the end of the first three experiments for each group of animals the tissue 
strips were incubated with the neurotoxin Tetrodotoxin (1µM) (Sigma, UK) and stimulated 
at 20Hz every 5 minutes for 3 stimulations. Victoria A. Coit, 2008     Chapter 4, 92 
4.2.6 Non-Adrenergic, Non-Cholinergic Neurogenic Electrical 
Field Stimulation Protocol 
This was performed after the initial neurogenic field stimulation protocol described in 4.2.5 
on strips that were not treated with Tetrodotoxin.  In all cases a minimum of 4 strips from 
each animal were used. 
After the initial frequency response protocol was carried out all strips were washed 
repeatedly, allowed to rest for 30 minutes and then tensioned until stable at 4g resting 
tension.  A train of stimulations was then performed at 20 Hz and supramaximal voltage 
until 3 consecutive, stable responses were obtained.  This train was continued in all strips, 
with 2 strips receiving no chemical additions to act as time controls.  Atropine (Sigma, 
UK), a competitive antagonist at muscarinic receptors, was then added to the other baths to 
give a bath concentration of 1µM and the train of stimulation continued until 3 further 
stable contractions were obtained.  α-, β- methylene ATP Atropine (Sigma, UK),  an agent 
known to stimulate and
 then to desensitize P2-purinoceptors (Shinozuka et al., 1990), was 
then added to these baths to give a final bath concentration of 10µM and the chain of 
stimulation continued until 3 further stable contractions were obtained. 
 
4.2.7 Data Analysis 
All data were normalised for wet weight of tissue and results expressed as mean ± s.e.mean 
tension (g/mg of wet tissue) (n = number of animals).  Results for response to atropine and 
α-, β- methylene ATP are expressed as percentage of maximal, non-treated response. 
A minimum of 2 strips of bladder tissue per animal were analysed and the mean results 
from these strips used in further calculations where applicable.  Data were graphed and 
statistical analysis was performed using GraphPad Prism® v.5 software.  In all cases the 
maximal tension was the mean maximal tension of all the strips from that animal.  The 
LogEC50 values were calculated by GraphPad Prism® v.5 software from the mean data for 
each animal.  Comparisons between groups were made using analysis of variance 
(ANOVA) with Bonferroni post-test. A probability (P) less than or equal to 0.05 was 
considered significant.  Correlations between responses to muscarinic and electric field 
stimulation and the age and weight of the animals, were conducted using Spearman’s test 
with a significance threshold for P (two tailed) < 0.05.  Victoria A. Coit, 2008     Chapter 4, 93 
4.3 Results 
4.3.1 Response to KCl Stimulation 
There was concentration dependent contraction in all urinary bladder smooth muscle strips, 
in response to KCl.  Contraction was measurable at 10mM and reached a maximum at 
40mM, with the exception of the neutered females suffering from acquired urinary 
incontinence where the maximum contraction was seen at 30mM (Fig. 4-1).  Upon further 
addition of KCl, strips showed varying but progressive degrees of relaxation in all groups.  
Analysis of variance showed that there was no effect of gender on the contractile responses 
to KCl but that neutering was associated with a significantly decreased maximal response 
to KCl (P<0.05): entire females 0.34 ± 0.08g/mg (n = 6), neutered females 0.18 ± 
0.04g/mg (n = 5), entire male 0.31 ± 0.06g/mg (n = 8), neutered males 0.16 ± 0.06g/mg (n 
= 7).  There was no statistically significant interaction between the effects of gender and 
gonadal status on the KCl response of the tissue strips and no correlation between age or 
weight of the animal and maximal KCl values. 
The group of neutered female animals suffering from acquired urinary incontinence (n = 3) 
had a lower maximal response (0.09 ± 0.005g/mg) than that of all of the other groups but 
this difference in response was not statistically significant compared to that of the 
continent neutered females (95% CI -0.031 to 0.133).   
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Figure  4-1.  Cumulative  concentration  response  curves  to  KCl  in  isolated  canine  urinary 
bladder smooth muscle strips. Each point is the mean ± s.e.mean of observations from n 
animals. ■ entire male, n = 8, □ neutered male, n = 7, ● entire female, n = 6, ○ neutered 
female, n = 5, ▲ neutered female known to be suffering from acquired urinary incontinence, 
n = 3.  ** P<0.05 compared to animals of same gender. 
 
 
4.3.2 Response to Carbachol Stimulation 
In all groups, concentration dependant contractions were observed in response to carbachol 
(Fig. 4-2).  Neutering, regardless of gender, was associated with a significant decrease in 
the maximum contractile response of the isolated strips of bladder smooth muscle to 
carbachol compared to entire animals (p<0.05).  This change in maximum contractile 
response was accompanied by a significant decrease in sensitivity of the isolated strips of 
bladder smooth muscle to carbachol, as measured by the LogEC50 values (p<0.001) (Table 
4-1).  The group of neutered females suffering from acquired urinary incontinence had 
lower maximal responses to carbachol and lower sensitivity, as measured by LogEC50 
values, than other groups, but neither maximal response or sensitivity were significantly 
lower than from the continent neutered females (95% CI -0.340 to 1.103 and -0.580 to 
0.083 respectively).  2 way ANOVA indicated that there was no statistically significant 
effect of gender on the maximal responses to carbachol, and there was no interaction 
between gender and gonadal status on the response of the tissue to carbachol.  In addition, Victoria A. Coit, 2008     Chapter 4, 95 
the statistical analysis indicated that there was no correlation between age or weight of the 
canines and the tissue responses to carbachol. 
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Figure  4-2.  Cumulative  concentration  response  curves  to  carbachol  in  isolated  canine 
urinary bladder smooth muscle strips. Each point is the mean ± s.e.mean of observations 
from n animals.  Where the s.e.mean cannot be seen they lie within the symbols area.  ■ 
entire male, n = 15, □ neutered male, n = 11, ● entire female, n = 17, ○ neutered female, n = 8, 
▲  neutered  female  known  to  be  suffering  from  acquired  urinary  incontinence,  n  =  3.             
** P<0.05 compared to animals of same gender. 
 
 
  ME (n=15)  MN (n=11)  FE (n=17)  FN (n=8)  FN AUI (n=3) 
Emax  1.04 ± 0.11
 
0.51 ± 0.06
†  1.32 ± 0.14  0.56 ± 0.06
††  0.18 ± 0.03 
Log EC50   -6.97 ± 0.04  -6.47 ± 0.05
††  -7.02 ± 0.05  -6.51 ± 0.07
††  -6.26 ± 0.06 
Table 4-1. Maximum (Emax) and Log EC50 values for Carbachol in isolated strips of detrusor 
muscle  from  entire  and  neutered  male  and  female  canines  (ME,  MN,  FE  and  FN 
respectively),  and  neutered female  canines  known  to be suffering  from  acquired  urinary 
incontinence (FN AUI).  Data are expressed as g/mg of wet tissue with results given as mean 
± s.e.mean where  n =  number of  animals.   †
  P<0.05,  ††
  P<0.005 indicates different  from 
entire of same gender. 
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4.3.3 Response to Neurogenic Field Stimulation 
In all groups, frequency dependant contractions were observed in response to electrical 
field stimulation, with maximum tension observed at 20Hz.  The effects of neutering on the 
response of isolated strips of bladder smooth muscle to neurogenic electrical field 
stimulation were similar to those of carbachol, with a significantly (p<0.05) decreased 
maximal contractile response seen in neutered compared to entire animals, regardless of 
gender (Fig. 4-3); entire males 0.50 ± 0.05g/mg (n = 15), neutered males 0.29 ± 0.03g/mg 
(n = 9), entire females 0.69 ± 0.10 (n = 10), neutered females 0.27 ± 0.03 (n = 7).  
Unfortunately, data was only obtained from two of the three neutered female animals 
suffering from acquired urinary incontinence, due to equipment failure.  Maximal 
responses in these two animals were lower (Canine 22: 0.18g/mg, Canine 57: 0.26g/mg) 
than that seen in the neutered female group (95% CI is 0.264 to 0.362).  As with the 
responses to carbachol, there was no statistically significant effect of gender on size of the 
maximal response, and there was no interaction between gender and gonadal status on the 
response of the tissue to neurogenic field stimulation.  In addition the statistical analysis 
indicated that there was no correlation between age or weight of the canines and the tissue 
responses to neurogenic field stimulation. 
A significant positive correlation (P<0.001) was noted between the maximal contractile 
responses of the strips of urinary bladder smooth muscle to carbachol and neurogenic field 
stimulation, for all of the animals for which both sets of data were available; 9 entire 
males, 8 neutered males, 9 entire females, 6 neutered females, 2 neutered females suffering 
from acquired urinary incontinence (Fig. 4-4).  
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Figure 4-3. Frequency response curves to neurogenic field stimulation in isolated canine 
urinary bladder smooth muscle strips.  Each point is the mean ± s.e.mean of observations 
from n animals. ■ entire male, n = 15, □ neutered male, n = 9, ● entire female, n = 10, ○ 
neutered female, n = 7, ▲ neutered female known to be suffering from acquired urinary 
incontinence, n = 2.  ** P<0.05 compared to animals of same gender. 
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Figure 4-4. Graph showing the correlation between maximal tensions produced in response 
to carbachol and neurogenic field stimulation (correlation coefficient = 0.769). Each point is 
the combined data of one animal. ■ entire  male, n = 9, □ neutered male, n = 9, ● entire 
female, n = 10, ○ neutered female, n = 6, ▲ neutered female known to be suffering from 
acquired urinary incontinence, n = 2. 
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4.3.4 The Non-Adrenergic, Non-Cholinergic System 
In all animals there was minimal decrease in contractile response of the isolated strips of 
detrusor muscle to electrical field stimulation over time (<5% decrease). 
In all groups atropine produced a reduction in the response to electrical field stimulation 
demonstrating that part of the responses seen were mediated via the muscarinic receptors.  
However, as the response was not abolished by atropine this also demonstrated that part of 
the responses seen were mediated by the non-adrenergic, non-cholinergic system (Fig. 4-
5).  The atropine resistant component of the contractile response to electrical field 
simulation was statistically similar in each group studied. 
 
ME
MN
FE
FN
0
20
40
60
%
 
o
f
 
C
o
n
t
r
a
c
t
i
o
n
 
R
e
s
i
s
t
e
n
t
 
t
o
 
A
t
r
o
p
i
n
e
 
Figure  4-5.    Graph  showing  the  atropine  resistant  (non-adrenergic,  non-cholinergic 
mediated)  component  of  the  electrical  field  stimulation  induced  contractile  response  of 
isolated  strips  of  canine  urinary  bladder  smooth  muscle  from  entire  male  (ME,  n  =  5), 
neutered male (MN, n = 4), entire female (FE, n = 4) and neutered female canines (FN, n = 3). 
 
 
In all groups α-, β-methylene ATP produced a similar reduction in the maximal contraction 
produced by the isolated strips of detrusor muscle via the non-adrenergic, non-cholinergic Victoria A. Coit, 2008     Chapter 4, 99 
system in response to electrical field stimulation (Fig. 4-6).  Statistical analysis indicated 
that there was no difference in the size of the reduction between groups and that was no 
correlation between age or weight of the canines and the tissue responses to either atropine 
or α-, β-methylene ATP addition. 
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Figure 4-6.  Graph showing the α-, β- ATP sensitive component of the non-adrenergic, non-
cholinergic  mediated  contractile  response  of  isolated  strips  of  canine  urinary  bladder 
smooth muscle to electrical field stimulation.  Groups are entire male (ME, n = 5), neutered 
male (MN, n = 4), entire female (FE, n = 4) and neutered female canines (FN, n = 3).   
 
 
Over all carbachol, KCl, electrical field stimulation and non-adrenergic, non-cholinergic 
stimulation protocols it was noted that a small proportion of the isolated strips of detrusor 
muscle (minimum 8 strips per animal per protocol) failed to respond to stimulation.  This 
was more noticeable in the neutered animals (average 25% of strips) compared to the entire 
animals (average 12.5% of strips), and clearly more pronounced in the animals suffering 
from acquired urinary incontinence (average 62.5% of strips) than in the other groups.  
There was no correlation between age or weight of the animal and the number of strips 
from that animal that responded.   Victoria A. Coit, 2008     Chapter 4, 100 
4.4 Discussion 
This study investigated the effects of neutering on the in vitro contractility of the smooth 
muscle of the canine urinary bladder in response to a variety of stimulatory systems, to 
determine whether functional changes occur following neutering that may be associated 
with acquired urinary incontinence in the bitch.  This study further explored whether the 
non-adrenergic, non-cholinergic stimulation of detrusor activity had a role to play in 
electrical field stimulation induced contraction of the canine detrusor muscle in vitro and 
whether this differed between male and female, entire and neutered canines. 
The results from this present study demonstrate that, regardless of gender, there is a 
marked decrease in the magnitude of the response of the smooth muscle of the urinary 
bladder wall to KCl, carbachol and neurogenic electrical field stimulation in neutered 
compared to gonad intact animals and that the responsiveness of the bladder wall is further 
decreased in animals known to be suffering from acquired urinary incontinence.  In 
addition a decrease in sensitivity to carbachol, as measured by LogEC50 values, was also 
observed in the detrusor muscle strips from neutered compared to entire animals.  These 
changes could indicate a decrease in bladder muscle strength and contractility in vivo and 
thus could contribute to susceptibility to, and clinical signs of, acquired urinary 
incontinence.  
The generalised decrease in responsiveness of the detrusor muscle from neutered canines 
observed in this study is similar to that described in human patients where impaired 
contractility of the detrusor muscle is recognised as a predisposing factor for urinary 
incontinence in post-menopausal women (Resnick et al., 1987).  In post-menopausal 
humans, impaired bladder contractility is characterised by slow contraction of the bladder 
with contractions being of decreased magnitude that lead to partial emptying of the bladder 
and consequent retention of urine (Resnick et al., 1987), this is thought to predispose the 
person to developing urinary incontinence.  It is thus hypothesized that the decrease in 
response of the canine detrusor muscle, shown in the present study may, similarly be a 
causative factor for acquired urinary incontinence in the neutered bitch. 
KCl causes non-specific, receptor independent depolarisation of the cellular membrane 
leading to contraction of smooth muscle cells (see chapter 2).  Thus, the decrease in 
responsiveness to KCl seen in the neutered animals in this study could indicate a 
generalised decrease in contractility of the bladder in these animals.  As the response to 
KCl is further decreased in the animals known to be suffering from acquired urinary Victoria A. Coit, 2008     Chapter 4, 101 
incontinence it is possible that a decrease in bladder contractility could be at least partially 
responsible for the development of urinary incontinence in these animals.  If this were to 
be correct, this decrease in the strength of bladder contraction at the time of urination could 
result in incomplete urination and an accumulation of urine within the bladder that may be 
voided inappropriately, for example when abdominal pressure increases or the bladder 
contracts inappropriately, as in idiopathic detrusor instability in women.  Residual urine 
within the bladder may also lead to irritation of the bladder lining and wall and a 
propensity to develop cystitis, which is frequently seen in animals suffering from acquired 
urinary incontinence. 
The effects of neutering on the response to KCl in female canines seen in this study are 
supported by work in the rat and rabbit which showed that long term ovariectomy can 
significantly reduce the responsiveness of the bladder to KCl in vitro (Lin et al., 2006a; 
Longhurst et al., 1992).  Furthermore, work on the rabbit has shown that ovariectomy 
increases the RhoA / Rho-associated kinase (ROK-alpha) intracellular signalling pathway 
in the bladder (Lin et al., 2006b) which is known to be involved in bladder contraction 
(Christ et al., 2007).  The increase in Rho/ROK-alpha following ovariectomy in the rabbit 
is thought to be a compensatory mechanism by which the bladder strives to maintain 
contractility and function (Lin et al., 2006b), and the enhancement of this pathway may be 
responsible for the involuntary partial contraction of the bladder seen in patients diagnosed 
with idiopathic detrusor instability and associated urinary incontinence.  Lin et al. (2006b) 
also demonstrated that ovariectomy results in a decrease in the smooth muscle to collagen 
ratio within the urinary bladder which may also contribute to the decrease in the overall 
contractile responses of these bladders (Lin et al., 2006a).   
Carbachol is a non specific muscarinic agonist that causes contraction of the bladder via 
activation of the muscarinic pathways which are thought to be the primary pathways 
responsible for bladder emptying (Chess-Williams, 2002) and the pathways stimulated by 
electric field stimulation (Creed et al., 1983; D'Agostino et al., 1989) (see chapter 2).  This 
commonality of pathway regulation of contraction for both carbachol and electrical field 
stimulation is further supported by data which shows a positive correlation between 
maximal responses obtained to these stimulations in all animals studied.  The differences in 
function within these pathways in entire and neutered canines observed in the current study 
could dramatically alter the bladder’s ability to contract fully as a single functional unit and 
thus affect normal bladder function.  This possibility is supported by the data from 
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contractile response to carbachol fell below the 95% CI for the continent neutered female 
group. 
Urinary incontinence is recognised as a multimodal condition in all species studied.  In 
human patients urinary incontinence has been linked to decreased responsiveness of the 
detrusor muscle to muscarinic and electrical field stimulation in vitro that may be due to 
changes in the muscarinic receptor effector pathway, as described above, and idiopathic 
detrusor instability (Mills et al., 2000).  Clinically idiopathic detrusor instability can lead to 
urge incontinence and inappropriate leakage of urine as bladder tone is unstable and thus 
partial contraction of the detrusor muscle, during the storage phase of micturition, can 
occur out-with the conscious and voluntary control of the patient (Mills et al., 2000; 
Resnick et al., 1989).  Whilst idiopathic detrusor instability has not been studied 
functionally in the bitch, the results of this in vitro study demonstrate a decrease in the 
responsiveness of the bladder smooth muscle to neurogenic field stimulation in neutered 
canines, which is similar to that seen in human patients suffering from idiopathic detrusor 
instability, and thus is consistent with a role for detrusor instability in acquired urinary 
incontinence in the bitch. 
As discussed previously acquired urinary incontinence in canines is gender specific 
(Arnold et al., 1989; Aaron et al., 1996).  Interestingly this study demonstrated that 
changes in responsiveness to KCl, carbachol and electrical field stimulation occur in 
bladder smooth muscle in neutered canines of both genders.  Whilst the functional changes 
observed in this study could support the development of acquired urinary incontinence in 
the neutered bitch, it is worthy of note that similar changes occurred in the bladder of 
neutered male canines, which do not typically become incontinent.  This sex difference in 
the propensity to develop acquired urinary incontinence despite similar changes in detrusor 
contractility could reflect an interaction between post neutering effects on smooth muscle 
function and known anatomical differences in the urethra of male and female canines, that 
make the development of acquired urinary incontinence less likely in the male.  Namely, 
the increased urethral length and passage of the urethra through the prostate and penile 
structures in the male is thought to provide a greater and more consistent urethral closure 
pressure than in the female (Aaron et al., 1996), and this could counter the effects of 
neutering on the detrusor muscle and help explain why urinary incontinence is less 
prevalent in neutered male canines.  
Although the primary pathway responsible for bladder contraction is known to be the 
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proportion of contraction may be mediated via other mechanisms such as the adrenergic 
and non-adrenergic, non-cholinergic mechanisms.  It is known that in most mammalian 
species part of the neuronally induced bladder contraction is resistant to atropine 
(Andersson, 1993).  This atropine resistant component of contraction is termed the non-
adrenergic, non-cholinergic mediated response and it’s contribution to the total contraction 
has been reported to vary with both species and the frequency of stimulation used in in 
vitro studies.  The results of the present study suggest that this mechanism has a role to 
play in mediating contraction in the canine urinary bladder and that it may mediate up to 
50% of the electrically stimulated response.  It has been reported that the non-adrenergic, 
non-cholinergic system may be responsible for up to 75% of the contractile response in 
isolated strips of detrusor muscle from rats (Andersson et al., 2004a) but in rabbits and 
pigs this figure falls to 60 and 25% respectively (Brading et al., 1991).  In the human 
bladder the role of the non-adrenergic, non-cholinergic mechanism is still disputed 
(Andersson et al., 2004a), however, it has been reported that the non-adrenergic, non-
cholinergic mechanism is responsible for between 0 and 50% of the nerve mediated 
contraction of the urinary bladder in the human (Cowan et al., 1983; Sibley, 1984).   
This present study also demonstrated that although the maximal contraction to electrical 
field stimulation varied with gonadal status, the proportion of the response mediated via 
the non-adrenergic, non-cholinergic system was not significantly different in all groups 
studied, although a trend was seen for the non-adrenergic, non-cholinergic component of 
electrical field stimulated contraction to be less in entire animals.  This trend agrees with 
the original hypothesis that stated that gonadectomised animals would have a significantly 
higher proportion of the contractile response mediated by the non-adrenergic, non-
cholinergic system, although further study including larger numbers of animals should be 
conducted before further analysis and conjecture.  The original hypothesis was based on a 
number of reported studies looking at the role of the non-adrenergic, non-cholinergic 
mechanism in bladder contraction in certain disease states in humans, namely bladder 
outflow obstruction and detrusor overactivity that resulted in urinary incontinence.  These 
studies have reported a variety of results but agreed that the atropine resistant component 
of electrically induced contraction was much greater (25 – 65%) in association with 
bladder outlet obstruction and detrusor overactivity than in controls (Andersson et al., 
2004b).   
The functional neurotransmitter(s) responsible for the non-adrenergic, non-cholinergic 
mechanism have not yet been fully identified, however a number of compounds have been 
proposed.  These include Adenosine-5'-triphosphate (ATP), nitric oxide, various Victoria A. Coit, 2008     Chapter 4, 104 
neuropeptides and prostanoids.  Of these, ATP has been the most extensively studied and 
demonstrates the most compelling evidence for involvement in the non-adrenergic, non-
cholinergic mechanism of bladder contraction (Andersson et al., 2004a).  The present 
study demonstrated that the majority of the non-adrenergic, non-cholinergic mediated 
response in the canine, regardless of gender and gonadal status, is mediated by ATP.  This 
result agrees with a number of studies in humans and guinea-pigs which have 
demonstrated that the atropine resistant portion of contraction can be blocked by α, β- 
methylene ATP (Andersson et al., 2004a; O'Reilly et al., 2002; Palea et al., 1993).  It is 
known that ATP works via stimulation of P2X receptors (Andersson et al., 2004a), and it 
has been shown that the P2X receptor subtypes are present in the human bladder (Hardy et 
al., 2000; O'Reilly et al., 2002).  Further studies have shown that other animals, such as the 
rat, mouse, rabbit and cat have multiple purinergic excitatory receptors present within the 
bladder as well (Andersson, 1993).  It is hypothesised that ATP mediates detrusor 
contraction via activation of a ligand-gated cation channel (the P2X receptor) that 
promotes the influx of extracellular Ca
2+ (Andersson et al., 2004a).  This all suggests that 
ATP may contribute to excitatory neurotransmission within the bladder, and that the 
purinergic system, as part of the non-adrenergic, non-cholinergic mechanism may have a 
role to play in contraction of the canine bladder.  
In conclusion, the results of this study support the first hypothesis and demonstrate that the 
neutering of canines, regardless of gender, is associated with a reduction in the response of 
the detrusor muscle to non specific KCl, muscarinic and electrical field stimulation in 
vitro.  This important observation has not been reported previously, as prior studies in 
rodents have only investigated the effects of neutering on females.  It is hypothesized that 
the generalised decrease in responsiveness seen in neutered animals may be due to relative 
changes in urinary bladder wall structure, such as decreased smooth muscle and/or 
increased connective tissue.  This study also demonstrates that there is a non-adrenergic, 
non-cholinergic mediated component of contraction in the canine.  This non-adrenergic, 
non-cholinergic component appears to be mediated mainly via the purinergic system which 
is definitely not affected by gender nor gonadal status. 
The changes seen to muscarinic and electrical field stimulation in neutered canines in this 
study may also be due to an, as yet, unidentified mechanism that involves the muscarinic 
receptor effector- pathway that could result in a condition similar to idiopathic detrusor 
instability and impaired contractility of the bladder in the human.  Further factors that may 
interact with the receptor effector pathway are changes in sex hormone concentrations and 
steroid or gonadotrophin receptor expression in the bladder wall, that occur post neutering Victoria A. Coit, 2008     Chapter 4, 105 
(Reichler et al., 2005b; Welle et al., 2006).  That the observed changes in KCl, muscarinic 
and electrical responsiveness are important factors for predisposing individuals to acquired 
urinary incontinence is supported by the data collected from neutered females that were 
identified as suffering from acquired urinary incontinence, as they showed the lowest 
contractility and responsiveness of the detrusor muscle.  The muscarinic pathway may, 
therefore, present a potential new therapeutic target for treatment of this debilitating 
condition in the bitch, and an understanding of this pathway may help further our 
understanding of certain forms of the condition in the human model.106 
5  Morphometric Analysis of the Canine Urinary 
Bladder – The Effect of Neutering on Percentage 
Collagen 
5.1 Introduction 
As previously discussed, acquired urinary incontinence in the bitch is a debilitating and so 
far incurable condition.  Acquired urinary incontinence is hypothesised to be hormonally 
related as it is reported to affect 20% of neutered bitches (Arnold et al., 1989) compared to 
0-1% of intact bitches (Holt et al., 1993).  Acquired urinary incontinence in the bitch is 
associated with a decrease in maximal urethral closure pressure (Rosin et al., 1981) but as 
this is not a defining characteristic, the exact pathophysiology of the condition remains 
unknown and multiple causative factors are likely to be involved.  Urinary incontinence is 
also seen in post menopausal women where it is known that changes within the bladder 
wall are an important contributory factor to its development (Resnick et al., 1987).   
Previous studies have reported that neutering of canines is associated with decreased 
bladder responsiveness to KCl and neurogenic field stimulation, and decreased sensitivity 
and responsiveness to muscarinic stimulation (chapter 4).  These results are similar to those 
of women suffering urinary incontinence due to impaired contractility of the bladder and 
idiopathic detrusor instability (Elbadawi et al., 1993a; Elbadawi et al., 1993b).  These two 
conditions have been hypothesised to cause decreased strength of contraction of the 
bladder at the time of voluntary urination; as well as involuntary and unconscious partial 
contractions of the bladder during the storage phase of micturition.  It has also been 
hypothesised that, in women, an increase in the collagen to smooth muscle ratio within the 
wall of the urinary bladder contributes to the pathophysiology of both idiopathic detrusor 
instability and impaired bladder contractility as it may physically change contractile ability 
and alter electrical conductivity within the smooth muscle that makes up the bladder wall 
(Charlton et al., 1999; Chen et al., 2002a). 
The smooth muscle of the bladder wall is the component of the bladder that is directly 
responsible for bladder relaxation during the storage phase and bladder contraction during 
the expulsion phase of micturition.  The detrusor muscle is made up of three layers of 
smooth muscle bundles arranged in an outer and inner longitudinal layer with a middle 
circular layer (Dyce et al., 2002).  The layers are made up of muscle bundles which in turn Victoria A. Coit, 2008     Chapter 5, 107 
are composed of muscle fibres grouped into fascicles or functional units (Dyce et al., 
2002).  The smooth muscle of the bladder in the healthy individual contracts as a single 
unit via both gap junctions between the smooth muscle cells which allow direct electrical 
coupling, and via nervous coordination mediated by a dense nerve network (Andersson et 
al., 2004a).  In the human, it is known that a small amount of collagen is present within the 
bladder and that it is found within the connective tissue that surrounds the large muscle 
bundles as well as within the muscle bundles themselves (Andersson et al., 2004a).  If the 
amount of collagen increases in this area it can lead to problems with conductance of 
action potentials throughout the muscle layers due to disruption of the cell to cell contacts 
within the muscle bundles and could therefore affect micturition, potentially leading to 
urinary incontinence (Charlton et al., 1999). 
This study tested the hypothesis that, as in post menopausal women with urinary 
incontinence, the percentage collagen (relative to smooth muscle) within the urinary 
bladder wall will be increased in neutered compared to entire canines and that these 
changes will be most extreme in neutered bitches suffering from acquired urinary 
incontinence.   Victoria A. Coit, 2008     Chapter 5, 108 
5.2 Materials and Methods 
5.2.1 Animals 
A total of 81 canines were included in the study, with a mean age of 6.0 years (range 1-14 
years) and a mean weight of 25.6kg (range 8-48kg).  The study was approved by The 
University of Glasgow Veterinary School’s ethical review committee.  The canines were 
split into five groups depending on gender, gonadal status and incidence of acquired 
urinary incontinence: entire and neutered males (ME, n=29 and MN, n=14), entire and 
neutered females (FE, n=25 and FN, n=11), plus neutered females known to be suffering 
from acquired urinary incontinence (FN AUI, n=3), as ascertained by history and physical 
examination.  All the entire females in the study were considered to be in anoestrus, based 
on history and exam of the ovaries.  All of the neutered canines used in this study were 
understood to have been neutered at least 6 months prior to euthanasia.  To enable the best 
use of material obtained, a number of canines used in this study were also included in the 
tissue bath studies previously described.  The majority of canines were cross bred, with no 
pedigree breeds appearing more than once.  In all cases, tissue was collected within 2 hours 
of euthanasia (intravenous overdose of pentobarbatone), with full informed owner consent.  
In all cases, euthanasia occurred for reasons other than scientific investigation.  The 
majority of animals were destroyed for severe behavioural problems, the remainder for a 
number of different complaints, none of which involved the urinary system except in the 
case of those animals known to be suffering from acquired urinary incontinence.   
 
5.2.2 Preparation of Tissue 
A full, detailed history of each animal was taken and a gross post-mortem of the entire 
urinary tract performed before the urinary bladder was harvested.  The bladder was 
sectioned across the level of the ureters and a 2cm x 2cm full thickness section of the 
lateral dome removed and placed in 10% neutral buffered formalin (Bancroft et al., 2003) 
for a minimum of twenty four hours.  Any animal with a history of, or gross pathological 
signs of neurological, reproductive or urinary tract disease, other than acquired urinary 
incontinence, was excluded from the study. 
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5.2.3 Morphometric Analysis   
Samples were transferred to an Excelsior Vacuum Tissue Processor (ThermoShandon, 
Thermo Fisher Scientific, UK) and processed for paraffin wax embedding using a standard 
17 hour processing cycle.  Samples were then embedded into paraffin blocks (Embedding 
Centre, Bayer, UK) and 5 micron sections cut on a Finesse microtome (ThermoShandon). 
Sections were transferred to a 60°C incubator for 60 minutes and deparaffinised in Xylene 
before being taken to water through graded alcohols.  Sections were stained with 
Haematoxylin & Eosin and Masons Trichrome stain (Bancroft et al., 2003), with the 
modification that Light Green was used instead of Methyl Blue and Orange G staining was 
added to allow visualisation of red blood cells.   
Stained sections were evaluated for artefacts and staining qualities and two good quality 
sections (slices) from different areas of the tissue block were selected for detailed 
morphometric analysis.  Morphometric evaluations were performed by light microscopic 
stereologic analysis, at a magnification of 40X, as described previously (Bartsch et al., 
1979; Hashimoto et al., 1999; Shapiro et al., 1991).  Briefly, 2-3 images were captured 
from each tissue slice (making a total of 5-6 images per animal) with a DM 4000 B 
microscope (Leica, UK).  The percentage of collagen (stained green) relative to other 
tissue (all stained areas) within each field was then determined using image analyses 
software (FW 4000, Leica, UK).  In this the picture was pixelated and colour segmentation 
used so that the green stained area could be accurately identified and quantified by the 
software using binary techniques.  The green stained areas were calculated relative to all 
other stained areas, with any white areas within the field (such as produced by processing 
artefacts or the lumen of the bladder) discounted.  
 
5.2.4 Statistical Analysis  
A minimum of five fields over 2 tissue slices were evaluated for each animal and the 
results meaned to give the value for that animal.  Data for each group (male, female, entire 
and neutered as well as neutered female animals known to be suffering from acquired 
urinary incontinence) are expressed as mean ± s.e.mean (n = number of canines).   
Data were graphed and statistical analysis was performed using GraphPad Prism® v.5 
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variance (ANOVA) with Bonferroni post-test.  A probability (P) less than or equal to 0.05 
was considered statistically significant.  Correlations between percentage of collagen and 
the age and weight of the animals, as well as between percentage of collagen and maximal 
response to carbachol (chapter 4), where appropriate, were assessed using Spearman’s test 
with a significance threshold of P (two tailed) < 0.05.   Victoria A. Coit, 2008     Chapter 5, 111 
5.3 Results 
Staining with Masons Trichrome Orange G allowed visualisation of collagen (staining 
green) and smooth muscle (staining red) in all sections of bladder wall (Fig. 5-1).  The 
percentage collagen in the bladder wall of entire canines was not affected by gender: ME 
18.55 ± 0.99% (n=29), FE 17.45 ± 1.25% (n=25).  The percentage of collagen within the 
bladder wall of the neutered males (19.18 ± 1.19%, n=14), was also not statistically 
different to that seen in the entire male and female canines.  In stark contrast to the results 
seen in the males, the percentage collagen within the bladder wall in neutered females 
(42.94 ± 2.61%, n=11) was significantly increased (P<0.001) relative to that seen in their 
entire counterparts and indeed all other groups (Fig. 5-2).  Further, the three neutered 
female canines known to suffering from acquired urinary incontinence had some of the 
highest values of percentage collagen within the study (54.3%, 58.7% and 48.7%), these 
values being above the 95% CI values (37.12 – 48.6) for the female neutered group.  
Visual inspection of the sections indicated that the greater percentage of collagen in the 
bladder wall of the neutered female animals was due to greater collagen deposition both 
between and within the muscle bundles.  There was no correlation between age or weight 
and percentage of collagen within the urinary bladder wall. 
 
Figure 5-1.  Representative sections of bladder wall (X40 magnification) from each group 
stained with  Masson  Trichrome  Orange  G  to  allow  visualization  of  collagen  (green)  and 
smooth muscle (red). 
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Figure 5-2.  Summary data of percentage of collagen within the canine urinary bladder wall 
from entire and neutered male and female canines (ME n=29, MN n=14, FE n=25 and FN n=11 
respectively),  and  neutered  female  canines  suffering  from  acquired  urinary  incontinence 
(n=3). Data are mean ± s.e.mean. $$ P<0.05, *** P<0.001 compared to groups indicated. 
 
 
 
 
Analysis of correlation between percentage collagen within the urinary bladder wall and 
maximal tension produced by isolated strips of detrusor muscle for each group did not 
reveal a statistically significant result, which may reflect the relatively low number of 
animals per group for which both sets of data were available.  However, overall 
comparison of the maximal responses to carbachol and the percentage collagen within the 
urinary bladder wall indicated a statistically significant (P<0.05) negative correlation 
existed between these two characteristics (Fig. 5-3).  
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Figure 5-3.  Graph showing overall negative correlation between maximal tension produced 
in response to carbachol stimulation against percentage collagen within the bladder wall 
(P<0.05), r=-0.594.  ■ entire male,  □ neutered male,  ● entire female,  ○ neutered female,   
▲ neutered female known to be suffering from acquired urinary incontinence. Victoria A. Coit, 2008     Chapter 5, 114 
5.4 Discussion 
Due to the observed relationship between percentage collagen in the bladder wall of post 
menopausal urinary incontinent women, relative to their continent peers, this study tested 
the hypothesis that percentage collagen (relative to smooth muscle) within the urinary 
bladder wall of neutered canines will be increased, compared to entire canines, with the 
changes being most extreme in neutered female canines that suffered from acquired urinary 
incontinence.  The study included both male and female canines and, to the author’s 
knowledge is the first study to look at the association between neutering and percentage 
collagen of the urinary bladder in a male animal of any species.  The results demonstrate 
that the percentage of collagen within the urinary bladder of an entire canine is comparable 
between genders and interestingly that percentage collagen is only altered with gonadal 
status in females, in which a two-fold increase is seen, similar to that reported to occur in 
post menopausal human females who suffer from urinary incontinence (Elbadawi et al., 
1993a; Elbadawi et al., 1993b).   
The increase in the percentage of collagen within the bladders of the neutered bitches in 
this present study is also similar to that reported in ovariectomised rodents, in which a 
decrease in relative smooth muscle content and an increase in percentage of collagen 
within the bladder wall has previously been reported (Fleischmann et al., 2002; Zhu et al., 
2001).  The results of this present study and those reported in the rat (Fleischmann et al., 
2002; Zhu et al., 2001), however, are at odds with the results of a study conducted in 
rabbits which showed a relative decrease in the amount of connective tissue within the 
bladder after ovariectomy (Hashimoto et al., 1999).  While these differences in the post 
ovariectomy changes in percentage collagen in bladder wall structure could reflect species 
specific variation, it is important to note that there were also significant differences 
between the experimental designs used in these studies.  Most notable of these, was the 
interval between ovariectomy and investigation, as the rabbit study reported acute (6 week) 
but the rat chronic (4 month), effects of ovariectomy on bladder wall structure.  The 
changes noted in this canine study concur with those obtained in rats (Fleischmann et al., 
2002; Zhu et al., 2001) and in that respect it is important to note that both studies reported 
chronic effects of ovariectomy.  While the exact date of ovariectomy was not known for all 
of the animals in this present study population, based on anatomical features and the 
supplied history it can be reliably concluded that gonadectomy had occurred  >6 months 
prior to study.   Victoria A. Coit, 2008     Chapter 5, 115 
The observed increase in collagen within the bladder wall of the neutered females in this 
study appeared to occur both within and between the muscle bundles that make up the 
detrusor muscle.  This location has potential negative functional consequences with regard 
to normal bladder function, as it may decrease the contractility and elasticity of the 
detrusor and / or affect bladder compliance.  Both of these features may in turn affect the 
bladder’s ability to relax and expand to store urine, a feature of the bladder which has been 
linked to urinary retention and urinary incontinence in the human (Chen et al., 2002a).  
Intramuscular collagen deposition is also hypothesized to decrease conduction of action 
potentials throughout the muscle fascicle (Fleischmann et al., 2002), and thus could have a 
negative effect on the ability of the bladder to contract as a single functional unit.  The 
possibility that the observed changes in collagen deposition may predispose neutered 
bitches to acquired urinary incontinence is supported by the data from the neutered females 
known to be suffering from acquired urinary incontinence which had some of the highest 
percentage collagen of all the animals studied, but as shown in chapter 4, the lowest 
responses to KCl, muscarinic and electrical field stimulation of all animals tested.  An 
increase in percentage collagen has also been reported in the wall of the urinary bladder of 
women with detrusor instability, where it is associated with an altered sensory threshold 
for cholinergic stimulation of the bladder (Charlton et al., 1999), which leads to decreased 
bladder filling and increased partial bladder contractions, often out-with the conscious 
control of the patient. 
The changes in muscle structure and percentage collagen described above have been 
proposed to be brought about by the changes in female reproductive hormones, namely a 
loss of oestrogen, that occur after the menopause (Thom et al., 1998) or ovariectomy 
(Thrusfield, 1985).  This conclusion is supported by data from the rat and rabbit where 
smooth muscle fibres were demonstrated to be maintained, and in some cases increased, by 
exogenous oestrogen treatment of ovariectomised animals (Fleischmann et al., 2002; 
Hashimoto et al., 1999; Zhu et al., 2001).  In addition, a study that looked at the coronary 
vessels of female rats has also demonstrated that oestrogen has a protective effect on these 
structures, following ovariectomy, as it prevents the proliferation of fibroblasts and the 
deposition of collagen within the smooth muscle of the vessel walls (Blacher et al., 2000).  
Despite these reported protective effects of oestrogen on smooth muscle, there are no 
studies that document that exogenous oestrogen supplementation can prevent changes 
occurring after the discontinuation of treatment, as was hoped with hormone replacement 
therapy (HRT) or reverse changes that have already occurred.  Therefore, oestrogen 
supplementation after the appearance of clinical signs of urinary incontinence has 
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might accompany urinary incontinence.  Indeed, this may explain why replacement 
oestrogen therapy, a standard treatment for urinary incontinence in the bitch, whilst known 
to increase the urethral closure pressure in incontinent bitches (Creed, 1983), only 
produces improvement in continence in approximately 65% of bitches (Arnold et al., 1989; 
Janszen et al., 1997; Janszen BPM, 1997; Mandigers et al., 2001) and often only 
temporarily (Hotston Moore, 2001).   
This lack of efficacy of supplemental exogenous oestrogen, as a cure for acquired urinary 
incontinence in the bitch, is not necessarily the calamity it was once thought, however, as 
other studies that have looked at the effects of gonadectomy on smooth muscle structure 
and function (Fleischmann et al., 2002; Hashimoto et al., 1999; Zhu et al., 2001) have 
concentrated on the female and have not looked at the effects on the male of the species.  
These studies, therefore, may have concluded a potentially greater role for the loss of 
oestrogen than may be warranted.  The gender specific effect of neutering on the 
percentage of collagen within the urinary bladder that this present study has demonstrated 
is significant, as earlier work has shown that there is a significant decrease in contractility 
of the detrusor muscle to KCl, muscarinic and electrical field stimulation, and a decrease in 
sensitivity to muscarinic stimulation, in neutered animals of both genders (chapter 4).  
Previous studies in postmenopausal women and ovariectomised rodents have found similar 
decreases in function of the detrusor muscle, and the authors of these studies have related 
these changes to increases in the collagen to smooth muscle ratio within the bladders 
studied (Elbadawi et al., 1993a; Elbadawi et al., 1993b; Fleischmann et al., 2002).  This 
present study, the first to include male animals, shows clearly that the decrease in function 
following gonadectomy is evident in both males and females, but that the increase in the 
percentage of collagen is only evident in the bladders of the neutered female animals.  This 
suggests that a further mechanism is involved in the decrease in contractile function of the 
bladder in gonadectomised animals and this may involve the muscarinic receptor effector 
pathway which may in turn be influenced by the changes in gonadotrophin hormone 
concentrations post neutering, as well as other, as yet unidentified factors.   
In conclusion, this study demonstrates that neutering a bitch significantly increases the 
percentage of collagen within the urinary bladder wall, whilst neutering a male canine has 
no effect on percentage of collagen when compared to entire animals of either gender.  The 
results from the neutered bitches that were known to be suffering from acquired urinary 
incontinence show the highest percentage collagen of all animals studied and suggest that 
this increase may have a role to play in the development of clinical signs of urinary 
incontinence; however, the significance of this interaction remains unknown.  The Victoria A. Coit, 2008     Chapter 5, 117 
difference in the effects of gonadectomy on percentage collagen suggests that the role of 
collagen in altering the contractility of the bladder may have been overemphasised 
previously and with the previous in vitro contractility study, suggests that further 
mechanisms are involved in regulating the decreased responsiveness of the detrusor muscle 
post neutering in both genders.  For example, changes in reproductive hormone levels, 
their receptors and signalling mechanisms or in the muscarinic effector pathway within the 
bladder must be investigated to allow clearer understanding of the aetiology and 
pathophysiology of both acquired urinary incontinence in the bitch and postmenopausal 
incontinence in women. 118 
6  Pharmacological Characterisation of Muscarinic 
Receptors in Canine Urinary Bladder 
6.1 Introduction 
Acquired urinary incontinence in the bitch is a widespread problem causing significant 
welfare complications for the animals affected.  Acquired urinary incontinence is currently 
reported to affect up to 20% of all neutered bitches (Arnold et al., 1989), whilst less than 
1% of entire bitches and males are thought to suffer from the condition (Holt et al., 1986).  
Although a decrease in resting tone within the urethra has long been proposed as the 
primary mechanism by which acquired urinary incontinence occurs (Holt, 1988), further 
mechanisms are thought to have a role to play in the aetiology and pathogenesis of the 
condition.  In post menopausal women who suffer from urinary incontinence, a group 
thought to share a similar aetiology to that of the canine disease, the development of 
urinary incontinence is known to involve changes within the urinary bladder, including 
structural alterations and responsiveness to muscarinic stimulation (Elbadawi et al., 1993a; 
Resnick et al., 1987).   
The results of chapter 4 demonstrated that there is a significant decrease in in vitro 
sensitivity and maximal contractility in response to muscarinic stimulation of isolated 
strips of detrusor muscle in neutered compared to entire animals, regardless of gender.  
Furthermore I have demonstrated that these changes cannot be solely due to structural 
alterations within the bladder, as the percentage collagen within the bladder only increased 
in neutered female and not male animals (chapter 5).  This suggests that there is a common 
structural pathway or molecular target in both genders that is affected by neutering and has 
a role to play in the altered contractility of the bladder.  Given the above differences in 
response to muscarinic stimulation and as the muscarinic pathway is known to be the 
primary pathway responsible for micturition (Chess-Williams, 2002) it follows that 
changes within it may alter the contractility of the bladder. 
Studies in a number of animals have shown that all five muscarinic subtypes are present 
within the urinary bladder (Abrams et al., 2006; Chess-Williams, 2002; Wang et al., 1995), 
but that the M2 and M3 receptors predominate, with the M2 receptor out numbering the M3 
receptor subtype (Hegde et al., 1999; Wang et al., 1995).  Despite this, it is the M3 
receptors that are thought to be the principle receptors responsible for regulating 
micturition and bladder contraction in healthy individuals, including humans (Chess-Victoria A. Coit, 2008     Chapter 6, 119 
Williams, 2002), rats (Longhurst et al., 2000), guinea-pigs (Wang et al., 1995) and canines 
(Choppin et al., 2001).  Interestingly, however, a study using M2, M3 and M2/M3 receptor 
knockout mice has shown that the M2 receptor can not only enhance the contractile 
response to M3 activation but also directly stimulate detrusor contraction (Ehlert et al., 
2005).  This role for the M2 receptor in bladder contraction is further strengthened by a 
recent study in rats that indicated a minor role for both the M1 and M2 receptor subtypes in 
urinary bladder contraction and relaxation (Frazier et al., 2007).  Of particular interest with 
regard to an effect of receptor isoforms and possible causes of altered bladder function 
post-neutering or after alterations in hormone levels, are the reports that the proportions of 
muscarinic receptor subtypes within the urinary bladder may be altered in terms of density 
and function in different disease / physiological states (Abrams et al., 2006; Chess-
Williams, 2002).  In particular, it has been shown that following denervation of the 
bladder, the role of the M3 receptor is diminished and the M2 subtype becomes the 
predominate receptor responsible for bladder contraction (Braverman et al., 1998b; Pontari 
et al., 2004).  This is potentially significant, with regard to acquired urinary incontinence in 
the bitch, as a limited study in pigs has suggested that bladder contractions mediated via 
stimulation of the M2 receptor may be weaker than those mediated by the M3 receptor and 
that the sensitivity of the M2 receptor to carbachol may be less than that of the M3 receptor 
(Yamanishi et al., 2000). 
The above findings lead to the possibility that the altered contractility of the detrusor 
muscle demonstrated in neutered canines (chapter 4) may be influenced by a change in the 
functional muscarinic receptor subtype in the bladder.  This study will thus test the 
hypothesis that neutering will alter the functional muscarinic receptor subtype of the 
bladder from predominately the M3 to the M2 receptor. Victoria A. Coit, 2008     Chapter 6, 120 
6.2 Materials and Methods 
6.2.1 Animals 
The study was approved by The University of Glasgow Veterinary School’s ethical review 
committee.  Tissues from a total of 15 canines were included in the study, although not all 
animals were included in each protocol.  The study population had a mean age of 4.8 ± 1.2 
years (range 1-12 years) and a mean weight of 24.2 ± 3.7kg (range 9-45kg).  The canines 
were split into two groups depending on gonadal status.  The majority of canines were 
cross bred, with no pedigree breeds appearing more than once.  In all cases tissue was 
collected within 2 hours of euthanasia (intravenous overdose of pentobarbitone), with full 
informed owner consent, for reasons other than scientific investigation.  The majority of 
animals had been euthanized for severe behavioural problems, the remainder for a number 
of different complaints, none of which involved the urinary system.  In all cases a detailed 
history of each animal was taken and a gross post-mortem study of the entire urinary 
system was performed; any animals with a history of, or gross pathological signs of, 
urinary tract disease were excluded from the study. 
 
6.2.2 Preparation of Tissue 
For all tissue bath protocols, bladder tissue was used within 2 days of euthanasia of the 
animal (see chapter 3).  To maximise the use of tissues, a number of the animals included 
in this study were also included in the studies described in elsewhere in this thesis. 
Preparation of detrusor strips was as for chapter 4, with muscle strips being mounted on 
fixed hooks for carbachol concentration response protocols (6.2.4). 
Before addition of the muscarinic antagonists, strips were tensioned until stable at 4g 
tension and were re-tensioned as required throughout the incubation period.  During 
incubation procedures the isolated strips of detrusor muscle were maintained in the tissue 
baths at 37°C, bathed in standard Krebs solution (chapter 3), with the addition of the 
muscarinic antagonist in question and continually aerated with 95% O2 / 5% CO2.  
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6.2.3 Muscarinic Antagonist Preparations 
Pirenzepine (Sigma-Aldrich, UK), a selective M1 receptor antagonist (Caulfield et al., 
1998), was diluted in water (BDH, RNase and DNase free) to give a stock solution of 
10mM which was stored at -20°C.  On the day of each experiment, the stock solution was 
diluted in Krebs solution and added to each tissue bath, as described below, to give a final 
bath concentration of 10nM, 30nM or 100nM (these being the optimal concentrations, as 
determined by preliminary studies to determine the lowest concentration range of 
antagonist required to produced a right shift in the response to carbachol – data not shown).   
Methoctramine (Sigma-Aldrich, UK), an M2 selective antagonist (Caulfield et al., 1998), 
was diluted in water (BDH, RNase and DNase free) to give a stock solution of 10mM 
which was stored at -20°C.  On the day of each experiment, the stock solution was diluted 
in Krebs solution and added to each tissue bath, as described below, to give a final bath 
concentration of 100nM, 300nM or 1µM (these being the optimal concentrations, as 
determined by preliminary studies to determine the lowest concentration range of 
antagonist required to produced a right shift in the response to carbachol – data not shown). 
4-diphenyl-acetoxy-N-methyl piperidine methiodide (4-DAMP) (Tocris Bioscience, 
Bristol, UK), an M3 selective antagonist (Caulfield et al., 1998), was diluted in Dimethyl 
Sulfoxide (DMSO) (Sigma-Aldrich, UK) to give a stock solution of 100mM which was 
stored at -20°C.  On the day of each experiment, the stock solution was diluted in Krebs 
solution and added to each tissue bath, as described below, to give a final bath 
concentration of 1nM, 3nM or 10nM (these being the optimal concentrations, as 
determined by preliminary studies to determine the lowest concentration range of 
antagonist required to produced a right shift in the response to carbachol – data not shown). 
 
6.2.4 Carbachol Concentration Response Protocol with 
Muscarinic Antagonists  
All strips (~ 8 per animal) underwent a full carbachol concentration response protocol, the 
full results of which are incorporated into the data presented in chapter 4.   
Following completion of the initial carbachol concentration response protocol, the muscle 
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stable at 4g resting tension.  Pirenzepine, Methoctramine and 4-DAMP were then added to 
two baths each, to give the initial bath concentration for that antagonist described above, 
leaving two of the eight strips without any additional antagonist, to act as time controls.  
Strips were incubated for 30 minutes, after which time they were re-tensioned to 4g initial 
tension (as necessary) before a further full carbachol concentration response protocol was 
carried out in all eight strips.  This protocol of washing, re-tensioning, addition of 
muscarinic antagonist, incubation and full carbachol concentration response protocol was 
repeated as described above for all three concentrations of each antagonist. 
 
6.2.5 Data Analysis 
Data were normalised for wet weight of tissue and are expressed as g/mg of wet tissue. 
Results are presented as mean ± s.e.mean (n = number of animals).   
A minimum of 2 strips of bladder tissue per animal were analysed for each muscarinic 
antagonist, at each concentration and the mean results from these strips used in further 
calculations where applicable.  Data were graphed and statistically analysed using 
GraphPad Prism® v.5 software.  EC50 values (molar concentration producing half maximal 
response) were determined by non-linear regression fitting (variable slope) to the 
concentration response curves.  Data from curves from individual animals were used to 
derive mean –log EC50 (pEC50) values with s.e.mean.  Dissociation constants (pKB) for 
antagonists were determined from the equation: 
pKB = log(CR-1)-log[B] 
where CR is the concentration ratio (ratio of the EC50 values) in the absence and presence 
of the antagonist obtained with a concentration [B] of antagonist (Furchgott, 1972).  Schild 
analysis was also performed, and the resultant gradient used to assess the competitive 
nature of the antagonism (Arunlakshana et al., 1959).   
Differences in pEC50 and maximum responses, between groups, were determined by 
analysis of variance (ANOVA) with Bonferroni as a post-test.  A probability (P) less than 
or equal to 0.05 was considered significant.  Correlations between responses and the age 
and weight of the animals were conducted using Spearman’s test with a significance 
threshold for P (two tailed) < 0.05.   Victoria A. Coit, 2008     Chapter 6, 123 
6.3 Results 
As previously reported (chapters 3 and 4), carbachol induced concentration-dependant 
contractions of isolated strips of smooth muscle from canine urinary bladder.  Strips of 
bladder tissue from neutered animals had significantly lower maximal contractile responses 
(p<0.05) and significantly decreased sensitivity compared to tissue from entire 
counterparts (p<0.05), as previously shown in chapter 4.  Analysis of the control strips 
which received four consecutive carbachol concentration response curves, i.e. a time 
control study, indicated that potency and maximal response were not altered by repeated 
testing (Fig. 6.1).   
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Figure  6-1.  Cumulative  concentration  response  curves  to  carbachol  in  isolated  canine 
urinary  bladder  smooth  muscle  strips  over  time.  Each  point  is  the  mean  ±  s.e.mean  of 
observations from n animals.  ● Time 0 hours, ■ Time 1.5 hours, ▲ Time 3 hours, ▼ Time 
4.5hrs.  a, entire animals, n=9; b, neutered animals, n=6. 
 
 
In all tissues the M1 selective antagonist pirenzepine, the M2 selective antagonist 
methoctramine, and the M3 selective antagonist 4-DAMP acted as competitive antagonists 
of carbachol-induced contractile responses.  All antagonists produced parallel rightward 
shifts of the concentration-response curves to carbachol, without altering maximal 
responses (Fig. 6-2).  When Schild plots were calculated, however, only methoctramine 
and 4-DAMP produced slopes not significantly different from unity (Fig. 6-3).  In all 
cases, due to the low numbers of animals studied and the mixed gender groups the 
s.e.mean is greater than that for previous chapters.   Victoria A. Coit, 2008     Chapter 6, 124 
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Figure 6-2. Effects of Pirenzepine, Methoctramine and 4-DAMP on cumulative concentration 
response curves of carbachol in isolated strips of canine urinary bladder smooth muscle 
strips. Each point is the s.e.mean of observations from n animals.  a, c and e are from entire 
animals, n=9; b, d and f are from neutered animals, n=6. 
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Figure  6-3.    Schild  plots  for  antagonism  of  the  carbachol  response  by  Pirenzepine, 
Methoctramine and 4-DAMP in isolated strips of detrusor muscle. Each point represents the 
mean results from an individual animal at each concentration of antagonist. a, c and e are in 
entire animals; b, d and f are in neutered animals. ○ Female canines, □ Male canines. 
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To ensure the accuracy of the mean functional affinity estimate (pKB) for each antagonist, 
the pKB at each antagonist concentration was calculated (Table 6-1).  The rank order of 
antagonist affinities in the entire group of canines was methoctramine, pirenzepine and 4-
DAMP, and in the neutered group of canines was pirenzepine, methoctramine and 4-
DAMP.   
 
Antagonist  Concentration  pKB  - Entire  pKB - Neutered 
  10nM  8.14 ± 0.14  8.20 ± 0.04 
Pirenzepine  30nM  7.52 ± 0.17  7.84 ± 0.04 
  100nM  8.00 ± 0.09  8.19 ± 0.09 
  100nM  7.04 ± 0.08  8.19 ± 0.05 
Methoctramine  300nM  6.74 ± 0.13  7.93 ± 0.06 
  1µM  7.12 ± 0.07  8.18 ± 0.12 
  1 nM  9.38 ± 0.06  8.29 ± 0.03 
4-DAMP  3 nM  8.99 ± 0.05  7.92 ± 0.03 
  10 nM  9.40 ± 0.04  8.28 ± 0.05 
Table 6-1.  Affinity estimates (pKB) at each concentration for muscarinic antagonists in 
bladder smooth muscle from entire and neutered canines. 
 
 
As Schild plots did not give a slope of unity for pirenzepine the antagonist affinities 
obtained cannot accurately be correlated with the known muscarinic receptor subtype 
ranges, however for both methoctramine and 4-DAMP the slopes of unity obtained from 
Schild analysis suggests that there is binding at a single muscarinic receptor subtype.  For 
entire canines the overall affinity of both methoctramine and 4-DAMP was within the 
reported range for the M3 subtype, whilst in neutered canines the overall affinities were 
consistent with the M2 subtype (Table 6-2).   
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Antagonist  M1 
 
M2 
 
M3 
 
M4 
 
M5 
 
Entire 
Bladder  
Neutered 
Bladder  
Pirenzepine  7.8-8.5  6.3-6.7  6.7-7.1  7.1-8.1  6.2-7.1  n / a  n / a 
Methoctramine  7.1-7.8  7.8-8.3  6.3-6.9  7.4-8.1  6.9-7.2  6.90 ± 0.13  8.10 ± 0.09 
4-DAMP  8.6-9.2  7.8-8.4  8.9-9.3  8.4-9.4  8.9-9.0  9.06 ± 0.13  8.16 ± 0.12 
Table  6-2.    Antagonist  affinity  constants  (log  affinity  constants  of  pKB  values)  for 
mammalian muscarinic receptors and for bladder smooth muscle from entire and neutered 
canines.  Data are from a variety of mammalian species (Caulfield et al., 1998). 
 
Looking at individual animals within each group it is possible to see that five animals 
within the entire group have pKB values that are intermediate between the M2 and the M3 
receptor ranges in response to either methoctramine or 4-DAMP (Fig. 6-4), however no 
animal was intermediate for both antagonists.  When looking at individual animals in the 
neutered group only one animal has a pKB value that is intermediate between M2 and M3 
receptors, and that is only in response to methoctramine. 
Although the number of male and female animals in each group differed and was not large 
enough to allow detailed statistical analysis there did not appear to be an effect of gender 
on the results obtained within each group.  In addition statistical analysis demonstrated that 
there was no effect of age or weight on the resultant antagonist affinities. 
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Figure 6-4.  Affinity of subtype-selective antimuscarinics for inhibiting carbachol induced 
contraction of strips of urinary bladder smooth muscle in vitro from a, entire and b, 
neutered canines.  The shaded areas represent the affinity ranges of methoctramine and 4-
DAMP for the individual receptor subtypes reported in the literature (Caulfield et al., 1998).  
Symbols refer to the affinities that were determined by Schild analysis of the bladder tissue 
obtained from individual animals.  ○ Female canines, □ Male canines. 
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6.4 Discussion 
It is thought that detrusor muscle contractions in healthy individuals are mediated via the 
M3 receptor subtype.  This is based on in vitro evidence from a number of species 
including rat (Hegde et al., 1997), pig (Sellers et al., 2000), human (Chess-Williams et al., 
2001) and canine (Choppin et al., 2001).  There is also evidence from rats and humans, that 
in certain disease states, the muscarinic receptor subtype responsible for bladder 
contraction can change from the M3 to the M2 receptor subtype (Braverman et al., 1998b; 
Pontari et al., 2004).  This present study, the first to include neutered canines, confirms 
previous reports (Choppin et al., 2001) that contraction of the canine urinary detrusor in 
entire animals is mediated by the M3 receptor, but clearly demonstrates that in the neutered 
canine contraction of the urinary detrusor appears to be mediated via stimulation of the M2 
rather than the M3 receptor subtype.   
In all of the animals studied carbachol produced concentration dependant contraction of the 
isolated strips of detrusor muscle, as has been previously discussed, and the maximal 
tensions produced where similar to those described in chapter 4 of this thesis.  Despite this, 
the calculated s.e.mean for each group of animals was larger than that previously recorded. 
This may be due to a number of reasons including the relatively low numbers of animals 
included in each group, and the low number of muscle strips from each animal included for 
each antagonist studied.  A further factor to be considered is that due to low animal 
numbers for this study both male and female animals were included in the entire and 
neutered groups, thereby increasing the error.  Although male and females animals did not 
vary significantly in their response to carbachol (see chapter 4) there was a trend for the 
male animals to have lower responses than their female counterparts, and due to individual 
variation and numbers of animals used this is likely to account for the increased s.e.mean 
seen. 
Bladder contraction occurs from ACh-induced excitation of muscarinic cholinergic 
receptors on detrusor muscle (Chess-Williams, 2002).  There are known to be five 
muscarinic receptor subtypes, M1-M5, however only the first three have been consistently 
described as having a role in micturition (Braverman et al., 1998a; Chess-Williams, 2002; 
Somogyi et al., 1994).  Subtype selective antimuscarinic agents are available for the M1-
M3 subtypes that are at least 10-fold selective for individual subtypes allowing in vitro 
studies to identify functional receptors within a tissue (Caulfield, 1993).  M1 receptors have 
a high affinity for pirenzepine, a low affinity for methoctramine and an intermediate Victoria A. Coit, 2008     Chapter 6, 130 
affinity for 4-DAMP (Caulfield et al., 1998).  M2 receptors have a high affinity for 
methoctramine and a low affinity for 4-DAMP, whilst it is the opposite for M3 receptors 
which have a high affinity for 4-DAMP and a low affinity for methoctramine (Caulfield, 
1993).  Using these agents and calculating affinity values derived from Schild plot 
analysis, it has been shown that the M3 receptor is responsible for the contraction of the 
healthy human bladder, even though the number of M2 receptors far exceeds the number of 
M3 receptors (Chess-Williams et al., 2001).  This is consistent with results in other animal 
species that report that although the M2 receptor subtype is the most numerous, within the 
urinary bladder, it is the M3 receptor that is responsible for normal bladder contraction 
(Chess-Williams, 2002; Goepel et al., 1998; Wang et al., 1995). 
Studies into the role of the M1 receptor in the rat have shown that this receptor subtype 
may have a facilitatory role to play in contraction of the bladder by enhancing ACh release 
thereby enhancing contraction of the bladder (Braverman et al., 1998a; Somogyi et al., 
1994).  In this present study, Schild plot analysis did not demonstrate a slope of unity for 
pirenzepine antagonism of carbachol induced contractions in either entire or neutered 
canine bladder, however, the reliability of the data is limited by the low number of animals 
studied.  The affinity values of the neutered animals in response to pirenzepine all fell 
within the reported range for the M1 receptor (Caulfield et al., 1998), therefore it is 
possible that the M1 receptor subtype has a facilitatory role to play in the regulation of 
detrusor contraction in this subset of canines and this hypothesis requires further 
investigation.  For the entire canines the Schild plot gave a slop of less than 1, which can 
indicate that more than one receptor subtype is involved in mediating the contractile 
response (Wyllie et al., 2007).  It is interesting to note that the affinity values calculated for 
the gonadally entire group fell between the reported values for the M1 and M3 receptors 
(Caulfield et al., 1998).  This may indicate that both of the M1 and M3 receptor subtypes 
have a role to play in bladder contraction in this group. 
The results obtained in this study, using both methoctramine and 4-DAMP, confirm that 
the M3 receptor subtype is the primary receptor subtype responsible for bladder 
contraction in healthy gonadally entire canines (Chess-Williams 2002).  These results also 
are in agreement with a previous, limited, study by Choppin and Eglen which investigated 
functional receptor subtypes in the bladder using the muscarinic antagonists s-secoverine 
and darifenacin (Choppin et al., 2001).  In that study the affinities of the antagonists for 
inhibition of bladder contraction were shown to be correlated with their affinities for each 
of the muscarinic subtypes, expressed in clonal cell lines and it was assumed that the 
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method gives the same weighting to antagonists of varying or no specificity and also 
assumes that only a single muscarinic receptor subtype mediates contraction.  In the 
present study, the individual affinity values for each antagonist, in each animal were 
calculated, as this allows for more detailed analysis both within and between groups of 
animals and therefore removes the constraint of the assumption that only one receptor 
subtype is involved in contraction.  This is important, as previous studies have shown that 
more than one muscarinic receptor subtype is indeed involved in bladder contraction, 
either via indirect mechanisms that may influence neuronal acetylcholine release (Chess-
Williams, 2002) or altered calcium flow (Wang et al., 1995).  The results of the present 
study show that although overall the M3 receptor seems to be responsible for bladder 
contraction, if individual canine data is considered there are a number of animals with 
intermediate affinity values that fall between the reported values for the M2 and M3 
receptors to either methoctramine or 4-DAMP.  This result would suggest that there may 
also be a small role for the M2 receptor in bladder contraction in some entire animals.  This 
result supports those obtained in a study conducted using samples of human bladder that 
also concluded that in certain patients bladder contraction could be mediated by either the 
M2 or the M3 receptor (Pontari et al., 2004) and a study in rats that reported that both M2 
and M3 could mediate contraction in the normal rat bladder (Braverman et al., 2002).   
A role for the M2 receptor subtype in mediating bladder contraction in healthy individuals 
is further supported by rodent studies that identified both M2 and M1 receptors as being 
involved in bladder contraction (Frazier et al., 2007; Stengel et al., 2000).  Although this 
present study did not find a conclusive role for the M2 receptor in entire canine bladder 
contraction, the overall results for both methoctramine and 4-DAMP in the group of 
neutered canines supports a major role for the M2 receptor in this subset of animals.  Of the 
six animals studied only one animal had a calculated pKB value out-with that accepted as 
associated with the M2 receptor and that was only for the antagonist methoctramine; when 
the antagonist 4-DAMP was used, the calculated pKB value for that animal was consistent 
with the M2 receptor.  Although only a small number of animals were included in this 
study the consistency of the results, obtained to date, suggest that the M2 receptor is 
involved in bladder contraction in gonadectomised canines.  As this is the first study to 
include neutered canines this result is significant and may be linked to the decreased 
overall contractile response of the detrusor muscle in vitro in this group. 
There have been several hypothesized mechanisms through which M2 receptors may 
produce bladder contraction.  Studies looking at contraction of the rat urinary bladder after 
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adrenergic receptor induced relaxation, via activation of a GTP binding protein that 
inhibits adenylyl cyclase (Braverman et al., 1999b; Hegde et al., 1997).  While muscarinic 
receptor subtypes have been shown to preferentially couple with one type of G protein, 
using cloned receptors expressed in Chinese hamster ovary (CHO) cells, there does seem 
to be significant promiscuity in this coupling mechanism (Tucek et al., 2002).  This means 
that depending on the cell type and the biochemical state of the cell, certain receptors may 
be able to couple with several different types of G protein and therefore that a single 
receptor subtype may be able to mediate a number of cellular signals (Tucek et al., 2002; 
Wang et al., 1995).  Traditionally M2 receptors have been thought to couple with the Gi 
class of GTP binding proteins, however, it has been shown in human bladder (Wang et al., 
1995) that they can also couple to Gq proteins.  It follows, therefore, that differential 
coupling of M2 receptors to different G proteins, under varying conditions, may alter their 
effect on bladder tissue.  In other organs that contain smooth muscle, a number of other 
mechanisms of M2 receptor activation have been described and these may also have a role 
to play in the bladder.  These include the opening of non-selective cation channels which 
results in depolarisation, the influx of calcium and contraction of the cells (Bolton et al., 
1997), and the inhibition of conductance of action potentials through potassium channels 
(Cole et al., 1989). 
Despite the various hypotheses surrounding the mode of action of the M2 receptor subtype 
in mediating contraction of the bladder, there are conflicting reports as to its role in 
specific disease states.  Neurogenic overactivity of the bladder has been studied in both the 
rat model and in the human, with inconsistent results.  One group has reported that the M2 
receptor contributes to direct detrusor contraction in the urinary bladder obstructed rat and 
in the spinal injured, denervated, non-voiding rat (Braverman et al., 1999a; Braverman et 
al., 1998b; Braverman et al., 2003; Ruggieri et al., 2006), whilst another group could find 
no evidence of a role for the M2 receptor subtype in stimulating bladder contraction in the 
urinary bladder obstructed rat (Krichevsky et al., 1999).  In human patients with 
neurogenic overactivity of the bladder there are also conflicting reports, with one group 
concluding that the M2 receptor plays a role in bladder contraction in these patients 
(Pontari et al., 2004), and a further group finding no evidence to support a role for M2 and 
concluding that only the M3 receptor was responsible for bladder contraction in this patient 
group (Stevens et al., 2007).  One study has been reported, that looked at the role of 
muscarinic receptors in patients (n=7) that were suffering from idiopathic detrusor 
overactivity (Stevens et al., 2007).  They reported that the M3 receptor was the sole 
receptor responsible for bladder contraction in this group (Stevens et al., 2007).  These 
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including experimental design, low patient numbers, varying severity of disease and 
individual animal and patient variations, especially involving the degree of detrusor muscle 
hypertrophy, a factor that has been shown to be highly significant in the rat model 
(Ruggieri et al., 2006). 
The functional significance of a shift from M3 receptor mediated contraction to M2 
mediated contraction in the canine bladder as described in the present study has not been 
determined.  It has been shown, in chapter 4, that neutered canines have significantly lower 
maximal contractile responses and sensitivity to carbachol than their entire counterparts, 
regardless of gender, and the present study shows that contraction of the detrusor is 
mediated by the M2 receptor subtype in at least a subset of the same group of animals.  It 
may be that the decreased response to carbachol observed in neutered animals (chapter 4) 
is directly linked to this shift in dependence on the M2 receptor, as bladder contractions 
mediated by the M2 receptor subtype have been reported to be weaker than those induced 
by the M3 receptor subtype, at least in pigs (Yamanishi et al., 2000).  The sensitivity of the 
M2 receptor subtype to carbachol is controversial, however, as some studies in rats and 
humans have found an increased sensitivity of the bladder to carbachol in models of 
neurogenic detrusor overactivity (Braverman et al., 1998b; Saito et al., 1993), whilst a 
more recent study has reported no change in the response to carbachol in M2 compared to 
M3 mediated bladder contractions (Stevens et al., 2007).  As muscarinic receptors have 
been shown to couple to different G proteins under different conditions, as previously 
discussed, it could be that the response of the M2 receptor to stimulation by carbachol is 
also altered under varying conditions, therefore, the role of the M2 receptor in the 
decreased responses seen in this present study cannot be accurately presumed. 
In conclusion, the data obtained in this chapter supports the original hypothesis that the 
functional receptor subtype in the entire canine urinary bladder is the M3 receptor, and that 
neutering a canine shifts the predominant functional muscarinic receptor subtype of the 
detrusor muscle from the M3 to the M2 receptor.  The data also suggests a potential role of 
the M2 receptor in mediating or facilitating contraction of the bladder in entire animals.  It 
is hypothesised that the shift from M3 to M2 mediated bladder contraction in neutered 
canines might contribute to the decreased contractile response of detrusor strips, to 
carbachol, seen in vitro in this group, and as such may be involved in the development of 
acquired urinary incontinence.  Further investigations involving a greater number of 
animals and an increased range of muscarinic receptor subtype specific antagonists is 
needed to confirm the role these receptor subtypes play in mediating contraction of the 
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from acquired urinary incontinence is likewise required to determine the role of these 
receptors in that disease state. 135 
7  Effects of Acute Incubation with Reproductive 
Hormones on In Vitro Responses of Canine 
Detrusor Muscle Strips to Muscarinic and 
Electrical Stimulation 
7.1 Introduction 
Urinary incontinence is defined as the unconscious and involuntary loss of urine (Abrams 
et al., 2002) and, in the canine, it is an increasingly recognised and presently incurable 
problem.  Acquired urinary incontinence accounts for the majority of cases of urinary 
incontinence seen in the canine and is reported to affect up to 20% of all neutered bitches 
(Arnold et al., 1989) but less than 1% of intact bitches (Holt et al., 1993) and is rarely 
reported in male canines.  It has been established that there is a  direct relationship between 
acquired urinary incontinence in the canine and neutering (Thrusfield, 1985) and it has 
been proposed that acquired urinary incontinence occurs as a consequence of hormonal, 
vascular and/or neurological changes (Thom et al., 1998) within the bladder rather than 
mechanical damage to the lower urinary tract as a direct result of surgery (Gregory, 1994). 
Acquired urinary incontinence in the bitch was thought to be caused solely by a decrease in 
resting urethral pressure (Holt, 1988; Rosin et al., 1981), but as this is not a defining 
characteristic of the condition (Holt, 1988) it is now thought that multiple causative factors 
are involved in predisposing animals to this condition.  The results of previous in vitro 
studies (Chapter 4) suggest that functional changes occur within the detrusor muscle as a 
result of neutering in the canine.  Specifically, regardless of gender, neutering leads to a 
decrease in the maximal contractile response of the detrusor muscle to both muscarinic and 
electrical field stimulation and to a decreased sensitivity to muscarinic stimulation.  These 
results are similar to those reported for the detrusor muscle from postmenopausal women 
who suffer from urge urinary incontinence, relative to their premenopausal counterparts, 
and can occur either alone, as impaired contractility of the bladder, or in conjunction with 
idiopathic detrusor instability (Elbadawi et al., 1993a; Elbadawi et al., 1993b).   
Although there is insufficient data relating to the exact aetiology and pathophysiology of 
acquired urinary incontinence in neutered bitches and post menopausal women to allow 
determination of commonality of cause, it is intriguing that both groups are subject to a 
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hypothesis that the changes in steroid and associated hormones are mechanistically 
involved in the development of urinary incontinence in both humans (Stenberg et al., 1995; 
Thom et al., 1998) and canines (Arnold et al., 1989; Thrusfield, 1985).  Post menopause 
and neutering there is a significant decrease in circulating endogenous oestrogen and this 
has long been thought to be a causative factor in the development of urinary incontinence 
in both the bitch (Finco et al., 1974) and woman (Freedman, 2002).  Indeed, current 
recognised treatments for acquired urinary incontinence in the bitch include supplemental 
exogenous oestrogen which has been reported to restore continence, albeit temporarily, in 
up to 60% of animals (Mandigers et al., 2001).  Supplemental oestrogen has been reported 
to increase the resting tone of the urethra (Nickel, 1998) and it is possible that an increase 
in circulating oestrogen concentrations may also improve bladder function in terms of 
compliance, contractility and elasticity.  Based on limited urodynamic studies reported in 
rats and canines (Fleischmann et al., 2002; Nickel, 1998) all these factors could act to 
improve continence.  In vitro measurements of contractility and responsiveness, however, 
have not been made in steroid treated tissues collected from animals suffering from 
acquired urinary incontinence.  
In addition to the primary effects of ovarian oestrogen on the bladder, the decrease in 
oestrogen post neutering / menopause also interrupts the feedback mechanisms that act at 
the level of the hypothalamus and pituitary gland to regulate the secretion of additional 
hormones.  The removal of oestrogen negative feedback leads to an increase in GnRH 
secretion and a concomitant increase in the secretion of both FSH and LH (Burger, 1996; 
Olson et al., 1992; Reichler et al., 2004).  It has been hypothesized that this increase in 
gonadotrophins may be partially responsible for the development of urinary incontinence 
in both the canine (Reichler et al., 2004) and woman (Tao et al., 1998) and studies have 
demonstrated the presence of receptors for the gonadotrophins in the urinary bladder 
(Ponglowhapan et al., 2007a; Reichler et al., 2007; Tao et al., 1998).  Further support for 
an indirect effect of steroid removal on bladder function has been provided by a recent 
study in neutered canines suffering from acquired urinary incontinence which reported that 
administration of GnRH analogues, such as to decrease serum LH and FSH levels aided 
continence (Reichler et al., 2006b).  The study, however, did not address the mechanism 
through which these effects were mediated. 
It could be hypothesised therefore that exposure to elevated concentrations of GnRH, LH 
and FSH may have a negative effect on bladder function and that treatment with exogenous 
hormones, to counteract post neutering changes in their secretion, could be beneficial with 
regard to urinary continence.  In this study the hypothesis that acute exposure of the canine Victoria A. Coit, 2008     Chapter 7, 137 
detrusor to elevated concentrations of GnRH, LH, FSH or oestrogen will alter the 
contractility and sensitivity of strips of canine detrusor to muscarinic and electrical field 
stimulation was tested.  More specifically, it was hypothesised that acute incubation with 
oestrogen would improve contractility in isolated strips of detrusor muscle from neutered 
canines and acute incubation with GnRH, LH and FSH would decrease contractility in 
isolated strips of detrusor muscle from entire canines. Victoria A. Coit, 2008     Chapter 7, 138 
7.2 Materials and Methods 
7.2.1 Animals 
The study was approved by The University of Glasgow Veterinary School’s ethical review 
committee.  Tissue from a total of 20 canines was included in the study, although not all 
animals were included in each protocol.  The study population had a mean age of 6.1 ± 0.6 
years (range 2-14 years) and a mean weight of 23.6 ± 2.1kg (range 9-45kg).  The canines 
were split into two groups depending on gonadal status with both male and female canines 
being used for the GnRH, FSH and LH studies, whilst only bitches were used for the 
oestrogen study.  The majority of canines were cross bred, with no pedigree breeds 
appearing more than once.  In all cases, tissue was collected with full informed owner 
consent, within 2 hours of euthanasia (intravenous overdose of pentobarbitone) for reasons 
other than scientific investigation.  The majority of animals had been euthanized for severe 
behavioural problems, the remainder for a number of different complaints, none of which 
involved the urinary system.  In all cases, a detailed history of each animal was taken and a 
gross post-mortem study of the entire urinary system was performed; any animals with a 
history of, or gross pathological signs of, urinary tract disease were excluded from the 
study. 
 
7.2.2 Preparation of Tissue 
For all tissue bath protocols, bladder tissue was used within 2 days of euthanasia of the 
animal (see chapter 3).  To maximise the use of tissues a number of the animals included in 
this study were also included in the studies described elsewhere in this thesis. 
Preparation of detrusor strips was as for chapter 4, with muscle strips being mounted on 
fixed hooks for carbachol concentration response protocols (7.2.4, 7.2.5) and in Ag-AgCl 
ring electrodes for electrical stimulation protocols (7.2.6, 7.2.7). 
Before addition of the hormones, strips were tensioned until stable at 4g and were re-
tensioned as required regularly throughout the incubation period.  During incubation 
procedures, the isolated strips of detrusor muscle were maintained in the tissue baths at 
37°C, were bathed in standard Krebs solution (chapter 3) with the addition of the hormone 
in question and were continually aerated with 95% O2 / 5% CO2.  Victoria A. Coit, 2008     Chapter 7, 139 
7.2.3 Hormone Preparations 
GnRH (luteinising hormone releasing hormone human acetate salt, Sigma-Aldrich, UK) 
was diluted in water (BDH, RNase and DNase free) to give a stock solution of 100mg/ml 
which was stored at -20°C.  On the day of each experiment, the stock solution was diluted 
in Krebs solution and was added to each tissue bath as described below to give a final bath 
concentration of 10ng/ml.  As there are no reports of concentrations of GnRH in the 
peripheral circulation of canines this concentration was chosen as it represents a 
concentration marginally higher than that found to produce maximal increases in FSH and 
LH production when administered acutely (hours) and to produce a decrease in FSH and 
LH production when administered chronically (days) (Concannon, 1993). 
LH (porcine LH, supplied by A.F. Parlow of the National Hormone & Peptide Program, 
California, USA) was diluted in water (BDH, RNase and DNase free) to give a stock 
solution of 5mg/ml which was stored at -20°C.  On the day of each experiment the stock 
solution was diluted in Krebs solution and was added to each tissue bath, as described 
below, to give a final bath concentration of 10ng/ml.  This concentration was chosen as 
concentrations of LH in the peripheral circulation of a long-term (>42 week) neutered bitch 
average 8.3ng/ml (Reichler et al., 2004). 
FSH (canine FSH, Tucker Endocrine Research Institute LLC, USA) was diluted in water 
(BDH, RNase and DNase free) to give a stock solution of 1mg/ml which was stored at 
-20°C.  On the day of each experiment, the stock solution was diluted in Krebs solution 
and was added to each tissue bath, as described below, to give a final bath concentration of 
100ng/ml.  This concentration was chosen as concentrations of FSH in the peripheral 
circulation of a long-term (>42 week) neutered bitch average 75ng/ml (Reichler et al., 
2004). 
Oestrogen (Estradiol, standards from Estradiol MAIA calibrator 6, Bio-Stat, UK) was 
obtained in concentrations of 500pg/ml, 1500pg/ml and 5000pg/ml and were stored at 4°C. 
These were added to the tissue baths to give final bath concentrations of 3.3pg/ml, 15pg/ml 
and 50pg/ml.  These concentrations were chosen as they spanned the range of oestrogen 
concentrations seen in canines during anoestrus (1-5pg/ml) and oestrus (40-60pg/ml) 
(Concannon, 1986a). 
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7.2.4 Carbachol Concentration Response Protocol with GnRH, LH 
or FSH  
All strips (≥ 8 per animal) underwent a full carbachol concentration response protocol 
(4.2.4), the full results of which are incorporated into the data presented in chapter 4.   
Following completion of the initial carbachol concentration response protocol, the muscle 
strips were washed repeatedly, allowed to rest for 30 minutes and the tension adjusted until 
stable at 4g resting tension (Chapter 3).  GnRH, LH or FSH were then added to two baths 
each, to give the bath concentrations described above, leaving two of the eight strips 
without any additional hormone, as time controls.  Strips were incubated for 2 hours, after 
which time they were re-tensioned to 4g initial tension (as necessary) before a further full 
carbachol concentration response protocol was carried out. 
 
7.2.5 Carbachol Concentration Response Protocol with 
Oestrogen 
For this protocol only female animals were used and were split into two groups depending 
on gonadal status; entire and neutered. All strips (~ 8 per animal) underwent a full 
carbachol concentration response protocol (4.2.4), the results of which are incorporated 
into the data presented in chapter 4.   
After the initial concentration response protocol was carried out all strips were washed 
repeatedly, allowed to rest for 30 minutes and then tensioned until stable at 4g resting 
tension.  Oestrogen, at each of the three concentrations described above, was then added to 
two baths each, leaving two of the eight strips without any additional hormone, as time 
controls.  Strips were incubated with oestradiol for 2 hours, after which time the strips 
were re-tensioned to 4g initial tension, as necessary, before a further full carbachol 
concentration response protocol was carried out. 
The strips were then washed repeatedly, as before, rested for 30 minutes and tensioned 
until stable at 4g initial tension before re-addition of oestrogen, at the concentrations to 
which the strips were previously exposed and incubated with this concentration of 
oestradiol for a further 22 hours.  After the incubation, the strips were again re-tensioned to 
4g initial tension and a further full carbachol concentration response protocol carried out. Victoria A. Coit, 2008     Chapter 7, 141 
7.2.6  Neurogenic Electrical Field Stimulation Protocol with 
GnRH, LH or FSH 
All strips (≥8 per animal) underwent a neurogenic electrical field stimulation protocol 
(4.2.5), the results of which are incorporated into the data presented in chapter 4.   
After the initial frequency response protocol was carried out all strips were washed 
repeatedly, allowed to rest for 30 minutes and then tensioned until stable at 4g resting 
tension.  GnRH, LH or FSH were then added, to two baths each, to give the bath 
concentrations described above, leaving two of the eight strips without any additional 
hormone to be the time controls.  Strips were incubated for 2 hours, after which time the 
strips were re-tensioned to 4g initial tension, as necessary, before a full frequency response 
protocol was carried out. 
 
7.2.7 Neurogenic Electrical Field Stimulation Protocol with 
Oestrogen 
All strips (≥ 8 per animal) underwent a neurogenic electrical field stimulation protocol 
(4.2.5), the results of which are incorporated into the data presented in chapter 4.  
After the initial frequency response protocol was carried out, all strips were washed 
repeatedly, allowed to rest for 30 minutes and then tensioned until stable at 4g resting 
tension.  Oestrogen, at each of the three concentrations described above, was then added to 
two baths each, leaving two of the eight strips without any additional hormone to be the 
time controls.  Strips were incubated with oestrogen for 2 hours, after which time the strips 
were re-tensioned to 4g initial tension, as necessary, before a full frequency response 
protocol was carried out. 
The strips were then washed repeatedly as before, rested for 30 minutes and tensioned until 
stable at 4g initial tension before oestrogen was reapplied, at the concentration to which the 
strips were exposed previously, and the strips incubated for a further 22 hours after which 
time the above procedure was repeated. 
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7.2.8 Data Analysis 
All data were normalised for wet weight of tissue and are expressed as g/mg of wet tissue 
with results presented as mean ± s.e.mean (n = number of animals).   
A minimum of 2 strips of bladder tissue per animal were analysed for each hormone, at 
each incubation time and the mean results from these strips used in further calculations 
where applicable.  Data were graphed and statistical analysis performed using GraphPad 
Prism® v.5 software.  In all cases the maximal tension was defined as the mean maximal 
tension of all the strips from that animal for that protocol.  Comparisons within (time 
control) and between (differences in responses following hormone incubations) response 
protocols were made using analysis of variance (ANOVA) with Bonferroni as a post-test.  
A probability (P) less than or equal to 0.05 was considered significant.  Correlations 
between responses and the age and weight of the animals were conducted using 
Spearman’s test with a significance threshold for P (two tailed) < 0.05.   
Statistical analysis of the responses seen in the detrusor strips used as time controls 
indicated that there was no significant effect of time on either the maximal response or 
sensitivity of the strips to carbachol when repeated concentration response curves were run 
as required to test for effects of hormone incubation (Figs. 7-1 and 7-2).  There was also no 
effect of time on the response of the tissue strips to neurogenic field stimulation (Figs. 7-3 
and 7-4).  Therefore, the effects of hormone treatment on the responses of the muscle strips 
were statistically compared by analysis of variance.  Victoria A. Coit, 2008     Chapter 7, 143 
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Figure 7-1.  Time control cumulative concentration response curves to carbachol in isolated 
canine urinary bladder smooth muscle for GnRH, LH and FSH studies. ● Time 0 hours, ■ 
Time 2.5 hours.  Each point is the mean ± s.e.mean of observations from n animals.  a, 
entire animals, n=8; b, neutered animals, n=7. 
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Figure 7-2.  Time control cumulative concentration response curves to carbachol in isolated 
canine urinary bladder smooth muscle strips for oestrogen studies. ● Time 0 hours, ■ Time 
2.5  hours,  ▲Time  24  hours.  Each  point  is  the  mean  ±  s.e.mean  of  observations  from  n 
animals.  a, entire bitches, n=3; b, neutered bitches, n=3. 
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Figure  7-3.    Time  control  frequency  response  curves  to  neurogenic  field  stimulation  in 
isolated canine urinary bladder smooth muscle strips for GnRH, LH and FSH studies.  ● 
Time 0 hours, ■ Time 2.5 hours.  Each point is the mean ± s.e.mean of observations from n 
animals.  a, entire animals, n=7; b, neutered animals, n=6.  
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Figure  7-4.    Time  control  frequency  response  curves  to  neurogenic  field  stimulation  in 
isolated  canine  urinary  bladder  smooth  muscle  strips  for  oestrogen  studies.    ●  Time  0 
hours, ■ Time 2.5 hours, ▲Time 24 hours.  Each point is the mean of observations from n 
animals.  a, entire animals, n=2; b, neutered animals, n=2.  
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7.3 Results 
7.3.1 Acute Effects of Incubation with GnRH, LH or FSH on 
Responses to Carbachol Stimulation 
In all groups, when exposed to the first dose response protocol, dose dependant 
contractions were observed in response to carbachol.  As presented in chapter 4, neutering, 
regardless of gender, was associated with a significant decrease in the maximum 
contractile response and sensitivity of the isolated strips of bladder smooth muscle to 
carbachol, relative to tissue from entire animals (p<0.05).  As no significant differences 
were seen between genders, the results of the males and females within each gonadal status 
group were combined for all further analyses in this study. 
No statistically significant effects of incubation with GnRH, LH or FSH (for 2 hours), were 
seen on either maximal response or sensitivity to carbachol, of the isolated strips of bladder 
smooth muscle in animals of either gonadal status (Fig. 7-5).  In addition, statistical 
analysis indicated that there was no statistically significant effect of the age or weight of 
the animal on the response to carbachol following hormone incubation. 
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Figure  7-5.  Cumulative  concentration  response  curves  to  carbachol  in  isolated  canine 
urinary  bladder  smooth muscle  strips  following a 2  hour incubation: ● Control, ■  GnRH 
(10ng/ml),  ▲  LH  (5.0µg/ml),  ♦  FSH  (100ng/ml).    Each  point  is  the  mean  ±  s.e.mean  of 
observations from n animals.  a, entire animals, n=8; b, neutered animals, n=7. Victoria A. Coit, 2008     Chapter 7, 146 
7.3.2 Effects of Acute Exposure to Elevated GnRH, LH or FSH on 
Responses to Neurogenic Field Stimulation 
In all groups, during both stimulation protocols, frequency dependant contractions were 
observed in response to electrical field stimulation.  The effects of neutering on the 
response of isolated strips of bladder smooth muscle to neurogenic electrical field 
stimulation were similar to those of carbachol, with a significant decrease (p<0.05) in the 
maximal contractile response in neutered compared to entire animals, as presented and 
discussed in chapter 4.  As with the results obtained for the carbachol dose response study, 
described above, there was no gender difference in the responses to neurogenic electrical 
field stimulation, therefore, the results obtained for animals of both sexes were combined 
to provide ‘entire’ and ‘neutered’ groups for this study.   
Statistical analysis revealed no significant acute effect of incubation, for 2 hours, with 
GnRH, LH or FSH on the maximal response of the isolated strips of bladder smooth 
muscle to neurogenic field stimulation in either group (Fig. 7-6).  As with carbachol, there 
was no statistically significant effect of the age or weight of the animal on the response to 
neurogenic field stimulation.   
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Figure 7-6.  Frequency response curves to neurogenic field stimulation in isolated canine 
urinary  bladder  smooth  muscle  strips  following  2  hour  incubation  with  hormones:  ● 
Control, ■ GnRH (10ng/ml), ▲LH (5.0µg/ml), ♦ FSH (100ng/ml).  Each point is the mean ± 
s.e.mean of observations from n animals.  a, entire animals, n=7; b, neutered animals, n=6. 
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7.3.3 Effects of Oestrogen on Detrusor Muscle Responses to 
Carbachol Stimulation 
As presented and discussed in chapter 4, there was dose dependant contraction of the 
isolated strips of bladder smooth muscle when stimulated with carbachol, with strips from 
neutered bitches responding with significantly less sensitivity and maximal contraction 
than those from entire bitches.  As oestrogen is primarily a hormone of the female 
reproductive cycle and as its absence is thought to play a role in the development of female 
acquired urinary incontinence only female animals were used for this section of the study.  
There was no statistically significant effect of incubation with oestrogen for either 2 hours 
(Fig. 7-7) or 24 hours (Fig. 7-8), on the maximal response or sensitivity of the isolated 
strips of bladder smooth muscle to carbachol, in either gonadectomised or entire animals.  
In addition the statistical analysis indicated that there was no statistically significant effect 
of the age or weight of the animal on the response to carbachol.  
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Figure  7-7.    Cumulative  concentration  response  curves  to  carbachol  in  isolated  canine 
urinary  bladder  smooth  muscle  strips  following  a  2  hour  incubation  with  varying 
concentrations of oestrogen: ● Control, ■ 3.3pg/ml, ▲ 15pg/ml, ♦ 33pg/ml.  Each point is the 
mean ± s.e.mean of observations from n animals.  a, entire bitches, n=3; b, neutered bitches, 
n=3. 
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Figure  7-8.    Cumulative  concentration  response  curves  to  carbachol  in  isolated  canine 
urinary  bladder  smooth  muscle  strips  following  a  24  hour  incubation  with  varying 
concentrations of oestrogen: ● Control, ■ 3.3pg/ml, ▲ 15pg/ml, ♦ 33pg/ml.  Each point is the 
mean ± s.e.mean of observations from n animals.  a, entire bitches, n=3; b, neutered bitches, 
n=3. 
 
 
 
7.3.4 Effects of Oestrogen on Detrusor Muscle Responses to 
Neurogenic Field Stimulation 
In all groups, frequency dependant contractions were observed in response to electrical 
field stimulation as previously described.  As with carbachol, above, only bitches were 
included in this study and the maximal contractile response of the neutered bitches was 
significantly lower than that of the entire bitches.  Unfortunately, due to equipment failure, 
data was only available for 2 animals from each group.  There was no effect of either 2 
(Fig. 7-9) or 24 hour incubation (Fig. 7-10) with oestrogen on the response of the isolated 
strips of bladder smooth muscle to neurogenic field stimulation in animals of either group.   
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Figure 7-9.  Frequency response curves to neurogenic field stimulation in isolated canine 
urinary  bladder  smooth  muscle  strips  following  a  2  hour  incubation  with  varying 
concentrations of oestrogen: ● Control, ■ 3.3pg/ml,   ▲ 15pg/ml, ♦ 33pg/ml.  Each point is 
the mean of observations from n animals.  a, entire animals, n=2; b, neutered animals, n=2. 
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Figure 7-10.  Frequency response curves to neurogenic field stimulation in isolated canine 
urinary  bladder  smooth  muscle  strips  following  a  24  hour  incubation  with  varying 
concentrations of oestrogen: ● Control, ■ 3.3pg/ml,  ▲ 15pg/ml, ♦ 33pg/ml.  Each point is the 
mean of observations from n animals.  a, entire animals, n=2; b, neutered animals, n=2. 
 Victoria A. Coit, 2008     Chapter 7, 150 
7.4 Discussion and Conclusion 
Based upon the reported effects of GnRH analogues and oestradiol in the treatment of 
acquired urinary incontinence and the observed differences in responsiveness of the 
detrusor in gonadectomised animals in chapter 4 of this thesis, this study set out to test the 
hypothesis that acute exposure to GnRH, LH, FSH and oestrogen may alter responsiveness 
and sensitivity of isolated strips of detrusor muscle to muscarinic and electrical field 
stimulation.  From the results obtained it is possible to see that under the study conditions 
used this hypothesis was refuted.   
This thesis has previously shown that neutering a canine, of either gender, causes a 
decrease in sensitivity and contractility to both muscarinic and neurogenic field stimulation 
(chapter 4).  The observed decrease in sensitivity and contractility is similar to that 
described in a proportion of post-menopausal women where it is thought to play an 
important role in the development of urinary incontinence (Mills et al., 2000) and it was 
postulated that the changes in bladder contractility and sensitivity seen in neutered canines 
may play a similar role in the development of acquired urinary incontinence in the bitch.  
Although there are a number of theories as to why the known changes in sensitivity and 
contractility of the detrusor muscle occur, the longest held and most popular theory is that 
changes in reproductive hormone levels post neutering or post-menopause are causative 
factors (Arnold et al., 1989; Burger, 1996; Thrusfield, 1985; Zhu et al., 2001).  In vivo 
treatment of animals suffering from acquired urinary incontinence with either supplemental 
oestrogen or GnRH analogues to decrease LH and FSH concentrations has been shown to 
improve continence in a number of animals (Angioletti et al., 2004; Janszen et al., 1997; 
Reichler et al., 2003).  It is, therefore, plausible that changes to these hormone 
concentrations may cause changes in sensitivity or contractility of the detrusor muscle to 
stimulation via the muscarinic pathway, the primary pathway responsible for bladder 
emptying (Chess-Williams, 2002), possibly by altering muscarinic receptor expression as 
has been demonstrated in the rabbit in response to oestrogen (Batra et al., 1989). 
While the results of this study do not support the original hypothesis, consideration must 
be given to the timescale of the post-neutering changes in both hormone concentrations 
and continence, relative to the hypothesis and study design.  This study specifically 
investigated the effects of acute (2 and 24hr) exposure to altered hormone concentrations, 
however, while there are acute hormonal changes after neutering, peripheral hormone 
concentrations continue to change over a number of months (Reichler et al., 2004) and the Victoria A. Coit, 2008     Chapter 7, 151 
development of acquired urinary incontinence can take months or years to manifest.  
Furthermore, the responses of bitches suffering from acquired urinary incontinence to 
hormonal treatment can take weeks to fully develop (Angioletti et al., 2004; Reichler et al., 
2003; Trigg et al., 2001) which would suggest that chronic changes in reproductive 
hormones may be necessary to effect a change in response of the tissues.  Due to 
experimental and ethical constraints tissue was only obtained from animals which had no 
history of prior drug or hormonal treatment, therefore, the exposure of the bladder tissue to 
supplemental hormones could only occur in vitro and thus only relatively acute effects of 
hormone exposure were investigated.  It is possible that this relatively short incubation 
with hormones was insufficient to evoke any changes in sensitivity and contractility that 
may have been seen in response to chronic hormonal changes.  Furthermore, changes in 
responsiveness may be secondary to alterations in bladder structure or receptor number 
brought about by chronic hormone exposure thus requiring a prolonged time-course before 
functional changes are evident in vitro.  This later hypothesis is supported by reports that 
chronic changes in oestrogen concentrations over a number of weeks and months can cause 
structural changes to the urinary bladder in rodents (Fleischmann et al., 2002) and that 
chronic changes in gonadotrophin concentrations post-menopause in women can cause 
changes in receptor numbers within the bladder (Tao et al., 1998). 
To test the long term influence of hormonal changes on in vitro bladder responsiveness in 
the canine would require the use of animals that had been subjected to known changes in 
hormone concentrations over a chronic time frame.  For this, age-matched, breed-matched 
animals, ideally littermates, would be needed to allow some animals to be treated with 
supplemental hormones over a set number of weeks and months, whilst some animals were 
used as time controls.  Once treatment over the predestined time period was over, the 
animals would be sacrificed and isolated strips of detrusor muscle from each animal 
subjected to a full carbachol and neurogenic field stimulation protocol as described in 7.2.4 
- 7.2.7 above.  This would allow direct comparisons of in vitro bladder function in 
chronically hormonally treated animals and in matched control animals, however, this was 
not feasible within the confines of this project.   
In conclusion, therefore, the results of this study demonstrate that acute incubation with 
oestrogen, GnRH, FSH or LH has no effect on the in vitro responses of isolated strips of 
canine detrusor muscle to muscarinic and neurogenic field stimulation.  This disproves the 
original hypothesis which stated that alterations in responsiveness of bladder strips to the 
acute addition of these hormones would occur.  However, these results do not allow a 
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hormones would affect the responsiveness of the detrusor muscle to muscarinic or 
neurogenic field stimulation, by either causing alterations in the structure of the urinary 
bladder, or the number and distribution of receptors within it.  Further investigation into 
possible causes of the decrease in sensitivity and responsiveness of strips of detrusor 
muscle as described in chapter 4 is therefore warranted.153 
8  mRNA Expression of M1, M2 and M3 Receptors in 
the Canine Urinary Bladder – Effects of 
Neutering 
8.1 Introduction 
The propensity to develop acquired urinary incontinence in the bitch, a debilitating and 
currently incurable condition, has long been linked to neutering (Arnold et al., 1989; Holt 
et al., 1993; Thrusfield, 1985).  Despite this positive correlation, the exact aetiology and 
pathophysiology of the condition in the neutered bitch remains undetermined.  It is 
understood that there is a decrease in urethral closure pressure following neutering in the 
bitch (Holt, 1988) and this has been considered a primary causative factor for the 
development of acquired urinary incontinence for a number of years.  It has also been 
shown, however, that raising the urethral closure pressure does not result in continence in 
all canines (Barth et al., 2005), which has lead to the hypothesis that further factors are 
involved in the development of this condition.  The results of chapter 4 (Coit et al., 2008), 
demonstrate that the detrusor muscle of gonadectomised canines has a lower, in vitro, 
sensitivity and contractility to muscarinic and neurogenic field stimulation than that of 
gonad intact animals and this is hypothesised to contribute to the development of acquired 
urinary incontinence. 
The basis for the functional change in bladder contractility in vitro is not yet fully 
understood, however, a number of factors have been hypothesised to be involved including 
a change in bladder structure and a change in the number and subtype of muscarinic 
receptors present on and within the bladder wall.  To help address this chapter 5 
investigated whether neutering was associated with changes in bladder structure in terms of 
changes in percentage collagen.  The results demonstrated that, in the canine, neutering a 
bitch results in structural changes in the bladder wall, namely an increase in the percentage 
of collagen present within the detrusor, but interestingly that this change is not seen in the 
neutered male (chapter 5).  As neutering is associated with changes in bladder contractility 
and sensitivity in both male and female canines these results suggest that changes in 
bladder structure alone cannot account for the observed changes in bladder function and 
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It is known that the muscarinic receptor effector pathway is the primary pathway 
responsible for bladder contraction and emptying, and that the M3 receptor is the principal 
receptor subtype involved in normal urination (Chess-Williams, 2002; Chess-Williams et 
al., 2001; Fetscher et al., 2002).  It is also known that the M1 and M2 receptor subtypes 
may have a minor role to play in bladder contraction in healthy individuals (Frazier et al., 
2007).  Studies in both rats and humans have shown that the receptor complement of the 
bladder and the subtypes involved in normal bladder contraction can change with different 
disease states (Andersson et al., 2004b); for example, following denervation of the bladder 
the M2 receptor subtype becomes the predominant receptor subtype responsible for bladder 
contraction (Braverman et al., 1998b; Pontari et al., 2004).  In addition, chapter 6 of this 
thesis demonstrated that although the M3 receptor was responsible for detrusor muscle 
contraction in entire canines in vitro, it was the M2 receptor that was responsible for 
detrusor contraction in neutered canines.  Furthermore, a limited study in pigs has 
suggested that bladder contractions mediated via stimulation of the M2 receptor may be 
weaker than those mediated by the M3 receptor, and that the sensitivity of the M2 receptor 
to carbachol may be less than that of the M3 receptor (Yamanishi et al., 2000).  Together 
these results would suggest that a change in subtype, number or the ratio of muscarinic 
receptors may result in altered detrusor function and could therefore provide a means of 
explaining the results described in chapter 4 of this thesis. 
This study will therefore test the hypothesis that there is a difference in the expression of 
mRNA for the M1, M2 and M3 receptor subtypes within the urinary bladder of neutered 
relative to gonadally intact canines.  If this hypothesis holds true then these differences 
may be involved in the decreased sensitivity and contractility of the urinary bladders of the 
neutered animals to muscarinic stimulation in vitro seen in chapter 4, and may be involved 
in the development of acquired urinary incontinence. 
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8.2 Materials and Methods 
8.2.1 Animals 
The study was approved by The University of Glasgow Veterinary School’s ethical review 
committee.  Tissue from a total of 75 canines was included in the study.  The study 
population had a mean age of 5.6 ± 0.7years (range 1-16 years) and a mean weight of 22.6 
± 1.5kg (range 8-50kg).  The canines were split into five groups depending on gender, 
gonadal status and incidence of acquired urinary incontinence: entire and neutered males, 
entire and neutered female, plus neutered females known to be suffering from acquired 
urinary incontinence.  The majority of canines were cross bred, with no pedigree breeds 
appearing more than once.  In all cases, tissue was collected within 2 hours of euthanasia 
(intravenous overdose of pentobarbatone) with full informed owner consent, for reasons 
other than scientific investigation.  The majority of animals had been euthanized for severe 
behavioural problems, the remainder for a number of different complaints, none of which 
involved the urinary system.  A full gross post mortem of the urinary tract was performed 
before tissue harvesting and any animals with a history or signs of gross pathological 
urinary tract disease other than acquired urinary incontinence (e.g. tumours, cystitis) were 
excluded from the study.   
To maximise use of tissue and enable comparisons between different parameters, a number 
of the animals included in this study were also included in the studies described elsewhere 
in this thesis. 
 
8.2.2 Preparation of Tissue 
Full thickness biopsies (2cm by 2cm) were collected from the area of the bladder dome.  
Samples were immediately frozen in liquid nitrogen and stored at -80°C until required for 
mRNA studies. 
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8.2.3 mRNA Extraction 
RNA was extracted from small samples (~1mg) of frozen tissue by addition of  an 
appropriate volume of ice cold TRIzol
® Reagent (Invitrogen, Paisley, UK), usually 1.0ml, 
in a 2ml LysingMatrixD tube (Q Biogene) and homogenisation using a Ribolyser (Hybaid, 
UK) for five 30-second periods or as required for complete disruption of tissue 
architecture.  To isolate and purify the mRNA one tenth volume of chloroform was added 
to each sample and the contents mixed by vortexing.  Samples were then put on ice for 4 
minutes before being centrifuged for 15 minutes at 12,500rpm.  The upper aqueous layer 
was removed, the volume noted, and transferred to a 1.5ml eppendorf tube.  An equal 
sample volume of Isopropanol (Sigma, UK) was added to each sample and the tube placed 
on ice for 30 minutes to allow precipitation of the mRNA before centrifugation for 15 
minutes at 12,500rpm.  The centrifugation formed a pellet of the RNA precipitate.  The 
supernatant was decanted from each sample and the pellets washed with 700µl 80% 
ethanol before further centrifugation for 8 minutes at 8,000rpm.  The ethanol was then 
decanted and the pellets dried before resuspension of the mRNA in 30µl water (BDH, 
Rnase / Dnase free), 3µl of 3M NaAc (pH 7) and 60µl of absolute ethanol.  Samples were 
then incubated for 30 minutes at -70ºC, before centrifugation for 15 minutes at 2500rpm.  
The supernatant was again decanted and the samples dried before being dissolved in 30µl 
of water (BDH, Rnase / Dnase free).  The samples were then placed in a water bath at 65ºC 
for 5 minutes to ensure the RNA was in solution before being quick-frozen to -80ºC for 
storage. 
  
8.2.4 Reverse Transcription 
Master mixes were used in this protocol to allow more accurate pipetting of small volumes 
of reagents.  They were made fresh each day and exact volumes were calculated depending 
on the number of samples to be reverse transcribed. 
 Reverse transcription was carried out by the addition of the equivalent of 7.33µl dH2O 
(UV treated), 0.25µl dNTPs (ABgene, UK) and 0.13µl random hexamers (Invitrogen, UK), 
(all made up as a master mix), and 2.00µl of RNA template (protocol 8.2.3), for each 
sample, to a 0.5ml eppendorf.  This was heated at 65ºC for 5 minutes in a water bath, then 
immediately chilled on ice.  To this were added the equivalent of 1.00µl X5 RT buffer, 
1.00µl DTT, 0.15µl RNAse inhibitor (RNAsin, Promega, UK) and 0.15µl M-MLV RT Victoria A. Coit, 2008     Chapter 8, 157 
(Invitrogen, UK) (all made up as a master mix).  The mixture was then incubated in a 
water bath at 37ºC for 50 minutes, before the enzyme was inactivated by incubating at 
70ºC for 15 minutes.  The reaction product was then stored at -20ºC until required.   
 
8.2.5 Polymerase Chain Reaction 
The polymerase chain reaction allows amplification of specific target sequences of DNA 
using oligonucleotide primers, each complimentary to one end of the DNA target 
sequence.  These primers are extended in a 3’ direction by a thermo-stable DNA 
polymerase in a three-step reaction involving a high temperature denaturising step (95˚C), 
a low temperature-annealing step (50-55˚C) and an extension step (72˚C). 
Primers were designed with reference to information obtained from the canine genome and 
equivalent sequences in other species held within GenBank.  Primers were designed to be 
specific to the gene of interest and this specificity was verified by comparison with the 
entire GenBank database using BLAST.  Potential primers were checked to ensure they did 
not contain sequence that would give rise to significant secondary and complimentary 
structures and then appropriate primers ordered from MWG Biotech, UK.  Primers used in 
this study were between 17-28 bases long, with 50-60% GC content. 
PCRs were conducted using an Ampitaq Gold Kit (Applied Biosystems, UK).  Briefly, for 
each PCR reaction 3µl 10x buffer, 2.5µl MgCl2 (2mM), 0.16µl taq polymerase, 0.3µl 
dNTPs, primers (0.3µl each, 20pmol) and 2µl cDNA template (protocol 8.2.4), made up 
with 21.5µl dH2O (UV treated), were mixed on ice in 0.2ml domed topped eppendorf 
tubes.  Samples were then loaded into a PCR express machine (Thermo Hybaid, UK) and 
run with the following conditions: initial denaturation at 95˚C for 3 minutes, then 35 cycles 
of 95˚C denaturation for 30 seconds, a primer-specific annealing temperature for 30 
seconds and then 1 minute of 72˚C extension.  A terminal extension step of 5 minutes at 
72˚C was used.  Non-template controls were included in all reactions to confirm that no 
contamination had been introduced that could give rise to false results. 
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8.2.6 Gel Electrophoresis 
This allows the separation of DNA or RNA products on the basis of size and electric 
charge.  The DNA molecule is negatively charged and will migrate through a gel matrix 
towards a positive electrode.  Product size can be electrophoretically resolved by 
comparison with DNA size standards.  Loading buffer, containing glycerol and 
bromophenol blue, was added to the PCR products to allow estimation of sample 
migration.  Agarose gel matrix was used in this study.  Agarose gels were 1% unless 
otherwise stated, they were prepared in 0.5x TBE buffer (0.045M Tris-borate + 0.001M 
EDTA, pH 8.0) and heated to induce dissolution of the agarose.  While cooling, ethidium 
bromide was added (1µl ethidium to 100ml agarose gel) to permit visualisation of the 
DNA product under UV light.  A voltage difference of 10V/cm was applied to the gel and 
it was run for as long as required to induce separation of the DNA fragments. 
 
8.2.7 Purification of DNA from Agarose Gel 
DNA fragments of interest i.e. bands of the estimated size, were extracted from gels and 
cleaned using the GenElute Gel Extraction Kit (Sigma, UK).  The DNA fragment of 
interest was visualised under UV light, excised from the agarose gel, the gel block weighed 
and placed in a 1.5ml eppendorf.  3 gel volumes of Gel Solubilisation Solution were added 
to each gel block and the tubes incubated at 55ºC for 10 minutes before vortexing briefly to 
ensure complete solubilisation of the gel.  A GenElute Binding Column G, one for each 
sample being extracted, was then placed in a 2ml collection tube and 500µl of the Column 
Preparation Solution added before centrifugation at 12,000rpm for 1 minute.  The flow-
through liquid was discarded.  One gel volume of 100% Isopropanol was added to the tube 
containing the dissolved gel and the contents mixed until homogenous, before loading into 
the prepared binding columns.  If the volume of the gel mixture was >700µl the sample 
was loaded into the column in 700µl portions.  The columns were centrifuged at 
12,000rpm for 1 minute after each loading and the flow-through liquid discarded.  The 
columns were then washed by the addition of 700µl of Wash Solution and centrifuged at 
14,000rpm for 1 minute.  The flow-through liquid was again discarded and the tube 
centrifuged at 12,000rpm for a further 1 minute.  Once washed the binding columns were 
transferred to fresh collection tubes and 50µl of Elution Solution added to the centre of the 
membrane before incubation at 65ºC for 1 minute and centrifugation at 12,000rpm for 1 Victoria A. Coit, 2008     Chapter 8, 159 
minute.  The columns were then discarded and the purified products kept on ice until 
required. 
 
8.2.8 DNA Sequencing 
Sequencing of PCR products was carried out with the ABI PRISM Big Dye Terminator 
Cycle Sequencing Kit (Applied Biosystems, UK).  Amplification reactions were performed 
in a 0.2ml eppendorf containing 3µl Big Dye Buffer, 1µl Big Dye, 0.5µl sequence specific 
primer (3.2pmol concentration, sourced from MWG Biotech, UK) and 2µl of purified PCR 
product as template.  Thermal cycling was performed at 96ºC for 30 seconds, 50ºC for 15 
seconds and then 55ºC for 4 minutes for 25 cycles using a PCR Express Machine (Thermo 
Hybaid, UK). 
The amplified product was purified by ethanol precipitation.  To the reaction solution was 
added 8µl water and 32µl 95% ethanol to give a final concentration of ethanol of 60% ± 
3%.  This was left to stand at room temperature for 15-30 minutes to allow precipitation of 
extension products before centrifugation for 30 minutes at 14,000rpm at 4ºC.  The 
supernatant was then removed and the pellet washed in 150µl 70% ethanol.  Following 
further centrifugation at 14,000rpm at 4ºC for 10 minutes, the supernatant was removed, 
the pellet dried and re-suspended in 5µl formamide. 
Sequencing was performed on the ABI Prism 3100 Genetic Analyser (ABI Biosystems, 
USA).  The sequences were viewed and text files created using Chromas 2.3 
(Technelysium Pty Ltd, AUS). 
 
8.2.9 Real Time PCR 
To quantify the differences in receptor mRNA expression between bladder samples, real-
time PCR was used to measure relative mRNA levels in each sample.  For all samples a 
standard housekeeping gene, actin, which is expressed in all eukaryotic cells, was used as a 
standard to allow the relative quantification of gene expression.  For all experiments a non-
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between samples or been included on the plate.  If any contamination had been detected the 
results of that plate would have been discarded.  
The primer and probe sequences used for the analysis were designed using Primer Express 
(Applied Biosystems, UK) with sequence information supplied from Genbank and our 
previous sequencing studies.  All real time PCR primers and probes were ordered from 
Eurogentec (Southampton, UK). 
Real time PCRs were carried out in a 25µl reaction volume in a 96 well plate format.  The 
reaction was performed using the Amphitaq Gold kit (Applied Biosystems, UK).  Each 
sample was run in duplicate therefore the reaction was performed in 31.16µl H2O (DBH, 
Rnase / Dnase free), 6µl buffer, 6µl MgCl2 (25mM), 0.6µl dNTPs and 0.25µl Taq (made 
up as a master mix).  To this was added 2µl of probe and 1.5µl of each primer (forward 
and reverse).  This was then split and placed into two adjacent wells on the plate.  The 
thermal cycling consisted of an initial 7-minute 95ºC denaturation step then 35 cycles of 
95ºC for 30 seconds denaturation with a 55ºC annealing step for 30 seconds, followed by 
an extension step for 1 minute at 72ºC.  Thermal cycling and fluorescence detection was 
performed on a Stratagene Mx3000P machine (Agilent Technologies UK Limited, 
Cheshire, UK). 
 
8.2.10  Statistical Analysis 
Results for mRNA expression levels were analysed against both age and weight using 
multivariant analysis with P < 0.05 considered significant.   
Results are given as mRNA expression levels relative to β-actin using the comparative CT 
method (User Bulletin no. 2, PE Biosystems, UK).  Data was ln-transformed prior to 
statistical analysis to equalise the variance between groups and data compared by 2-way 
ANOVA for effects of gender and gonadal status.  Post-hoc comparisons were conducted 
using Tukey’s test with a significance threshold of P < 0.05. 
To examine relationships between the levels of mRNA expression of the muscarinic 
receptors studied and the ability of the detrusor to contract when stimulated with carbachol 
(chapter 4), mRNA expression levels of each muscarinic receptor for each animal studied 
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individual where available (as grams of tension produced per mg of wet tissue) and tested 
for a correlation using Spearman’s test with a significance threshold for P (two tailed) < 
0.05. 
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8.3 Results 
The mean age and weight of the 75 canines included in this study, 27 entire males (ME), 
16 neutered males (MN), 18 entire females (FE), 11 neutered females (FN), and 3 neutered 
females known to suffering from acquired urinary incontinence (FN AUI) are presented in 
Table 8-1.  There was no statistical difference between the mean ages and weights of the 
four groups. 
  
  ME (n=27)  MN (n=16)  FE (n=18)  FN (n=11)  FN AUI (n=3) 
Age (years)  5.6 ± 0.7  5.7 ± 1.0  6.1 ± 1.0  6.1 ± 0.9  4.3 ± 2.0 
Weight (kg)  23.7 ± 1.8  26.9 ± 3.0  21.9 ±2.2  22.4 ± 2.8  17.9 ± 5.0 
Table 8-1.  Mean ± s.e.mean values for age and weight in groups of entire and neutered male 
and female canines (ME, MN, FE and FN respectively) plus neutered females known to be 
suffering from acquired urinary incontinence (FN AUI).  n = number of animals. 
 
 
8.3.1 PCR for M1, M2 and M3 
Actin was used as the housekeeping gene, to provide a positive control for mRNA 
extraction and the primers used are shown in table 8-2.  Ventricular and atrial tissue, as 
well as bladder tissue, was used in initial studies as the M3 receptor protein has previously 
been identified within this tissue in the canine (Shi et al., 2004; Shi et al., 1999).  The 
primers that were found to be specific for the M1 and M3 receptors are shown in tables 8-3 
and 8-4 respectively. 
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β-Actin 
Forward Primer  5’ – TCC TTC CTG GGC ATG GAA TC – 3’ 
Reverse Primer  5’ – GGG CGC GAT GAT CTT GAT CT – 3’ 
Table 8-2.  β-Actin PCR primers 
 
Canine M1 Receptor 
Forward Primer  5’ – TGA CCT CAT CAT CGG TAC CTT C – 3’ 
Reverse Primer  5’ – ATT CTC CGT CTC CCG GTA GAT – 3’ 
Table 8-3.  M1 PCR primers 
 
Canine M3 Receptor 
Forward Primer  5’ – CCT GGC ATA GGT CAT CTC TT – 3’ 
Reverse Primer  5’ – CTC AGA GCC GAT GTC TTC CTC – 3’ 
Table 8-4.  M3 PCR primers. 
 
 
8.3.2 Gels 
PCR products were run against standard ladders to allow estimation of the number of base 
pairs in any resultant bands.  Bands of the correct estimated sizes were seen for actin 
(200bp), M1 (600bp) and M3 (500bp) using the primers above.   
Bands of the expected size for the M3 receptor and actin were visualised in atrial, 
ventricular and bladder samples (Fig. 8-1), and in bladder samples only for the M1 receptor 
(data not shown). 
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8.3.3 Sequences 
To confirm that the bands observed were the receptors of interest, the bands were excised, 
purified and sequenced as described in protocols 8.2.7 and 8.2.8 respectively.  The 
consensus sequences for M1 and M3 obtained from bladder tissue (and ventricular tissue in 
the case of M3) using the forward and reverse primers previously described are shown in 
tables 8-5 and 8-6 respectively.  When run against the entire BLAST database they were 
found to match the predicted canine M1 and M3 sequences and were similar, but not 
identical to, the identified M1 and M3 receptor sequences in other species (≥90% homology 
in the pig, ≥80% homology in the cow, rat and mouse). 
 
 
Figure 8-1.  Picture of a gel showing the actin bands (A), standard ladder (C) and M3 bands (D), 
where a is an atrial sample, b is ventricular, c and d are bladder samples and e is a negative 
control.   B was the result obtained with an additional set of potential M3 primers that were 
shown to be non-specific for the target gene.    
A 
C 
D 
a     b     c     d     e 
B  A Victoria A. Coit, 2008     Chapter 8, 165 
 
TGC  TCA  TGG  GCC  ACT  GGG  CGC  TGG  GCA  CAC  TGG  CCT 
GCG  ACC  TCT  GGC  TGG  CCC  TGG  ACT  ACG  TGG  CTA  GCA 
ATG  CCT  CCG  TCA  TGA  ACC  TGC  TGC  TCA  TCA  GTT  TTG 
ACC  GCT  ACT  TCT  CCG  TGA  CCC  GGC  CCC  TGA  GCT  ACA 
GAG  CCA  AGC  GCA  CAC  CCC  GCC  GGG  CAG  CCC  TGA  TGA 
TCG  GCC  TGG  CCT  GGC  TGG  TCT  CCT  TCA  TCC  TCT  GGG 
CCC  CGG  CCA  TCC  TCT  TTT  GGC  AGT  ACC  TGG  TAG  GGG 
AGC  GGA  CAG  TGC  TGG  CCG  GGC  AGT  GCT  ACA  TCC  AGT 
TCC  TCT  CCC  AAC  CCA  TCA  TC           
Table 8-5.  Partial sequence of M1 receptor in the canine. 
 
CTC  ATT  CAG  TTC  CTC  AGC  GAG  CCC  ACC  ATC  ACG  TTC 
GGC  ACG  GCC  ATC  GCT  GCC  TTC  TAT  ATG  CCC  GTC  ACC 
ATC  ATG  ACT  ATT  TTA  TAC  TGG  AGG  ATC  TAT  AAG  GAG 
ACC  GAG  AAA  CGT  ACC  AAA  GAG  CTT  GCC  GGG  CTG  CAG 
GCG  TCT  GGG  ACG  GAA  GCA  GAG  GCC  GAG  AAC  TTC  GTC 
CAC  CCC  ACA  GGC  AGC  TCT  CGA  AGC  TGC  AGC  AGC  TAT 
GAG  CTC  CAG  CAG  CAG  AGC  CTG  AAA  CGC  TCG  GCC  AGG 
AAG  AAG  TAC  GGC  CGC  TGC  CAC  TTC  TGG  TTT  GCC  ACC 
AAG  AGC  TGG  AAG  CCC  AGC  ACC           
Table 8-6.  Partial sequence of M3 receptor in the canine. 
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8.3.4 Real Time PCR 
Primers and probes for Real Time PCR were designed with reference to the sequences 
above, and those of the β-actin and the previously published canine M2 receptor (Shi et al,. 
2004) in the BLAST database.  The primers and probes designed and used in Real Time 
for β-actin, the M1, M2 and M3 receptors are shown in tables 8-7, 8-8, 8-9 and 8-10 
respectively. 
 
β-actin 
Forward Primer  5’ – GCC CTG AGG CTC TCT TCC A – 3’ 
Reverse Primer  5’ – GGA ATT GAA GGT AGT TTC GTG ATT – 3’ 
Probe  5’ – CCT TCC TTC CTG GGC ATG GAA TCC – 3’ 
Table 8-7.  β–actin rtPCR primers and probe. 
 
Canine M1 receptor 
Forward Primer  5’ – TCA TCA GTT TTG ACC GCT ACT TCT – 3’ 
Reverse Primer  5’ – GGG TGT GCG CTT GGC TC – 3’ 
Probe  5’ – CGT GAC CCG GCC CCT GAG CTA C– 3’ 
Table 8-8.  Canine M1 receptor rtPCR primers and probe. 
 
Canine M2 receptor 
Forward Primer  5’ – GAT GGC CTG GAG CAC AAC A – 3’ 
Reverse Primer  5’ – ACA CAG TTT TCG GTC ACA GCA T – 3’ 
Probe  5’ – TCC AGA ATG GCA AAG CCC CCA GA – 3’ 
Table 8-9.  Canine M2 receptor rtPCR primers and probe. 
 
 
 
Canine M3 Receptor 
Forward Primer  5’ – CTT TCT ATA TGC CCG TTC ACC – 3’ 
Reverse Primer  5’ – TGG TAC GTT TCT CGG TCT CCT – 3’ 
Probe  5’ – TGA CTA TTT TAT ACT GGA GGA TCT A – 3’ 
Table 8-10.  Canine M3 receptor rtPCR primers and probe. 
 Victoria A. Coit, 2008     Chapter 8, 167 
To validate the use of the reagents and allow use of the comparative Ct methods for 
analysis of gene expression, with these primer probe combinations, the efficiency of the 
amplification of the primer probe combinations was assessed with serial dilutions of the 
input amount of cDNA.  The results are shown in Fig. 8-2a, b and c for M1, M2 and M3 
respectively. 
To allow meaningful comparisons of mRNA expression and correct for differences in the 
amount of tissue extracted it is necessary to use relative gene expression whereby the 
expression of each gene is compared to a housekeeping gene, in this case β-actin, which is 
known to be evenly expressed within the tissue to be studied.  To assess the suitability of 
any pair of housekeeping gene and gene of interest, it is first necessary to ensure that the 
rate of amplification within the qPCR conditions used is similar.  This is achieved by 
comparing gene amplification from different dilutions of a stock mRNA sample.  For this, 
standard dilutions of a sample using the above primers and probes for β-actin and the gene 
of interest were made and run using Real Time PCR protocol 8.2.9.  If mRNA 
amplification efficiencies are equal a plot of  Ct versus dose should produce a horizontal 
line.  The results obtained using the real time PCR primers and probes for β-actin and 
canine M1, M2 and M3 receptors used for subsequent analysis are shown in Fig. 8-3. 
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Figure 8-2.  Linearity assessment of mRNA expression for a., M1, b,  M2 and c,  M3 receptor, 
using serial dilutions of input cDNA reverse transcribed from canine urinary bladder. 
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Figure 8-3.  Gene amplification assessment of a, M1, b, M2 and c, M3 receptor against the 
housekeeping gene β-actin. 
 
The mean levels of mRNA expression for M1, M2 and M3 receptor are shown in Figures 8-
4a, b and c respectively.  2-way ANOVA indicated significant effects of gonadal status on 
the expression of the mRNAs for all muscarinic receptors, with neutered animals having 
higher expression levels than their entire counterparts (p<0.05).  There was no interaction 
between the effects of gonadal status and gender on the expression of mRNA for any 
receptor subtype.  A significant effect (P<0.05) of gender on the mRNA expression levels 
for M1 receptor was also observed, with female animals having higher levels of expression 
than their male counterparts, regardless of gonadal status.  The mRNA expression levels 
for the M2 receptor for the females identified as suffering from acquired urinary Victoria A. Coit, 2008     Chapter 8, 170 
incontinence were the highest of all the animals in the study and fell above the 95% CI for 
the continent neutered female group (3.16- 3.27), however, this difference was not 
statistically significant (fig.  8-4b).  mRNA expression for the M1 and M3 receptor subtypes 
did not differ in the female neuters that suffered from acquired urinary incontinence as the 
levels of expression seen in these three animals fell within the 90% CI for the continent 
neutered female groups.   
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Figure 8-4.  Mean (± s.e.mean) mRNA expression for: a, M1 receptor, b, M2 receptor and c, M3 
receptor, in entire and neutered male and female canines (ME, MN, FE and FN respectively) 
and neutered female canines identified as suffering from acquired urinary incontinence (FN 
AUI).  mRNA values are logarithmically transformed.  *** P<0.001, ** P<0.01 compared entire 
of same gender.  $$$ P<0.001 compared to male animals of same gonadal status. Victoria A. Coit, 2008     Chapter 8, 171 
 
Carbachol induced dose dependant contraction of the isolated strips of detrusor muscle 
from this specific subset of animals, as was the case in the larger study population 
described in chapter 4.  As in the previous study, maximal response was significantly 
decreased (P<0.01) in neutered compared to entire canines of either gender (Figure 8-5).  
Sensitivity of strips to carbachol, as measured by Log EC50 values, was also decreased in 
neutered compared to entire animals (P<0.01).  2 way ANOVA revealed there was no 
effect of gender and no interaction between gender and gonadal status.  The group of 
animals identified as suffering from acquired urinary incontinence had the lowest maximal 
contraction of all animals studied, although this was not considered significant using 
ANOVA analysis. 
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Figure 8-5.  Mean (± s.e.mean) maximal tension  values (g/mg wet tissue) in response to 
carbachol in isolated strips of detrusor muscle from entire and neutered male and female 
canines  (ME,  MN,  FE  and  FN  respectively)  and  neutered  female  canines  identified  as 
suffering from acquired urinary incontinence (FN AUI).  Data is for canines for which both 
maximal contraction to carbachol and mRNA expression levels for muscarinic receptors are 
available.  ** P<0.01 compared entire of same gender 
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Statistical analysis revealed a significant negative correlation between the maximal tension 
produced by detrusor muscle strips and M1 (P<0.05, r=-0.362), M2 (P<0.01, r=-0.579) and 
M3 (P<0.05, r=-0.678) receptor mRNA expression (Figures 8-6a, b and c respectively).   
Multivariant analysis of the levels of expression of mRNA for the muscarinic receptors and 
the maximum tension produced by detrusor muscle strips indicated no significant effect of 
age or weight of the animal on the results. 
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Figure 8-6.  Correlation between maximal tensions produced by detrusor muscle strips in 
vitro in response to muscarinic stimulation and mRNA expression levels for: a, M1 receptor 
(P<0.05, r=-0.362), b, M2 receptor (P<0.001, r=-0.579) and c, M3 receptor (P<0.05, r=-0.678).     
■ entire male,  □ neutered male,  ● entire female, ○ neutered female, ▲ neutered female 
known to be suffering from acquired urinary incontinence. Victoria A. Coit, 2008     Chapter 8, 173 
8.4 Discussion 
This study is the first to report the presence of, and levels of expression for, mRNA for the 
M1, M2 and M3 receptors in the canine urinary bladder.  The results also show that the 
amplicons isolated for the canine M1 and M3 receptors in this study have 100% homology 
with the predicted canine sequence and are similar to the identified M1 and M3 receptor 
sequences in other species (≥ 90% homology in the pig, ≥ 80% homology in the cow, rat 
and mouse).  The results demonstrate that mRNA expression of M1, M2 and M3 receptors 
within the canine urinary bladder can be quantified by real time PCR, relative to β-actin.  
The present work demonstrates that mRNA for these receptors is expressed in canine 
urinary bladder and that a significant relationship exists between levels of mRNA 
expression and tissue contractility.  Furthermore, this study indicates a significant effect of 
neutering on mRNA expression levels for the M1, M2 and M3 receptors.   
This study has shown that neutered animals have significantly higher expression levels of 
mRNA for all three receptors than their entire counterparts, regardless of gender, and that 
female animals have higher expression levels of M1 receptor mRNA than their male 
counterparts.  For those animals known to be suffering from acquired urinary incontinence 
the levels of expression for the M2 receptor mRNA were the highest of all animals studied, 
however the expression for the M1 and M3 receptor mRNAs were similar to that of 
continent neutered animals.  This study has also demonstrated an inverse relationship 
between receptor mRNA expression and contractility of the bladder to muscarinic 
stimulation in vitro for all receptors, with animals known to be suffering from acquired 
urinary incontinence having the lowest contractility and highest M2 receptor mRNA 
expression of all animals studied. 
There have been no reported studies investigating the relationship between muscarinic 
receptor mRNA expression levels and impaired contractility of the detrusor in any species; 
therefore, accurate comparisons with the results of this study are not possible.  However, a 
number of other studies in various species have looked at the expression levels of the 
muscarinic receptor subtypes within the bladder, their functional properties and how these 
expression levels and properties change in certain disease states.  This allows the formation 
of hypotheses as to how the muscarinic receptors may mediate function in the canine 
urinary bladder and also helps aid understanding of the potential significance of the 
changes in muscarinic receptor mRNA expression levels demonstrated in this study. Victoria A. Coit, 2008     Chapter 8, 174 
The M1 receptor has been variably reported in the detrusor muscle of rats (Braverman et 
al., 1998a) and humans (Kondo et al., 1995), however, a further study has not found this 
receptor within the detrusor of human, rabbit, rat or guinea-pig bladder (Wang et al., 1995) 
and it is not considered to play a primary role in detrusor contraction (Chess-Williams, 
2002).  In contrast, the M1 receptor has been described as occurring on the pre-synaptic 
nerve terminals in a number of species where they are thought to facilitate transmitter 
release and enhance contraction of the bladder (Braverman et al., 1998a; Somogyi et al., 
1999; Somogyi et al., 1994).  Due to the limitations of this study it is not possible to 
determine if the M1 mRNA detected in the bladder of canines is presynaptic or on the 
detrusor muscle itself, however, evidence from studies in other species suggest that it is 
most likely to be presynaptic in origin.  If this is indeed the case, it is possible that the M1 
receptor is up-regulated in neutered animals in an attempt to facilitate ACh release and 
thereby enhance contractile force of the detrusor which has been decreased due to another, 
as yet unidentified mechanism. 
The results show an increase in the expression of the mRNA for the M2 receptor in 
neutered animals, with the incontinent animals having the highest level of M2 expression of 
all animals studied.  There are no reported studies looking at levels of M2 receptor in the 
bladder of humans suffering from urinary incontinence due to impaired contractility of the 
detrusor, however M2 expression has been shown to be increased in other disease states 
including denervation of the bladder where they are known to contribute significantly to 
contraction (Braverman et al., 1998b).  The M2 receptor has been shown to dominate 
within the urinary bladder in all species so far studied (Goepel et al., 1998; Wang et al., 
1995; Yamanishi et al., 2000) and it is described mainly on the detrusor muscle where it is 
thought to play a role in bladder contraction, as demonstrated by M2 knockout mice that 
have decreased bladder responsiveness (Stengel et al., 2000).  A study in pigs has shown 
that the contractile response of the M2 receptor to cholinergic stimulation may be smaller 
than that of the M3 receptor and that the sensitivity of the M2 receptor may also be less than 
that of the M3 receptor.  This could be significant in this study if the M2 receptor 
population is increasing to play a greater role in contraction of the bladder in neutered 
animals, as suggested by the data demonstrated in chapter 5 of this thesis in which it was 
shown that the M2 receptor is the primary receptor responsible for detrusor muscle 
contraction in neutered canines in vitro, then the contraction produced may be reduced in 
comparison to that produced by a healthy individual with a contraction mediated by the M3 
receptor.  This possibility is supported by the data from animals known to be suffering 
from acquired urinary incontinence which had the highest M2 receptor expression yet the 
lowest contractility and sensitivity of the bladder to muscarinic receptor stimulation.   Victoria A. Coit, 2008     Chapter 8, 175 
The M3 receptor has been reported on the detrusor muscle of all species so far studied, and 
is considered the primary receptor responsible for mediating detrusor contraction in 
healthy individuals (Braverman et al., 1998a; Braverman et al., 1998b; Chess-Williams, 
2002; Chess-Williams et al., 2001; Choppin et al., 2001; Goepel et al., 1998; Ikeda et al., 
1999; Longhurst et al., 2000; Sellers et al., 2000; Wang et al., 1995).  Despite its role in 
mediating contraction it has previously been reported that the M3 receptor does not 
predominate within the detrusor (Wang et al., 1995) and the results of this canine study are 
in agreement with this.  Due to its role in micturition it might reasonably be assumed that 
decreased contractility of the detrusor muscle would be accompanied by decreased 
expression of M3 receptor, however, the results of this present study demonstrate that 
decreased contractility of the detrusor muscle is associated with an increased M3 mRNA 
expression in neutered canines.  This apparent paradox may be due to the M3 receptor 
becoming dysfunctional (Eglen et al., 1994), however, it is also conceivable that the 
increased M3 receptor mRNA expression demonstrated in this study is not reflected by 
increased M3 protein expression as described by Braverman et al.  (Braverman et al., 2006) 
who reported a lack of correlation between mRNA and protein expression for this 
particular receptor.  It can therefore be hypothesised that the increase in M3 mRNA 
expression seen in neutered canines in this study is a compensatory response to the 
decreased detrusor contractility brought about by an as yet unidentified mechanism that 
may involve transcription or translation of the M3 receptor itself. 
In conclusion this study has shown that neutering a canine, regardless of gender, is 
associated with an increase in the levels of mRNA for M1, M2 and M3 receptors in the 
canine urinary bladder.  Furthermore, these results show that there is a negative correlation 
between increased mRNA expression of these receptors and decreased contractility of the 
detrusor to muscarinic stimulation in vitro.  It is hypothesised that the changes in mRNA 
expression for these receptors may be linked to the development of post neutering acquired 
urinary incontinence and this hypothesis is supported by data from a limited number of 
neutered female canines identified as suffering from acquired urinary incontinence which 
had the highest levels of M2 receptor mRNA expression and the lowest contractility to 
muscarinic stimulation of all the animals studied.  Further studies are required to 
investigate the protein expression levels of these receptors, as well as their function in 
mediating bladder contractility before the exact role of these receptors, and their suitability 
as therapeutic targets in acquired urinary incontinence in the bitch can be determined.176 
9  Neutering affects mRNA expression levels for 
the LH- and GnRH- receptors in the canine 
urinary bladder. 
9.1 Introduction 
Urinary incontinence is a debilitating and so far incurable condition that causes significant 
welfare problems for affected canines.  Urinary incontinence is seen most frequently in 
neutered female canines where the condition is termed acquired urinary incontinence, and 
is thought to be due to insufficient urethral closure pressure and / or abnormal bladder 
storage function (Arnold, 1997; Nickel et al., 1997). 
The previously reported in vitro studies have shown that neutering a canine of either 
gender leads to a decrease in maximal contractile response of the detrusor muscle to both 
muscarinic and electrical field stimulation, as well as a decreased sensitivity to muscarinic 
stimulation (Coit et al., 2008).  These decreases in contractile function in vitro are similar 
to those reported in post menopausal women who suffer from urinary incontinence due to 
impaired contractility of the bladder (Andersson et al., 2004a; Elbadawi et al., 1993a; Zhu 
et al., 2001).  It is hypothesised that this decrease in bladder function may be due to, or 
exacerbated by, hormone mediated effects.  In addition a common element between the 
two identified susceptible populations is that, in both spayed bitches and post menopausal 
women, there is a deficiency of endogenous gonadal steroid hormones.  This deficit in turn 
decreases or removes the normal negative feedback to the hypothalamo-pituitary axis, and 
results in greatly increased production and secretion of GnRH from the hypothalamus 
leading to increased secretion of the pituitary gonadotrophins LH and FSH (Burger, 1996; 
Olson et al., 1992; Reichler et al., 2004; Reichler et al., 2005b; Wise, 1999).  The post 
neutering increase in plasma concentrations of LH and FSH has been demonstrated to have 
a direct relationship with the development of urinary incontinence in the bitch (Reichler et 
al., 2005a) and a recent paper has described the clinical use of GnRH analogues to 
decrease LH and FSH concentrations in neutered female canines suffering from acquired 
urinary incontinence with a positive clinical outcome i.e. clinical continence, or an 
improvement in continence, during the treatment period (Reichler et al., 2006a; Reichler et 
al., 2003).  This result would suggest that the increase in the concentrations of either 
GnRH and/or the pituitary gonadotrophins could be a causative factor for acquired urinary 
incontinence in the bitch.   Victoria A. Coit, 2008     Chapter 9, 177 
While GnRH and the gonadotrophins are classically thought of as reproductive hormones 
of the hypothalamo-pituitary-gonadal axis,  the presence of their receptors in tissues such 
as skin (Welle et al., 2006), reproductive tract, prostate and mammary gland (Fields et al., 
2004; Ziecik et al., 2005) as well as the urinary bladder (Ponglowhapan et al., 2007b; 
Reichler et al., 2007; Tao et al., 1998) would suggest more widespread actions.  In 
particular the presence of receptors within the urinary tract could lead to local effects of 
elevated GnRH and gonadotrophin concentrations.  As tissue action and function rely upon 
the presence of specific receptors, it is possible that changes in either absolute receptor 
numbers or receptor-ligand concentration could influence the function of, or stimulate 
structural changes within a tissue.  In this regard a study in women has reported a decrease 
in  LH- receptor numbers in the bladders of post- compared to pre-menopausal women 
(Tao et al., 1998) and a number of recent studies in the canine have reported the mRNA 
levels of receptors within the canine bladder (Ponglowhapan et al., 2007a; Reichler et al., 
2007) but the results have been contradictory as both a decrease and no change were seen 
following neutering in these two studies.  To the authors knowledge there have been no 
reported studies looking at mRNA levels for the LH, FSH or GnRH receptors in the 
bladders of bitches known to be suffering from acquired urinary incontinence.  There have 
also been no studies reported looking at the correlation between detrusor contractility, a 
factor known to be involved in urinary incontinence (Elbadawi et al., 1993a; Elbadawi et 
al., 1993b) and receptor mRNA expression levels within the urinary bladder.  
This study tested the hypothesis that the expression levels of GnRH-, LH- and FSH- 
receptor mRNA in the canine urinary bladder will be altered by neutering and that these 
changes will be most extreme in neutered bitches suffering from acquired urinary 
incontinence.  Furthermore the hypothesis that there will be a correlation between the 
expression of the mRNAs for these receptors and maximal contractility of the bladder was 
tested. Victoria A. Coit, 2008     Chapter 9, 178 
9.2 Materials and Methods 
9.2.1 Animals 
The study was approved by The University of Glasgow Veterinary School’s ethical review 
committee.  Tissue from a total of 78 canines was included in the study.  The study 
population had a mean age of 6.0 ± 0.5years (range 1-16 years) and a mean weight of 22.7 
± 1.3kg (range 8-50kg).  The canines were split into five groups depending on gender, 
gonadal status and incidence of acquired urinary incontinence: entire and neutered males, 
entire and neutered females, plus neutered females known to be suffering from acquired 
urinary incontinence.  The majority of canines were cross bred, with no pedigree breeds 
appearing more than once.  In all cases, tissue was collected within 2 hours of euthanasia 
(intravenous overdose of pentobarbatone) with full informed owner consent, for reasons 
other than scientific investigation.  The majority of animals had been euthanized for severe 
behavioural problems, the remainder for a number of different complaints, none of which 
involved the urinary system.  None of the animals used in the study were receiving medical 
treatment in the 7 days prior to euthanasia and there was no evidence of previous medical 
therapy in at least the month prior to this.  A full gross post mortem of the reproductive and 
urinary tract was performed before tissue harvesting and any animals with a history or 
signs of gross pathological urinary, neurological or reproductive tract disease (e.g. 
tumours, cystitis, pyometra) were excluded from the study.   
To ensure best use of tissue available and to allow comparisons between different 
parameters a number of the animals included in this study were also included in the studies 
described elsewhere in this thesis. 
 
9.2.2 Preparation of Tissue 
Full thickness biopsies (2cm by 2cm) were collected from the area of the bladder dome.  
Ovarian tissue as well as skin biopsies, from the shoulder and groin regions were collected 
from a subset of animals included in the study, as a control for FSH receptor mRNA 
expression (Welle et al., 2006).  Samples were immediately frozen and stored at -80°C 
until required for mRNA studies. 
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9.2.3 mRNA Extraction 
The same protocol as described in 8.2.3 was used in this study. 
 
9.2.4 Reverse Transcription 
The same protocol as described in 8.2.4 was used in this study. 
 
9.2.5 Real Time PCR 
The primers and probes for the three receptor mRNAs were as described by Welle et al  
(Welle et al., 2006), sourced from Eurogentech (Southampton, UK).   
The protocol used was as described in 8.2.9. 
 
9.2.6 Statistical Analysis 
Results for mRNA expression levels were analysed against both age and weight using 
multivariant analysis with P ≤ 0.05 considered significant.   
Results are given as mRNA expression levels relative to β-actin using the comparative CT 
method (User Bulletin no. 2, PE Biosystems, UK).  Data was ln-transformed prior to 
statistical analysis to equalise the variance between groups and data compared by 2-way 
ANOVA for effects of gender and gonadal status.  Post-hoc comparisons were conducted 
using Tukey’s test with a significance threshold of P < 0.05. 
To examine relationships between the levels of mRNA expression of the hormone 
receptors studied and the ability of the detrusor to contract when stimulated with carbachol 
(chapter 4), mRNA expression levels of each hormone receptor were plotted against 
maximal contraction (as grams of tension produced per mg of wet tissue) and tested for a 
correlation using Spearman’s test with a significance threshold for P (two tailed) < 0.05. Victoria A. Coit, 2008     Chapter 9, 180 
9.3 Results 
The mean age and weight of the 78 canines included in this study, 27 entire males (ME), 
17 neutered males (MN), 18 entire females (FE), 13 neutered females (FN), and 3 neutered 
females known to suffering from acquired urinary incontinence (FN AUI) are presented in 
Table 9-1.  There was no statistical difference between the mean ages and weights of the 
four groups. 
 
  
  ME (n=27)  MN (n=17)  FE (n=18)  FN (n=13)  FN AUI (n=3) 
Age (years)  5.6 ± 0.7  5.8 ± 0.9  6.1 ± 1.0  6.5 ± 1.0  4.3 ± 2.0 
Weight (kg)  23.7 ± 1.8  27.4 ± 3.2  21.9 ±2.2  21.1 ±3.1  17.9 ± 5.0 
Table 9-1.  Mean ± s.e.mean values for age and weight in groups of entire and neutered male 
and female canines (ME, MN, FE and FN respectively) and neutered female animals known 
to be suffering from acquired urinary incontinence.  n = number of animals (FN AUI). 
 
 
9.3.1 Validation of qPCR primer probes combinations to study 
hormone receptor gene expression  
To validate the use of the reagents and allow use of the comparative Ct methods for 
analysis of gene expression, with these primer probe combinations, the efficiency of the 
amplification of the primer probe combinations was assessed with serial dilutions of the 
input amount of cDNA.  The results are shown in Fig. 9-1a and b for LH and GnRH 
respectively.  
As in chapter 8, amplification efficiencies were calculated for each of the receptors of 
interest against the housekeeping gene β-actin, as shown in Fig 9-2. 
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Figure  9-1.    Linearity  assessment  of  mRNA  expression  for  a,  LH  receptor  and  b,  GnRH 
receptor, using serial dilutions of input cDNA reverse transcribed from canine bladder. 
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Figure 9-2.  Gene amplification assessment of a, LH receptor and b, GnRH receptor against 
the housekeeping gene β-actin. 
 Victoria A. Coit, 2008     Chapter 9, 182 
9.3.2 Comparison of LH and GnRH receptor gene expression 
between groups.   
The mean levels of mRNA expression for LH and GnRH receptor are shown in Figures 9-
3a and b respectively.  2-way ANOVA indicated significant effects of gonadal status on 
the expression of the mRNAs for both LH- and GnRH-receptor, whilst there was an 
additional effect of gender on the expression of LH-receptor mRNA.  There was no 
statistically significant interaction between the effects of gonadal status and gender.  
Neutering was associated with significantly (p<0.01) higher levels of mRNA expression 
for both LH- and GnRH- receptor in both genders.  Furthermore, female animals showed 
significantly (p<0.05) greater levels of mRNA expression for LH- receptor, than their male 
counterparts, regardless of gonadal status (Figure 9-3a).   
mRNA expression levels for both LH- and GnRH- receptor for the females identified as 
suffering from acquired urinary incontinence were the highest of all the animals in the 
study and fell above the 95% CI for the continent neutered female group, however, the 
difference between the incontinent and continent neutered females was not statistically 
significant.  
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Figure 9-3.  Mean (± s.e.mean) mRNA expression for: a, LH receptor and b, GnRH receptor, 
in isolated strips of detrusor muscle from entire and neutered male and female canines (ME, 
MN,  FE,  and  FN  respectively)  and  neutered  female  canines  identified  as  suffering  from 
acquired urinary incontinence (FN AUI).  mRNA values are logarithmically transformed.  *** 
P<0.001, ** P<0.01 compared entire of same gender.  $ P<0.05 compared to male animals of 
same gonadal status. 
 
 
9.3.3 Real time PCR for FSH receptor mRNA 
Real time PCR was performed for the quantification of FSH receptor mRNA expression 
within samples of urinary bladder.  In all cases, expression was found to be below the 
limits of detection of the assay system.  To ensure validity of the primers and probes used, 
they were tested against samples of canine ovary and skin as described by Welle et al 
(Welle et al., 2006).  mRNA for the FSH- receptor was found at very low levels (3.22E
-15, 
n=2) in samples of canine skin but was not detectable in samples of canine ovary. 
 
9.3.4 Relationship between receptor mRNA expression and tissue 
contractility 
Analysis of the contractility of the tissue strips for which mRNA levels were also 
quantified, indicated that as shown previously (Chapter 4), the maximal response in Victoria A. Coit, 2008     Chapter 9, 184 
neutered compared to entire canines of either gender was significantly decreased (P<0.01) 
and the group of animals identified as suffering from acquired urinary incontinence had the 
lowest maximal contraction of all animals studied (Figure 9-4). 
Statistical analysis revealed a significant negative correlation between the maximal tension 
produced by detrusor muscle strips and both LH- (P<0.001, r=-0.671) and GnRH- 
(P<0.001, r=-0.612) receptor mRNA expression (Figures 9-5a and b respectively).  
Multivariant analysis of the levels of expression of mRNA for both GnRH- or LH-receptor, 
and the maximum tension produced by detrusor muscle strips indicated no significant 
effect of age or weight of the animal on the results. 
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Figure 9-4.  Mean (± s.e.mean) maximal tension values (g/mg wet tissue) in response to 
carbachol in isolated strips of detrusor muscle from entire and neutered male and female 
canines (ME, MN, FE and FN respectively) and neutered female canines identified as 
suffering from acquired urinary incontinence (FN AUI).  Data is for canines for which both 
maximal contraction to carbachol and mRNA expression levels for GnRH and LH are 
available.  ** P<0.01 compared entire of same gender. 
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Figure 9-5.  Correlation between maximal tensions produced by detrusor muscle strips in 
vitro  and  mRNA  expression  levels  for:  a,  LH  receptor  (P<0.001,  r=-0.671)  and  b,  GnRH 
receptor (P<0.001, r=-0.612). ■ entire male,  □ neutered male, ● entire female, ○ neutered 
female, ▲ neutered female known to be suffering from acquired urinary incontinence. Victoria A. Coit, 2008     Chapter 9, 186 
9.4 Discussion 
Bladder contractility is thought to play a significant role in the development of clinical 
signs of urinary incontinence (Andersson et al., 2004a).  The results presented in chapter 4 
(Coit et al., 2008) showed that the maximal contractile response and sensitivity of isolated 
strips of detrusor muscle to muscarinic and neurogenic stimulation is significantly 
decreased in neutered compared to entire canines of either gender and the same result was 
seen in the subset of animals for which tissue was processed for mRNA comparison in this 
study.  These results are similar to those of women who suffer from urinary incontinence 
due to impaired contractility of the bladder (Elbadawi et al., 1993a), a condition known to 
cause decreased speed and magnitude of detrusor contractions during the emptying phase 
of micturition, often leading to residual urine retention, shortened storage phase and 
predisposing the patient to cystitis (Resnick et al., 1987).  Although impaired bladder 
contractility has been implicated in urinary incontinence, the exact mechanisms 
responsible for its development have not been reported.  This study tested the hypothesis 
that changes in reproductive hormones and their receptors post neutering may alter the 
contractility of the bladder. 
The possibility that gonadotrophins could influence bladder function was first suggested in 
a study which showed that postmenopausal women, who are most likely to suffer from 
urinary incontinence, had lower numbers of LH mRNA transcripts and receptors in their 
bladders than their premenopausal counterparts (Tao et al., 1998).  As postmenopausal 
women have a similar hormonal profile to neutered canines and as both post-menopausal 
and post-neutering urinary incontinence are thought to be hormonally related, it follows 
that a similar aetiology and pathophysiology may link both conditions.  These results 
clearly show that neutering a canine, regardless of gender, significantly increases levels of 
mRNA expression for both LH- and GnRH- receptors and that, in general, female animals, 
regardless of gonadal status have higher levels of mRNA expression for these receptors 
than their male counterparts.  Although the results for female canines are in contrast to the 
study by Tao et al. the results of this present study include age matched groups of healthy 
entire and neutered animals as well as those known to be suffering from acquired urinary 
incontinence.  The study by Tao et al. compared women of two distinct age groups, thus it 
is not possible in that study to dissect out the individual effects of age or menopausal status 
on LH receptor mRNA expression and as a number of patients in both groups suffered 
from urinary incontinence, it is not possible to determine if the observed decrease in LH 
receptor mRNA expression was linked to predisposition to urinary incontinence. In Victoria A. Coit, 2008     Chapter 9, 187 
addition it should be noted that there are multiple types of urinary incontinence recognised 
in human medicine hence the observation of incontinence in both pre and post menopausal 
groups. Thus more detailed analysis of the human data would be required wherein patients 
were separated into subgroups based on the type of urinary incontinence in addition to their 
menopausal status.  The results of the current study, however, interestingly, suggest that 
LH- receptor mRNA may actually be increased in animals suffering from acquired urinary 
incontinence relative to their continent counterparts.  These findings support the hypothesis 
that gonadotrophins have a role in the pathophysiological mechanism that leads to post-
neutering urinary incontinence in the bitch (Reichler et al., 2003). 
The present findings of canine receptor mRNA levels, however, contrast with those 
reported by Reichler et al. (Reichler et al., 2007) and Ponglowhapan et al. (Ponglowhapan 
et al., 2007a) as they reported either no change or a decrease in mRNA expression for LH 
and GnRH receptors in neutered canines, respectively.  These differences in results may 
reflect differences in the study populations and conditions.  In both of the studies by 
Reichler et al. and Ponglowhapan et al. a substantially smaller number of animals were 
used which may affect the results obtained.  In addition in the study by Reichler et al. the 
groups were not age matched and included entire bitches in varying stages of the oestrus 
cycle, which, if bladder hormone receptor expression is influenced by changes in the 
reproductive hormones as hypothesised, could significantly affect the results obtained, 
however, oestrous cycle stage was not included in the analysis.  Thus the small sample size 
and increased variation may have prevented statistical observation of an effect of neutering 
on LH receptor mRNA expression.  The study by Ponglowhapan et al. was conducted 
using animals that had been neutered for a relatively short time (24-40 weeks).  As it has 
been shown that plasma concentrations of FSH and LH continue to increase until week 42 
post neutering (Reichler et al., 2004) and that some structural changes may have a chronic 
time course (Fleischmann et al., 2002) it is possible that the decrease in receptor mRNA 
expression in that study reflect more acute changes.  Indeed it could be hypothesised that if 
receptor mRNA was produced at a relatively constant level that it should be inversely 
related to protein expression and thus a decrease in expression could be seen initially as 
receptor number increases in association with steroid withdrawal, but then levels increase 
as receptor down regulation results in decreased translation. 
A further difference between this study and that of Tao et al. and Ponglowhapan et al. is 
that this study uses real time PCR techniques with fresh frozen tissue to quantify mRNA 
expression levels, whilst the former two studies used in situ hybridisation techniques with 
formalin fixed, paraffin-embedded tissue.  It is known that degradation of
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acids occurs during formalin fixation and paraffin-embedding
 procedures (Goelz et al., 
1985; Rupp et al., 1988), and that artificial mutations can occur (Williams et al., 1999), 
which would affect analysis (Mc Sherry et al., 2007).  
The changes in expression of mRNA for LH- and GnRH- receptors observed in this study 
could support a role for altered expression of GnRH/LH receptors in the development of 
acquired urinary incontinence in the neutered bitch.  It is worthy of note that increases in 
LH and GnRH receptor mRNA expression also occurred in the bladders of neutered male 
canines, however, which do not typically become incontinent. The magnitude of the 
increase in expression for both receptor mRNA species, however, was smaller than in the 
females in association with neutering and the final levels of expression were only 
marginally above those of entire female canines which also rarely become incontinent, thus 
it is possible that there is a threshold effect.  The case for a threshold level of LH- and 
GnRH- receptor expression, above which urinary incontinence is more likely to develop is 
supported by the fact that the three animals included in the study that were known to be 
suffering from acquired urinary incontinence (all neutered females) had the highest 
observed LH- and GnRH receptor mRNA expression levels.   
The exact role of the LH receptor in the urinary bladder has not yet been described.  It has 
previously been reported that plasma concentrations of LH increase in both post 
menopausal women and in neutered canines (Overlie et al., 1999; Reichler et al., 2004), 
but that LH in both populations is still released in a pulsatile manner.  It is also known that 
these two subsets of their respective populations are more prone to developing urinary 
incontinence.  This present study has shown that neutering causes an increase in mRNA 
expression levels for the LH receptor in the canine urinary bladder and that these 
expression levels are highest in bitches known to be suffering from acquired urinary 
incontinence.  It has also been shown that maximal bladder contractility is decreased in 
neutered animals and is lowest in bitches suffering from acquired urinary incontinence and 
that there is a direct inverse correlation between bladder contractility and mRNA 
expression levels for LH.  It therefore follows that the increase in mRNA for the LH 
receptor may be implicated in the decrease in contractility of the detrusor muscle, either 
directly or via interactions with another mechanism, possibly involving the muscarinic 
receptor effector pathway, the primary pathway involved in bladder contraction (Chess-
Williams, 2002).   
The exact role of the GnRH receptor within the urinary bladder has not been characterised 
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threshold volume following administration of GnRH analogues to neutered continent 
bitches it has been hypothesized that it may have a role in determining bladder function 
(Reichler et al., 2006a).  This could occur if GnRH receptor expression modulated the 
bladders sensitivity to muscarinic stimulation to affect the bladder threshold volume, 
possibly via the sympathetic nervous system where GnRH has been shown to act as a co-
transmitter in cholinergic nerve terminals (Jan et al., 1983).  As a direct receptor-mediated 
effect of GnRH on smooth muscle cells of the gastro-intestinal tract has also been 
demonstrated in rats (Chen et al., 2004), it is plausible that GnRH could exert direct effects 
on the detrusor smooth muscle in canines.  This hypothesis is supported by the data 
contained within this study where a decrease in in vitro detrusor muscle sensitivity to 
muscarinic stimulation was seen in neutered canines when GnRH receptor mRNA 
expression levels were found to be high.  Thus, the increase in GnRH- receptor expression 
could be associated with a decreased sensitivity of the detrusor which would allow further 
relaxation of the bladder and increased capacity. 
While two other studies (Ponglowhapan et al., 2007b; Welle et al., 2006) have reported 
FSH mRNA expression in the canine bladder the current study does not document 
significant levels of mRNA expression.  The reason for this difference could be 
methodological, as Ponglowhapan et al (Ponglowhapan et al., 2007b) used in situ 
hybridization whilst this study used real time PCR techniques.  Alternatively it could be 
related to differences in the FSH mRNA sequences used.  This present study used the same 
primer and probe sequences published by Welle et al (Welle et al., 2006) and 
unsurprisingly the results are more similar to those of Welle et al than Ponglowhapan et al.  
To verify the results of the present study the presence of FSH mRNA in both the ovary and 
skin was examined as positive controls (Minegishi et al., 1997; Welle et al., 2006).  The 
results of this present study supported the results of Welle et al but the lack of expression 
in the ovary which is known to be sensitive to FSH action would suggest that this primer 
probe combination is picking up a non reproductive FSH receptor isoform.  Indeed, FSH is 
known to express multiple isoforms (Zambrano et al., 1999) therefore it is a possibility that 
the primers and probes used in this study and that of Welle et al (Welle et al., 2006) were 
designed against part of the mRNA sequence of an FSH receptor isoform that is expressed 
in skin but not in the bladder.  Thus, at this point, it is not possible to make any definitive 
conclusions with regard to the effects of neutering on FSH receptor mRNA expression 
within the bladder wall.  
In conclusion this study has shown that neutering a canine, regardless of gender, is 
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canine urinary bladder, and that female animals, regardless of gonadal status have higher 
LH/GnRH receptor mRNA expression levels than males.  A further novel observation 
shown by this study is the positive correlation between increased mRNA expression for 
LH- and GnRH- receptors and the negative correlation between expression of these 
receptors and contractility of the detrusor to muscarinic stimulation in vitro.  It is 
hypothesized that the changes in mRNA expression for both GnRH- and LH- receptor may 
have a role to play in the development of post neutering acquired urinary incontinence and 
this hypothesis is supported by data from a limited number of neutered female canines 
identified as suffering from acquired urinary incontinence which had the highest levels of 
LH- and GnRH- receptor mRNA expression and the lowest contractility to muscarinic 
stimulation of all the animals studied.   191 
10  Thesis Overview 
Canine acquired urinary incontinence is known to be a widespread problem in a variety of 
countries around the world, with up to 20% of all neutered bitches affected, compared to 
less than 1% of entire bitches and male canines (Arnold et al., 1989). The condition can be 
severely debilitating and can lead to a number of further problems and complications 
including urine scalding, skin infections, secondary bacterial cystitis and even sepsis and 
death (Hotston Moore, 2001).  The development of acquired urinary incontinence in a 
bitch prompts welfare considerations, and presents a financial burden to the owner who, in 
addition, is often required to make lifestyle changes to accommodate their pet’s needs.  
This can all lead to the difficult and emotionally traumatic decision to have the affected 
animal euthanized.   
Although acquired urinary incontinence in the canine has been recognized for a number of 
years, the exact pathophysiology of the condition remains unknown.  Furthermore, 
regardless of advances in diagnostic and surgical techniques and the development of new 
pharmacological therapies, it is still impossible to affect a long term cure for this disease 
due to either diminishing of the surgical effect or a refractory response to pharmacological 
therapy seen over time (Angioletti et al., 2004; Arnold, 1997b; Holt, 1990; Hotston Moore, 
2001; Janszen et al., 1997; Mandigers et al., 2001; Reichler et al., 2006).   
It has been shown that neutering a bitch is directly linked to the development of acquired 
urinary incontinence, and it has also been demonstrated that it is not mechanical damage of 
the urinary tract during this procedure that leads to the development of the disease 
(Gregory, 1994).  Further studies have shown a positive correlation between increasing 
normal adult body weight of a bitch and the development of acquired urinary incontinence, 
as well as between obesity and the development and severity of the disease (Arnold et al., 
1989; Holt et al., 1993); this latter relationship is likely to become more important as the 
number of obese pets in our society rises.  There is also a positive correlation between tail 
docking and the disease, likely due to damage of the nerves that leave the sacral spinal 
cord during the procedure (Holt et al., 1993), although this is likely to play a decreasing 
role now that tail docking for cosmetic reasons has been banned in the United Kingdom 
and elsewhere.   
It has been reported that neutering a bitch leads to a decrease in the resting urethral tone 
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in tone can in turn lead to clinical signs of urinary incontinence as the urethra is no longer 
able to overcome any increases in pressure within the bladder, such as when the animal lies 
down or sneezes (Gregory et al., 1996; Rosin et al., 1981).  Although there is no doubt that 
this decrease in urethral tone has a role to play in the development of acquired urinary 
incontinence in the bitch, it is not a defining characteristic of the disease, as increasing the 
urethral tone will not restore continence in all bitches and some bitches will regain 
continence without an increase in their urethral closure pressure (Reichler et al., 2006).   
As the urethra may, therefore, not be wholly responsible for the development of acquired 
urinary incontinence in the bitch I hypothesized that other factors may be involved.  It has 
long been recognized that acquired urinary incontinence in the bitch is linked to 
gonadectomy and the resultant changes in reproductive hormones that this entails (Holt et 
al., 1993; Thrusfield, 1985).  This is similar to our understanding in those women who 
develop urinary incontinence post menopause (Thom et al., 1998) where the hormone 
status is similar to that of a neutered bitch.  As a known cause of urinary incontinence in 
post-menopausal women is the bladder and the structural and functional changes that can 
take place within it (Abrams et al., 2002; Andersson, 2003; Holroyd-Leduc et al., 2004b; 
Thom et al., 1998), I hypothesized that changes at the level of the bladder, in terms of 
bladder contractility, structure and receptor compliment, may also have a role to play in the 
development of acquired urinary incontinence in the bitch.   
Although there have been no reported urodynamic studies in bitches to determine the exact 
role of the bladder in the overt clinical signs of urinary incontinence, anecdotal evidence 
exists to support a role for this organ.  Whilst the most common presentation of acquired 
urinary incontinence in the bitch is that she unconsciously loses urine whilst asleep 
(Arnold, 1997a), a proportion of owners report that their animal gets very agitated 
immediately before the incontinent episode and may be seen to try and get to their usual 
toileting place, often getting ‘caught short’ before they make it.  This is similar in 
presentation to women who suffer from urge incontinence who find the sudden onset of the 
urge to urinate discomforting and who may not reach a suitable place to urinate before 
unconscious leakage of urine occurs (Holroyd-Leduc et al., 2004a) and therefore suggests 
that the bladder may have a role to play in acquired urinary incontinence in a number of 
bitches. 
The aim of this thesis was therefore to investigate whether functional, structural and 
molecular changes occur within the bladder of a canine post neutering that may lead 
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methods including in vitro tissue bath experiments to determine if neutering altered the 
maximal contractile response and sensitivity of isolated strips of canine detrusor muscle in 
response to both muscarinic and electrical field stimulation in both male and female 
canines.  Males were included as they undergo similar hormonal changes post neutering 
but few develop urinary incontinence.  The studies also included a small number of 
neutered female canines known to be suffering from acquired urinary incontinence.  
Studies then explored the mechanisms that might underlie the changes seen in these initial 
experiments.  This included the pharmacological characterization of the muscarinic 
mediated response of the tissue strips, as well as considering the effects of short-term 
incubation of bladder smooth muscle strips with reproductive hormones.  Further studies 
included morphometric analysis of the canine urinary bladder to determine changes in 
percentage collagen within the bladder post-neutering; whilst the mRNA expression levels 
for the muscarinic receptors and for hormonal receptors within the bladder wall were also 
investigated. 
The initial studies into the effects of neutering on the in vitro responses of canine detrusor 
muscle strips to carbachol and electrical stimulation showed a significant effect of 
neutering on both maximal response and sensitivity of the strips to muscarinic stimulation, 
and the maximal contractile response seen to electrical field stimulation.  The studies 
showed that neutering a canine of either gender resulted in a lower maximal contractility 
and sensitivity of the detrusor muscle strips to both carbachol and electrical field 
stimulation.  It was also shown that the few animals known to suffering from acquired 
urinary incontinence at the time of the study had the lowest maximal contractile response 
of all the animals studied and that there was a positive correlation between the maximal 
contractile response to carbachol and electrical field stimulation in all animals.   This later 
correlation was to be expected as both carbachol and electrical field stimulation are known 
to act via the muscarinic pathway (D'Agostino et al., 1989).  Although the decrease in 
response is seen in both male and female canines it is known that female canines are at 
significantly greater risk of developing urinary incontinence.  This is thought to be due to 
the differences in the anatomy of the lower urinary tract in males compared to female 
canines, as male canines have a significantly longer urethra which passes through the 
penile structures leading to a higher urethral closure pressure which is exerted over a much 
greater length (Dyce et al., 2002) .  This suggests that decreased responses seen in neutered 
animals may be involved in the development of acquired urinary incontinence in the bitch, 
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It is probable that the decreased responses seen in vitro are mimicked in vivo, in which 
case they would be expected to be responsible for lower magnitude contractions of the 
bladder which may be insufficient to empty the bladder fully leading to small residual 
volumes of urine post voiding and the propensity to develop cystitis.  This change in 
contractility post steroid loss is similar to that reported in a subset of women suffering 
from urinary incontinence due to impaired contractility of the bladder (Elbadawi et al., 
1993a; Resnick et al., 1987).  Although many women who suffer from urge incontinence 
may have impaired contractility of the bladder (Resnick et al., 1987), a proportion of these 
women also suffer from detrusor overactivity which has been reported to cause an increase 
in response to carbachol stimulation in vitro (Stevens et al., 2007).  As the canines known 
to be suffering from acquired urinary incontinence in this present study had decreased 
responsiveness it may be that the post-neutering canine bladder is more akin to that of 
women suffering from impaired contractility of the bladder than those with detrusor 
overactivity although, more animals need to be studied before firm conclusions can be 
drawn.   
Although both carbachol and electrical field stimulation are known to act via the 
muscarinic pathway (D'Agostino et al., 1989; Rang et al., 2007) it has been shown in other 
species that part of the response to electrical field stimulation can be mediated via the non-
adrenergic, non-cholinergic system (Andersson et al., 2004).  Further studies in canines 
were therefore conducted to look at the non-adrenergic, non-cholinergic system and to 
determine if this was altered in neutered compared to entire canines.  These studies 
demonstrated that there is a non-adrenergic, non-cholinergic mediated portion to the 
contractile response in the canine, and that the proportion it contributes lies between that of 
the rat and human (Andersson et al., 2004).  The proportion it contributes in the canine 
does not alter significantly between neutered and entire animals; however, there is a trend 
towards neutered animals having a greater non-adrenergic, non-cholinergic component of 
contraction than their entire counterparts.  This trend is similar to that seen in human 
patients suffering from bladder outlet obstruction and detrusor overactivity (Andersson et 
al., 2004b) thus supporting the original hypothesis that stated that gonadectomised animals 
would have a significantly higher proportion of the contractile response mediated by the 
non-adrenergic, non-cholinergic system.  Although this trend may have a minor role to 
play in the decreased contractility of the bladder seen in neutered compared to entire 
canines it is probable that alterations in the muscarinic receptor or receptor/effector 
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As all muscarinic receptor subtypes are expressed in the bladder wall and as it has been 
reported that the functionally important subtype can be altered in disease states (Chess-
Williams, 2002) I then undertook both pharmacological characterization studies to 
determine the muscarinic receptors responsible for the in vitro contraction to carbachol and 
molecular studies to determine the amount of expression of the different muscarinic 
receptor subtype mRNAs within the canine urinary bladder wall.  Pharmacological 
characterization of the muscarinic receptor subtypes using pirenzepine, methoctramine and 
4-DAMP, selective antagonists of the M1, M2 and M3 receptors respectively (Caulfield et 
al., 1998), demonstrated that although the M3 receptor is mainly responsible for bladder 
contraction in entire animals, the M2 receptor appears to dominate in neutered animals.  As 
this is the first study to investigate effects of gonadectomy on the muscarinic subtypes 
mediating bladder contraction it is not known if this finding is unique to the canine or if it 
is repeated in other species.  It has been reported by one group studying micturition in the 
obstructed rat bladder that there is a shift from M3 to M2 in this disease state (Braverman et 
al., 1999; Braverman et al., 2003; Braverman et al., 2006), however, another group 
studying a similar model could find no evidence of M2 receptor involvement (Krichevsky 
et al., 1999), possibly due to differences in experimental techniques and animal numbers.  
This is similar to the picture in humans where one group claimed a role for the M2 receptor 
in patients suffering from neurogenic overactivity of the bladder (Pontari et al., 2004), 
whilst another group concluded that only the M3 receptor was responsible (Stevens et al., 
2007).  These conflicting results may be due to differences in experimental design, low 
patient numbers and individual variation in patients / animals, as well as in disease state.  It 
is therefore plausible that the shift towards the M2 receptor seen in the neutered canines in 
this study may be involved in the decreased bladder contraction seen in vitro and in the 
development of acquired urinary incontinence in the canine.  
It has been demonstrated that the M2 receptor does have a role to play in bladder 
contraction in vitro in some species as shown by the decreased responsiveness of detrusor 
muscle strips to muscarinic stimulation seen in M2 knock-out mice (Stengel et al., 2000).  
This is further supported by a rodent study that identified both the M1 and M2 receptors as 
being involved in bladder contraction (Frazier et al., 2007).  This work is complemented 
by a study in anaesthetized rats that has demonstrated an in vivo role for the M2 receptor in 
mediating bladder contraction (Hegde et al., 1997).  As the contractions mediated by the 
M2 receptor are postulated to be weaker than those mediated by the M3 receptor, at least in 
pigs (Yamanishi et al., 2000), it is possible that the shift from the M2 receptor to the M3 
receptor as seen in neutered canines in this present study is responsible for the decreased 
contractile function seen. Victoria A. Coit, 2008     Chapter 10, 196 
Although a role for the M2 receptor in mediated bladder contraction has been demonstrated 
the exact mechanism by which it affects this response has not been reported.  It has been 
postulated that the M2 receptors may mediate smooth muscle tone under conditions of high 
sympathetic activity (Eglen et al., 1994) whereby the activation of the M2 receptors 
effectively switches off the sympathetic inhibitory mechanisms mediated by the β-
adrenoceptors leading to improved contraction and emptying of the bladder.  This is 
hypothesized to occur via activation of a GTP binding protein associated with inhibition of 
adenylyl cyclase (Braverman et al., 1999; Hegde et al., 1997).  Although specific 
muscarinic receptor subtypes appears to preferentially couple to particular G proteins there 
does now appear to be considerable promiscuity in this coupling mechanism (Tucek et al., 
2002).  This means that depending on the particular cell type and the biochemical state of 
the cell a single subtype of receptor may be able to couple with several different types of G 
protein, meaning that a single receptor could mediate a number of cellular signaling 
pathways to effect differing responses (Tucek et al., 2002; Wang et al., 1995).  
Traditionally the M2 receptor has been thought to couple with the Gi class of GTP binding 
proteins, however it has been shown, in the human bladder, that they can also bind to the 
Gq class of proteins (Wang et al., 1995), the same class of G proteins that the M3 receptor 
classically binds to (Rang et al., 2007).  It therefore follows that differential coupling of the 
M2 receptor to different G proteins may alter its effect on bladder tissue and may allow it 
to assume the role of primary muscarinic receptor responsible for bladder contraction in 
certain disease states, potentially including acquired urinary incontinence in the canine. 
Although, as previously stated, the M3 receptor is considered the primary receptor 
responsible for bladder contraction in healthy individuals it is the M2 receptor which is the 
most numerous muscarinic receptor within the bladder of all species so far studied (Chess-
Williams, 2002).  The results for mRNA expression levels obtained in canines in this study 
are in agreement with this, although the ratio of M2:M3 receptors is slightly lower than 
that of other species studied at 1.5:1, compared to 3:1 in the human and 9:1 in the rat 
(Chess-Williams, 2002).  These differences may reflect inter-species or subject differences 
or variations in protocol and methodology, however, the functional role of the M2 and M3 
receptors in rats and humans appear to be similar and mimic that found for healthy entire 
canines in this study.   
The mRNA expression levels for the M1, M2 and M3 receptors, regardless of gender, were 
shown to be increased in neutered compared to entire canines in this study.  The expression 
levels for the M2 receptor were also shown to be highest in neutered female canines known 
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negative correlation between expression levels of mRNA for the muscarinic receptors and 
maximal contraction of the bladder in vitro to muscarinic stimulation.  Taken with the 
results from the pharmacological characterization of the muscarinic receptors which 
showed a shift towards the M2 receptor in mediating bladder contraction in neutered 
animals these results are significant.  It has been shown in rats suffering from denervation 
of the bladder that the expression of the M2 receptor is enhanced in certain disease states, 
and this model also demonstrated the significant contribution of the M2 receptor in 
mediating bladder contraction (Braverman et al., 1998b).  The increased amount of mRNA 
for the M2 receptor in the canine may therefore be involved in the increased role of the 
receptor in the function of the bladder and, if mimicked by changes in receptor protein, 
may provide the basis for a potential therapeutic target for treating acquired urinary 
incontinence in the bitch. 
Considering the finding of the pharmacological characterization study showing the shift 
from M3 to M2 receptor in neutered canines it may have been predicted that the expression 
levels for the M3 receptor would decrease in the neutered compared to entire canines, 
however the results of this study show the opposite to occur.  This seemingly contradictory 
set of data may be due to a number of factors, including the possibility that the increased 
M3 receptor mRNA is not accompanied by an increase in the M3 receptor protein, possibly 
due to alterations in translation of the gene.  It has been shown in a recent study in rats that 
the mRNA expression and protein levels for this specific receptor may not be correlated 
(Braverman et al., 2006), therefore further studies to investigate protein levels of the 
muscarinic receptors in the canine are warranted.  It is also plausible the increased 
expression of the M3 receptor mRNA seen in neutered canines is a compensatory response 
to the decreased detrusor contractility brought about by an as yet unidentified mechanism 
that may involve the M3 receptor itself. 
As the functional role of the M1 receptor in the canine bladder cannot be established from 
the studies so far conducted the significance of the increased expression levels of mRNA in 
neutered canines cannot be ascertained.  It is known that the M1 receptor is usually found 
on pre-synaptic nerve terminals where it is thought to facilitate neurotransmitter release 
(Braverman et al., 1998a; Somogyi et al., 1999; Somogyi et al., 1994).  If this is the case in 
the canine it is possible that the M1 receptor is up-regulated in neutered canines to facilitate 
transmitter release and thereby increase the contractile force of the bladder, however the 
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Although it has been demonstrated that the primary pathway responsible for bladder 
contraction is the muscarinic pathway, it is possible that changes to other receptors and 
pathways may also modulate bladder contraction, therefore may be involved in the 
decreased contractility of the canine detrusor in vitro seen in neutered animals.  It has been 
a long held hypothesis that changes in the sex hormones of a bitch post neutering lead her 
to develop acquired urinary incontinence (Arnold et al., 1989; Stenberg et al., 1995; Thom 
et al., 1998; Thrusfield, 1985), and a similar hypothesis, involving changes in gonadal 
steroids, has been considered in the development of urinary incontinence in post-
menopausal women (Stenberg et al., 1995; Thom et al., 1998).  Post-menopause and after 
neutering there is a significant decrease in circulating endogenous oestrogen and this has 
been hypothesised to be a causative factor in the development of urinary incontinence in 
both the bitch (Finco et al., 1974) and woman (Freedman, 2002).  This decrease in 
circulating oestrogen following menopause / gonadectomy is also known to interrupt the 
feedback mechanisms that act at the level of the hypothalamus and pituitary gland to 
regulate the secretion of gonadotrophin hormones leading to an increase in the secretion of 
both FSH and LH (Burger, 1996; Olson et al., 1992; Reichler et al., 2004).  It has been 
hypothesized that this increase in gonadotrophins may be partially responsible for the 
development of urinary incontinence in both the canine (Reichler et al., 2004), and woman 
(Tao et al., 1998), and studies have demonstrated the presence of receptors for the 
gonadotrophins in the urinary bladder (Ponglowhapan et al., 2007a; Reichler et al., 2007; 
Tao et al., 1998).  Further support for this indirect effect of steroid removal is provided by 
a recent study in neutered canines suffering from acquired urinary incontinence which 
reported that administration of GnRH analogues, such as to decrease serum LH and FSH 
levels, aided continence (Reichler et al., 2006).  Part of this thesis therefore looked at the 
effect of neutering on the expression levels of mRNA for the FSH, LH and GnRH 
receptors in the canine urinary bladder.  Although another study has reported the FSH 
receptor in the canine bladder (Ponglowhapan et al., 2007b) it was not consistently present 
at detectable levels in this study.  The levels of both GnRH and LH were detectable 
however, and expression levels of mRNA for both of these receptors, relative to β-actin, 
were increased in neutered canines of either gender in this study.  This is in contrast to 
other studies in the canine that showed either no change in these receptors (Reichler et al., 
2005), or a decrease in their expression in neutered bitches (Ponglowhapan et al., 2007a).  
The differences in results between studies may reflect a number of factors including small 
sample size, time from neutering to sampling, differing stages of the oestrus cycle in the 
entire bitches included as controls, as well as technique used.  This present study used real 
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hybridization techniques with formalin fixed, paraffin-embedded tissues which is known to 
allow degradation of target nucleic acids (Goelz et al., 1985; Rupp et al., 1988) and 
artificial mutations to occur (Williams et al., 1999), affecting analysis (Mc Sherry et al., 
2007). 
It is possible that the changes in expression of mRNA for both LH and GnRH receptors 
observed in this present study may be involved in the decreased bladder contractility seen 
in vitro as further analysis showed a negative correlation between increasing mRNA 
expression levels and decreasing contractility.  This hypothesis is supported by the data 
from the neutered female canines known to be suffering from acquired urinary 
incontinence that not only had the lowest contractility but also the highest expression 
levels for both the LH and GnRH receptors.  To investigate this, further studies were 
conducted to determine the effects of short term in vitro incubation with LH, FSH, GnRH 
and oestrogen on the responses of strips of detrusor muscle to muscarinic stimulation.  
These studies could find no significant effect of these hormones on either maximal 
contractile response or sensitivity of the detrusor to muscarinic stimulation.  This may be a 
reflection of the in vivo system, suggesting that although there may be changes in the 
mRNA expression levels for some of these hormone receptors within the bladder these do 
not produce functional changes.  It is also conceivable, however, that functional changes 
within the bladder take considerably longer to develop than the constraints of this study 
allowed, as demonstrated by the fact that the responses of bitches suffering from acquired 
urinary incontinence to hormonal treatment can take weeks to fully develop (Angioletti et 
al., 2004; Reichler et al., 2003).  Furthermore, changes in responsiveness may be 
secondary to alterations in bladder structure or receptor number brought about by chronic 
hormone exposure over a number of weeks or months, thus indicating that prolonged 
exposure in vivo would be required before functional changes are seen in vitro.  This is 
supported by reports that chronic changes in oestrogen concentrations can cause structural 
changes to the urinary bladder in rodents which are thought to contribute to alterations in 
bladder function (Fleischmann et al., 2002). 
The structural changes seen in the urinary bladder in rodents (Fleischmann et al., 2002) are 
also seen in women where they are thought to contribute to urinary incontinence.  In post-
menopausal women suffering from both impaired contractility of the bladder and 
idiopathic detrusor instability there is an increased collagen to smooth muscle ratio 
(Elbadawi et al., 1993a; Elbadawi et al., 1993b) which is hypothesized to alter electrical 
conductivity within the smooth muscle bundles of the bladder and therefore alter the 
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women suffering from impaired contractility of the bladder can have decreased responses 
to muscarinic stimulation in vitro, as reported in this canine study, it was hypothesized that 
similar changes may occur in the bladder of neutered canines.  This was proven to be the 
case in the female canines studied, however, this hypothesis did not hold true for neutered 
male canines that had the same collagen percentage as their entire counterparts.  As this is 
the only reported study looking at collagen percentage within the bladder of 
gonadectomised males of any species, it is not known if the changes seen are particular to 
the canine or if they are representative of the male gender as a whole.  Regardless of this, 
the changes in percentage collagen seen in this study cannot be wholly not responsible for 
the decreased contractility of the canine bladder seen in vitro, as the decreased contractility 
occurs in neutered canines of both genders, whilst the increase in percentage collagen is 
unique to the neutered female.   
This observed increase in collagen within the bladder wall of the neutered female canines 
appeared to occur both within and between the muscle bundles that make up the detrusor 
muscle.  This has the potential to decrease the contractility and elasticity of the detrusor 
and / or affect bladder compliance, in turn affecting the bladder’s ability to relax and 
expand to store urine, a feature of the bladder which has been linked to urinary retention 
and incontinence in the human (Chen et al., 2002).  An increase in percentage collagen has 
also been reported in the wall of the urinary bladder of women with detrusor instability, 
where it is associated with an altered sensory threshold for cholinergic stimulation of the 
bladder (Charlton et al., 1999).  It is also hypothesized that intramuscular collagen 
deposition will decrease conduction of action potentials throughout the muscle fascicle 
(Fleischmann et al., 2002), and thus could have a negative effect on the ability of the 
bladder to respond to stimulation as a single functional unit.  The possibility that the 
observed increases in collagen relative to smooth muscle tissue may predispose a neutered 
bitch to develop acquired urinary incontinence is supported by the data from those animals 
known to be suffering from acquired urinary incontinence that had some of the highest 
percentage collagen but the lowest responses to muscarinic and electrical field stimulation 
of all animals tested.  It is therefore feasible that although the increase in percentage 
collagen cannot be wholly responsible for the decreased contractile function of the bladder 
in neutered canines, it may still be involved, possibly in a synergistic manner, alongside 
other mechanisms such as changes in the muscarinic or purinergic pathways or sex 
hormone receptors.    
The data presented in this thesis together with previously reported investigations of 
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has a multifactorial pathogenesis, with changes occurring in both the urethra and the 
bladder which may contribute to the disease development.  Among the changes seen within 
the bladder of neutered canines of both genders are a decreased maximal contractility and 
sensitivity of the detrusor muscle to muscarinic stimulation in vitro, a functional shift from 
the M3 to the M2 receptor mediating this contraction, and an increase in the expression 
levels of mRNA for the M1, M2 and M3 receptors.  Other changes demonstrated include an 
increase in the expression levels of mRNA for the LH and GnRH receptors, although the 
functional significance of these are unknown as short term incubation of detrusor muscle 
strips with these hormones, as well as FSH and oestrogen, produced no change in 
contractility in vitro.  Finally, increased percentage collagen within the wall of the urinary 
bladder of neutered bitches has been reported and has been inversely correlated with the 
decreased bladder contractility recorded and this relationship has been shown to be 
especially prominent in those animals known to be suffering from acquired urinary 
incontinence. 
Many of these changes are similar to those of women known to be suffering from urinary 
incontinence due to various conditions of the bladder such as the decreased functional 
responses to muscarinic and electrical field stimulation seen in neutered canines in vitro 
which are akin to those seen in women suffering from impaired contractility of the bladder.  
The change towards the M2 receptor in neutered canines is similar to that of women with 
detrusor overactivity and the increase in collagen in neutered bitches is similar to that of 
women suffering from urinary incontinence due to idiopathic detrusor instability with or 
without impaired contractility of the bladder.  In contrast, the increased expression level of 
mRNA for the LH receptor in neutered canines is the opposite of that reported by a study 
in women which found a decrease in LH mRNA levels in post- compared to pre-
menopausal women; although the link between these changes and urinary incontinence in 
either species is not clear.  It is therefore plausible to say that the bladder of the neutered 
bitch and the post menopausal woman share a number of common characteristics, along 
with the propensity to develop urinary incontinence, and therefore further investigation 
into the bladder of the bitch post neutering is warranted both to identify possible 
therapeutic targets for treatment of acquired urinary incontinence in the bitch and to 
confirm the gonadectomised canine is a suitable model to study aspects of post-
menopausal urinary incontinence in the woman. 
There have been many studies looking at the dynamic function of the bladder in the 
woman however none have been reported in the bitch.  Due to the constraints of 
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suffers from similar symptoms to that of incontinent women, such as urgency and partial 
involuntary bladder contractions.  A long term in vivo study observing normal micturition 
and bladder parameters in both healthy bitches before and after neutering, as well as in 
animals known to be suffering from acquired urinary incontinence, would therefore 
enhance our understanding of the processes involved in micturition in normal and 
incontinent animals.  This would also allow us to evaluate the time scale involved in the 
development of bladder and urethral changes post neutering.  This could be achieved via 
the use of telemetry with a transmitter-catheter device placed in bitches a number of 
months prior to neutering, and maintained during and after gonadectomy for a further 
number of months / years.  Using this protocol it would also be possible to hormonally 
treat a number of animals using both oestrogen and GnRH analogues both before and after 
gonadectomy to monitor changes in bladder function brought about by chronic hormone 
therapy.  Ideally bladder tissue from all of the animals involved would also be harvested 
before and after gonadectomy for both in vitro functional studies and molecular 
characterisation.  This would also potentially allow age and breed matched animals to be 
included in the studies, factors that were not possible to control in this thesis due to the 
source of tissues obtained.  Although statistical analysis throughout this thesis did not 
demonstrate an effect of age or weight of the animals, the tissue obtained came from many 
varied and mixed breeds; it would therefore be beneficial to have matched groups to negate 
as much variation as possible. 
Even though this thesis has demonstrated a number of changes post-neutering in the 
bladder of a bitch that may be involved in the development of acquired urinary 
incontinence, the low number of animals positively identified as suffering from the disease 
has made accurate and robust statistical analysis of this group impossible.  Any further 
studies should therefore look to involve a greater number of such animals, a minimum of 6 
animals is required to allow statistical analysis and ideally 10 or more animals to make the 
statistical analysis robust.  One possible way of obtaining tissue from this group of animals 
would be to take small (2cm by 1cm) full-thickness biopsies from the bladder dome at the 
time of other abdominal or bladder surgery.  Although this is unlikely to yield enough 
tissue for extensive tissue bath experiments it would allow molecular studies into mRNA 
expression levels, and possibly into protein expression levels, as well as yield 4-8 strips of 
detrusor muscle for in vitro functional studies. 
The in vitro functional studies so far conducted investigating the muscarinic receptor 
subtype responsible for bladder contractions in the canine have yielded potentially 
significant results and therefore warrant further investigation.  As well as including more Victoria A. Coit, 2008     Chapter 10, 203 
animals in this study, especially those known to be suffering from acquired urinary 
incontinence, additional specific muscarinic antagonists should be utilised.  There is a 
degree of overlap between the specificity and affinity of muscarinic antagonists, therefore 
studying the effects of a greater number of these, especially those that are specific for the 
M2 and M3 receptor subtypes, such as gallamine and darifenacin, would make the study 
more robust. 
Along with the in vitro functional muscarinic receptor studies the in vivo effects of various 
antimuscarinic compounds such as tolterodine and propantholine bromide, which may 
make suitable future treatments for acquired urinary incontinence in the canine, should be 
tested on entire and neutered canines, as well as those known to be suffering from acquired 
urinary incontinence.  This would best be achieved by the use telemetry to monitor bladder 
responses as well as cardiac function, as many antimuscarinic agents may also affect 
cardiac function.  Close monitoring of other body systems and parameters such as tear 
production, salivation and gastric motility would also be advisable to monitor for adverse 
effects of the drugs on other body functions.  Telemetry should be started a number of 
weeks before the agents are administered and continued throughout the treatment period.  
As with the study into the in vivo functional effects of gonadectomy, bladder tissue could 
be harvested at various time points in this study for in vitro pharmacological 
characterisation studies, as well as for molecular studies to monitor any changes in the 
expression levels of mRNA and protein for the muscarinic receptors. 
The mRNA studies undertaken for this thesis have shown significant differences in the 
expression levels of mRNA for some of the muscarinic receptors, as well as for GnRH and 
LH.  As these changes in receptor levels have also been correlated with the decreased 
contractility of the neutered canine bladder in vitro further investigation into the exact 
location of the receptors, their protein expression levels and whether they are co-expressed 
is advised.  Investigation into the receptors so far studied, as well as FSH and oestrogen (α 
and b) has the potential to provide important insights into the pathophysiology of the 
bladder and its role in the development of acquired urinary incontinence and may also 
provide therapeutic targets for effective treatment of this debilitating disease.  
Although the molecular studies investigating the expression levels of mRNA for the 
muscarinic receptors have yielded potentially significant data, the expression levels for the 
receptor proteins remain unknown.  Work on this area was initiated during the course of 
this thesis by The University of Glasgow’s Pathology Department, using commercially 
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immunocytochemistry studies; however the proteins were not detected.  This may be due 
either the experimental conditions or antibodies used.  The antibodies and techniques were 
proven to work in mouse control tissue, therefore operator or technique errors are unlikely.  
To maximise the chance of the antibodies binding the experiments were also conducted 
under a variety of standard and non-standard conditions.  As there is only thought to be 
approximately 90% homology between the sequences for the muscarinic receptor subtypes 
in the canine and the mouse and rabbit, it may be that the antibodies used were not specific 
enough to bind to the canine receptors.  To investigate the protein levels of the muscarinic 
receptor subtypes in the canine bladder it would therefore be necessary to develop canine 
specific antibodies, however this was beyond the budget capabilities and time limitations 
of this thesis.  It may also be possible to employ further techniques to study the protein 
levels of all the receptors so far mentioned, including western blotting and radioligand 
binding, although specific antibodies may again need to be custom designed for some of 
these studies. 
A further area for investigation into the role of the bladder in the development of acquired 
urinary incontinence in the bitch would be to look for the presence and effect of any 
urothelium derived relaxing factor(s) on the contractility of the detrusor muscle.  This 
factor, the exact nature of which is still unknown, has been identified in both human and 
pig bladder, and has the potential to alter the contractile function of the bladder in various 
disease states.  One way in which to study the influence of diffusible factors produced by 
the urothelium on the contraction of the detrusor muscle, in response to both 
pharmacological and electrical stimulation in the canine would be to use both detrusor and 
anococcygeus (control) muscle.  Smooth muscle strips from both muscles would be 
mounted in a classical tissue bath and enveloped in a layer of urothelium, thus allowing 
evaluation of the influence of urothelium-derived relaxing and contracting factors on the 
enclosed smooth muscle strip.  As with all the experiments thus conducted tissue derived 
from male and female, entire and neutered canines as well as those known to be suffering 
from acquired urinary incontinence should be used.   
In conclusion, the results of this thesis have provided invaluable insights into the role of 
the canine urinary bladder in the development of acquired urinary incontinence in the 
bitch, a debilitating and so far incurable condition known to affect up to a fifth of all 
neutered bitches.  This thesis has also established that the bladder of a neutered bitch has 
many similarities to that of a post-menopausal woman.  The studies have demonstrated a 
decrease in the in vitro contractility of the detrusor from neutered canines, and have linked 
this to both gross structural and molecular level changes.  From the information so far Victoria A. Coit, 2008     Chapter 10, 205 
gathered it appears that changes in the muscarinic receptor pathway have a potentially 
significant role to play in the development of acquired urinary incontinence and, as such, 
may prove to yield future therapeutic targets for treatment of this serious disease, 
potentially by drugs such as propantheline bromide and tolterodine.  Further investigation 
is now warranted into both the muscarinic and hormonal receptors of the bladder, as well 
as into further novel mechanisms such as urothelium derived relaxant factors.  These 
further studies would benefit from concurrent in vivo functional investigations to help aid 
our understanding of the pathophysiology and time-course of acquired urinary 
incontinence in the bitch, as well as the inclusion of an increased number of bitches known 
to be suffering from acquired urinary incontinence in all parts of the study.  Finally, this 
thesis verifies that the urinary bladder has a role to play in acquired urinary incontinence in 
the bitch and suggests areas for further investigation that may provide therapeutic targets 
for effective treatment of the disease. 
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